CURRICULUM VITAE
LAMK MOHAMED LAMKI
M.D., FRCPC, FACR, FACNM
TABLE OF CONTENTS
Description
Page
Personal Details
1
Undergraduate Education
2
Post Graduate Training
2
Academic Appointments
4
Hospital Appointments
7
Licensure
9
Certifications
9
PROFESSIONAL ORGANIZATIONS and Committees
9
a) Membership of Professional Organization
b) Officer of Professional Organization
c) Committees and Board of Professional Organization
9
10
10
Honors and Awards
16
Listed In
20
Special Invitations
21
Editorial Positions – Journals
21
Editorial Board Member – Journals
21
PEER REVIEWER
a) Referee For Scientific Journal Manuscripts
b) Book Reviews
22
22
22
SERVICE
a) National Grant Review Panels, NIH Study Sections, Committees
b) Service On Hospital / University Committees
i.
Etobicoke General Hospital Committee, Toronto, Canada
ii.
Central Hospital Committees, Abu Dhabi, UAE
iii.
Victoria Hospital Committees, University Of Western
Ontario, London, Canada
iv.
MD Anderson Cancer Center Committees, University Of
Texas, Houston, Texas
v.
University of Texas – Houston Health Science Center
vi.
University of Texas – Houston Medical School (UTHMS)
vii.
University of Texas Med. School Affiliated Hospital
Committees
viii.
Sultan Qaboos University and Sultan Qaboos University
Hospital
c) Service to Local, State, National, International Medical
23
24
24
24
24
25
25
25
26
26
28
TEACHING
a) Medical Student/Resident/Fellows/Other Teaching
b) Teaching Technology Students
c) Research Mentor and Teaching Clinical Observers
29
29
30
30
GRANT Support
Pending Grants when I left University of Texas
31
39
PUBLICATIONS
a) ORIGINAL Articles in Refereed Journals
b) Invited Articles in Journals
c) Published Abstracts
d) Book Chapters
e) Other Professional Communications
E.1. Oral Presentations from 1990
E.2. Exhibits from 1990
E.3. Invited Lectures
 International
 National
 State
 Local
E.4. Letters to the Editor
E.5. Special Media Coverage
E.6. Conference Facilitator
E.7. Recent Conferences
E.8. Administrative Courses
E.9. Consultancy Services
40
49
50
70
71
71
81
87
87
91
94
95
104
104
105
107
108
108
Updated CV December 2013
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 1
CURRICULUM
VITAE
NAME:
LAMK MOHAMED LAMKI
M.D., FRCPC, FACR, FACNM
PRESENT TITLE:
Advisor to H.E. Vice Chanchellor on Health Affairs
Sultan Qaboos University
Al Khodh, Oman
Professor of Radiology
Department of Radiology and Molecular Imaging
Sultan Qaboos University
Muscat, Oman
Consultant Radiologist (Nuclear)
Department of Radiology and Molecular Imaging
Sultan Qaboos University Hospital
Muscat, Oman
Director of Postgraduate Medical Education
Oman Medical Specialty Board
Sultan Qaboos University Hospital
Muscat, Oman
HOME ADDRESS:
House # 457, Street # 37
P.O. Box 906, P.C. 130,
Athaiba
Muscat, Oman
968-2449-4487 …………….. Residence
968-9927-6800 …………..... Mobile GSM
968-2414-4845 & -4807….…Work Phone
SOCIAL:
Married
3 Children
CITIZENSHIP:
Omani
I.D. # 01300605
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 2
UNDERGRADUATE
EDUCATION:
St. Joseph’s Convent School
Zanzibar, Tanzania
Completed and earned the…….
Cambridge Overseas High School Certificate,
With Distinction, and……
High School Certificate (London University "A" Level)
Pure Mathematics / Physics and Chemistry,
Medical School
Royal College of Surgeons, Dublin, Ireland
M.D, LRCPI, LRCSI, 1960 -1965
ECFMG - USA, 1965
LMCC - Canada, 1967
POST-GRADUATE
TRAINING:
Internship:
Glencove Hospital, Long Island, New York, USA
Rotating Internship
1965-1966
Residency:
1966-1970 at University of Toronto Teaching Hospitals:
Sunnybrook Hospital, University of Toronto
Toronto, Canada
Junior Assistant Resident, Medicine
1966-1967
Senior Assistant Resident, Medicine
St. Michael’s Hospital, University of Toronto
Toronto, Canada
Senior Assistant Resident, Medicine
1967-1968
Sunnybrook Hospital, University of Toronto
Toronto, Canada
Assistant Resident, Biochemistry
July 1968 - December 1968
Sunnybrook Hospital, University of Toronto
Toronto, Canada
Assistant Resident, Pathology
January 1969 - June 1969
Toronto General Hospital, University of Toronto
Toronto, Canada
Assistant “Chief Resident”, Medicine
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 3
July 1969-June 1970
Toronto General Hospital
Toronto General Hospital
Toronto, Canada
Endocrinology Resident
January 1970 - June 1970
Fellowships:
1970-72 at Univ. of Toronto Institutions & at UWO 1980-81:
Banting Institute and Toronto General Hospital
University of Toronto, Toronto, Canada
Medical Research Council Fellow
(Nuclear Medicine & Endocrinology /
Drs. C. Ezrin and S. Murray)
July 1970 - June 1971
Wellesley Hospital, University of Toronto
Toronto, Canada
Medical Research Council Fellow
(Nuclear Medicine & Endocrinology / Dr. R. Volpe)
July 1971 - June 1972
Middlesex Hospital
London, U.K.
Refresher Fellowship in Nuclear Medicine
(Professor Williams and Drs. P. Ell & N. Brow)
March 1978 - April 1978
University of Western Ontario
London, Ontario, Canada
Fellow in Nuclear Medicine
July 1980 - December 1981
Other Postgraduate
Training:
Radioisotope & Nuclear Medicine
Toronto General Hospital, University of Toronto,
Toronto, Canada
Basic Science Advanced Training
Examination Passed for Registry at
Atomic Energy Commission Control Board of Canada 1971
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 4
ACADEMIC APPOINTMENTS:
July 1972-Jan. 1973
Head of Medical Outpatient and Emergency Department
Clinical Institute, The Addiction Research Foundation
Toronto, Canada
Mar. 1972-Oct. 1976
Active Staff
Consultant Internist and Endocrinologist
Etobicoke General Hospital
Toronto, Canada
Nov. 1973-June 1980
Honorary Lecturer
Department of Medicine
University of Toronto, Toronto, Canada
(Part of this time spent on sabbatical to United Arab Emirates.)
Active Staff, Consultant Physician
Wellesley Hospital
Toronto, Canada
Teaching Staff, Endocrinology and Internal Medicine
University of Toronto
Toronto, Canada
Oct. 1975-Oct. 1977
Consultant Physician and Endocrinologist
General Hospital
Abu Dhabi, United Arab Emirates
Nov. 1977-Jan. 1980
Chief Physician
Departments of Internal Medicine and Endocrinology
Al Jazeira Hospital, Abu Dhabi, United Arab Emirates
Nov. 1977-Jan. 1980
Chief Nuclear Physician
Nuclear Medicine Department
Al Jazeira Hospital
Abu Dhabi, United Arab Emirates
Jan. 1980-June 1980
Nuclear Medicine Consultant Physician
Scarborough General Hospital
Department of Nuclear Medicine
Toronto, Canada
Consultant Physician and Endocrinologist
Orthopaedic and Arthritic Hospital
University of Toronto
Toronto, Canada
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 5
July 1980-Dec. 1983
Assistant Professor (Clinical)
Department of Diagnostic Radiology
and Nuclear Medicine
University of Western Ontario
London, Canada
Cross-Appointment, Department of Internal Medicine
and Department of Radiation Oncology
July 1980-Dec. 1983
Active Staff
Department of Nuclear Medicine
Victoria Hospital
London, Canada
July 1981-Dec. 1983
Assistant Chief
Department of Nuclear Medicine
Victoria Hospital
London, Canada
Jan. 1985-2004
Consultant and Attending Staff
Veterans Administration Medical Center (VAMC)
Department of Radiology
Houston, Texas
Nov. 1987-June 1990
Associate Professor of Radiology
The University of Texas-Houston Medical School
and Nuclear Physician
Hermann Hospital
Houston, Texas
Jan. 1984-June 1990
Associate Professor of Medicine (Nuclear Medicine)
and Associate Internist
Division of Diagnostic Imaging
Department of Nuclear Medicine
M.D. Anderson Cancer Center
Houston, Texas
July 1990 – Aug 2004
Professor of Radiology
Chief, Division of Nuclear Medicine
Department of Radiology
The University of Texas-Houston Medical School
Houston, Texas
July 1990-Aug. 2004
Professor of Medicine
Associate Director of Nuclear Cardiology (1990-1993)
Department of Medicine (Cardiology)
The University of Texas-Houston Medical School
Houston, Texas
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 6
July 1990-July 1993
Adjunct Professor of Radiology
Department of Nuclear Medicine
M.D. Anderson Cancer Center
Houston, Texas
Nov. 1990-Oct 2005
Attending Radiologist (Nuclear Medicine)
Harris County Hospital District
Houston, Texas
Nov. 1990 - 2007
Adjunct Professor of Radiology
Baylor College of Medicine
Houston, Texas
Nov. 1991-July 1993
Professor of Nuclear Medicine
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas
July 1993-June 2005
Adjunct Professor of Nuclear Medicine
Division of Diagnostic Imaging
Department of Nuclear Medicine
M.D. Anderson Cancer Center
Houston, Texas
Sept. 2004 – Present
Professor, Department of Radiology and Molecular Imaging
Sultan Qaboos University Hospital
Al Khodh, Oman
Sept. 2004 – 2007
Clinical Professor of Radiology
Department of Nuclear Medicine
The University of Texas-Houston Medical School
Houston, Texas
July 2010 – Present
Director of Post Graduate Medical Education
Oman Medical Specialty Board (OMSB)
For OMSB Residency Programs at SQU
Muscat, Oman
Sept. 2011 – Present
Advisor to H.E. the Vice Chancellor on Health Affairs
Sultan Qaboos University
Muscat, Oman
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 7
HOSPITAL APPOINTMENTS:
1972 - 1973
Head, Medical Outpatient & Emergency Department
Clinical Institute
The Addiction Research Foundation
Toronto, Canada
Mar. 1972-Oct. 1976
Active Staff
Consultant Internist and Endocrinologist
Etobicoke General Hospital
Toronto, Canada
Nov. 1973-June 1980
Active Staff, Consultant Physician
Wellesley Hospital
Toronto, Canada
Clinical Instructor in Endocrinology and Internal Medicine
University of Toronto
Toronto, Canada
(Part of this time spent on sabbatical to United Arab Emirates.)
Nov. 1973-June 1980
Oct. 1975-Oct. 1977
Consultant Physician and Endocrinologist
General Hospital
Abu Dhabi, United Arab Emirates
Nov. 1977-Jan. 1980
Chief Physician
Departments of Internal Medicine and Endocrinology
Al Jazeira Hospital, Abu Dhabi, United Arab Emirates
Nov. 1977-Jan. 1980
Chief Nuclear Physician
Nuclear Medicine Department
Al Jazeira Hospital
Abu Dhabi, United Arab Emirates
1977 - 1980
Head of Nuclear Medicine Department
Al-Jazeira Hospital
Abu Dhabi, United Arab Emirates
(I established the Department in 1977)
Jan. 1980-June 1980
Nuclear Medicine Consultant Physician
Scarborough General Hospital
Department of Nuclear Medicine
Toronto, Canada
Consultant Physician and Endocrinologist
Orthopaedic and Arthritic Hospital
University of Toronto
Toronto, Canada
July 1980-Dec. 1983
Assistant Professor (Clinical)
Department of Diagnostic Radiology
and Nuclear Medicine
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 8
University of Western Ontario
London, Canada
Cross-Appointment in Department of Internal Medicine
and Department of Radiation Oncology
July 1980-Dec. 1983
Active Staff
Department of Nuclear Medicine
Victoria Hospital
London, Canada
Assistant Chief of Department, final two years.
1981-1983
Assistant Chief, Department of Nuclear Medicine
Victoria Hospital, University of Western Ontario
London, Canada
Jan. 1984-June 1990
Associate Professor of Medicine (Nuclear Medicine)
and Associate Internist
Division of Diagnostic Imaging
Department of Nuclear Medicine
M.D. Anderson Cancer Center
Houston, Texas
Jan. 1985-2004
Consultant and Attending Staff
Veterans Administration Medical Center
Department of Radiology
Houston, Texas
1990 - 1993
Associate Director of Nuclear Cardiology
at Hermann Hospital
Department of Medicine
The University of Texas-Houston Medical School
Houston, Texas
1990-2004
Attending Radiologist (Nuclear Medicine)
Harris County Hospital District
Houston, Texas
1990 – 2004
Director, Nuclear Medicine
Lyndon B. Johnson Hospital, Harris County
Houston, Texas
1990 - 2004
Chief, Division of Nuclear Medicine
Department of Radiology, Hermann Hospital
The University of Texas-Houston Medical School
Houston, Texas
2004 – 2011
Head, Department of Radiology and Molecular Imaging
Sultan Qaboos University Hospital
Al Khodh, Oman
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 9
LICENSURE:
1966 - Great Britain and Ireland, GMC,
1967 - Ontario, Canada,
1979 - Texas, U.S.A.,
CERTIFICATION:
F R C P C - 1970
Canada (Internal Medicine)
Fellow of The Royal College of Physicians and Surgeons
of Canada
F R C P C - 1981
Canada (Nuclear Medicine)
Fellow of The Royal College of Physicians and Surgeons of
Canada
DIPLOMATE - 1981 American Board of Nuclear Medicine (ABNM)
FACNM – 1993
Honorary Fellow, American College of Nuclear Medicine
FACR – 1996
Honorary Fellow, American College of Radiology
PROFESSIONAL ORGANIZATIONS (& COMMITTEES THEREOF):
a) MEMBERSHIP of Professional Organizations :
Arab American Medical Association
American College of Nuclear Medicine
American College of Nuclear Physicians
American College of Radiology
Harris County Medical Society
International Association of Radiopharmacology
Royal College of Physicians and Surgeons of Canada
Radiological Society of North America
Society of Nuclear Medicine
Texas Association of Nuclear Physicians
Texas Medical Association
Texas Radiologic Society
Oman Radiology and Molecular Imaging Society
Oman Medical Association
Gulf Nuclear Medicine Association
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 10
b) OFFICER in Professional Organizations:
1988 - 1989
President, Texas Association of Nuclear Physicians
1987 - 1988
Vice-President, Texas Association of Nuclear Physicians
1993 - 1996
Treasurer, Southwestern Chapter of Society of Nuclear Medicine
1994 - 1995
Secretary, Arab American Medical Association, Houston Chapter
1996 - 1997
Vice-President, Southwestern Chapter of Society of Nuclear
Medicine
1996 - 1998
Vice-President, Arab American Medical Association, Houston
Chapter
1997 - 1998
President-Elect, Southwestern Chapter of Society of Nuclear
Medicine
1998 - 1999
President, Southwestern Chapter of Society of Nuclear Medicine
1998 - 1999
President-Elect, Arab American Medical Association, Houston
Chapter
1994 - 1995
Secretary
1998 - 1999
Vice President Elect, American College of Nuclear Medicine
1999 - 2000
Vice President, American College of Nuclear Medicine
1999 - 2000
President, American Arab Medical Association, Houston Chapter
2000 - 2001
President, American College of Nuclear Medicine
c) COMMITTEES & BOARDS of Professional Organizations:
INTERNATIONAL
1977 - 1980
Member, Hospital Board, Al Jazeira Hospital Abu Dhabi, United
Arab Emirates
1978 - 1979
Member, Ministerial Committee to Create “Law on the Use of
Ionizing Radiation” for the United Arab Emirates, U.A.E.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 11
1979
Chairman, Symposium Committee for Ministry of Health of the
United Arab Emirates to Organize international Symposia on
Endocrinology and Nuclear Medicine, Abu Dhabi, United Arab
Emirates
1985
Co-Chairman, 29th Annual Clinical Conference, The University of
Texas System Cancer Center M.D. Anderson Hospital and Tumor
Institute, Houston, TX
1987
Chairman, Technical Exhibits Committee, Society of Nuclear
Medicine/ Southwestern Chapter, Houston, TX
1988
Subchairman, Scientific Program Committee (Oncology), Society of
Nuclear Medicine Annual Meeting, San Francisco, CA
1989
Subchairman, Scientific Program Committee
(Hematology/Oncology), Society of Nuclear Medicine Annual
Meeting, St. Louis, MO
1989 - 1990
Member, Quality Assurance Committee, American College of
Nuclear Physicians
1990
Chairman, Local Arrangements Committee, Society of Nuclear
Medicine/Southwestern Chapter Annual Meeting, Houston, TX
1990 - 1991
Member, Quality Assurance Committee, American College of
Nuclear Physicians
1990 - 1992
Member, Board of Trustees, Southwestern Chapter of The Society of
Nuclear Medicine
1990 - 1993
Member, Scientific Awards Committee, RSNA Annual Assembly,
Chicago, IL
1991
Member, Program Committee, Society of Nuclear
Medicine/Southwestern Chapter Annual Meeting, Oklahoma City,
OK
1991
Reviewer, Scientific Program Committee, Society of Nuclear
Medicine Annual Meeting, Cincinnati, OH, June 1991.
1991 - 1993
Member, Quality Assurance Committee, American College of
Nuclear Physicians
1992
Abstract Reviewer, Scientific Program Committee, Society of
Nuclear Medicine Annual Meeting, Los Angeles, CA, June 11, 1992.
1992
Abstract Reviewer, Program Committee: Fifth Asia and Oceania
Congress in Nuclear Medicine and Biology, October 25-30, 1992.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 12
1994
Subchairman, Scientific Program Committee, “Oncology/Antibody”,
Society of Nuclear Medicine Annual Meeting, Orlando, FL
1995
Member, Program Committee, Southwestern Chapter of The Society
of Nuclear Medicine, San Antonio, TX, March 1995.
1995 - 1996
Member, Ad Hoc Investment Advisement subcommittee,
Southwestern Chapter of The Society of Nuclear Medicine
1995 - 1996
Chairman, Scientific Program, Southwestern Chapter of Society of
Nuclear Medicine Annual Meeting, Austin, TX
1996 - 2004
Advisor, Muslim Health Professional Society (MYPS) for Muslim
Students
1996 - 1997
Member, Education Committee Member, American College of
Nuclear Medicine
1997 - 1998
Chairman, Education Committee Member, American College of
Nuclear Medicine
1997
Reviewer, Scientific Program Subcommittee: “Oncology Therapy”,
Society for Nuclear Medicine Annual Meeting, San Antonio, TX
1997 - 1998
Member, Program Committee, Annual Scientific Meeting American
College of Nuclear Medicine
1998 - 1999
Chairman, Program Committee, Annual Scientific Meeting American
College of Nuclear Medicine
1997 - 1998
Member, Nominations Committee, Society of Nuclear Medicine, The
Society of Nuclear Medicine
1997 - 1998
Member, House of Delegates, Society of Nuclear Medicine
1998 - 1999
Member, Program Committee, Southwestern Chapter of Society of
Nuclear Medicine Annual Meeting for 1999.
1998
Member, Commission on Chapters, Society of Nuclear Medicine,
The Society of Nuclear Medicine 45th Annual Meeting
1998
Co-Chairman, Symposium, "Quality Control at the Worldwide
Level", World Health Organization / International AEA Symposium,
Division of Human Sciences at the Joint Congress of the European
Association of Nuclear Medicine and the World Federation of
Nuclear Medicine and Biology, Berlin, Germany
1999 - 2000
Member, Program Committee, Southwestern Chapter, Society of
Nuclear Medicine Annual Meeting for the year 2000.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 13
1999 - 2003
Member, Diagnostic Radiology Study Section, Center for Scientific
Review, National Institute of Health (NIH).
2000 - 2004
RSNA Nuclear Medicine Subcommittee of the Scientific Exhibits
Committee
2001 - 2004
RSNA Nuclear Medicine Subcommittee of the Education Exhibits
Committee
2001 - 2004
Board of Directors – Board member, American Board of Science In
Nuclear Medicine (ABSNM)
2001 - 2002
Member of Grading & Examination Committee, ABSNM
2002 - 2003
Nominating Committee of American College of Nuclear Medicine
2002 - 2005
Member, Texas Board for Licensing of Professional Medical
Physicists
2003 - 2004
Member of the Syllabus Committee of the American Board of Science
in Nuclear Medicine
NATIONAL
1985
Consultant to establish the Nuclear Medicine Department, Royal
Hospital, Muscat, Oman, 1985, 1986, 1990, 1993.
2005 – Present External Examiner, Radiography Department, Institute of Health
Sciences, Muscat, Oman
2005 – Present Board Member. Institute of Health Sciences, Muscat, Oman.
2006 - Present Chairman, Radiology Scientific Committee. Oman Medical
Specialty Board, Muscat, Oman
2007 - Present Chairman, Accreditation Committee. Oman Medical Specialty
Board, Muscat, Oman
2007 - Present Member, Executive Board. Oman Medical Specialty Board, Muscat,
Oman.
2007 – 2010
Member. Radiology Examination Subcommittee. Oman Medical
Specialty Board, Muscat, Oman.
2007 – Present Member. Radiology Organizing Funding Committee. Oman
Medical Specialty Board, Muscat, Oman.
2007 – 2010
Member. Radiology Internal Review Subcommittee. Oman Medical
Specialty Board, Muscat, Oman.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 14
2007 – Present Member. Committee on Reviewing Private Colleges and
Universities. Ministry of Higher Education, Muscat, Oman.
2007
Chairman. Sub-Committee for Evaluation of Oman Medical
College. Ministry of Higher Education, Muscat, Oman.
2007 – Present Chairman. Private Colleges and Medical Schools Assessment
Committee. Ministry of Higher Education, Muscat, Oman.
2009 - 2011
Chairman. Advanced Training in Nuclear Medicine. Radiology
Residency Program. Oman Medical Specialty Board, Muscat,
Oman.
2009 - Present Chairman, Quality Assurance for Post Graduate Medical Education
Oman Medical Specialty Board, Muscat, Oman
2010 - Present Health Research Expert. The Research Council (TRC) Research
Area Experts for Health Sector. TRC. Muscat, Oman.
2010 – Present Member, TRC Grant Committee for Health Sector, The Research
Council, Muscat, Oman
2010 – Present Member, Education Advisory Committee for Oman Medical
Specialty Board, Muscat, Oman
2011 – Present Member, Liaison Committee. Oman Medical Specialty Board &
Affiliated Training Centers, Muscat, Oman
2011 – Present Member, The Ministry of Health Task Force for Physician
Appointment & Promotion Guidelines, Muscat, Oman
2011 - Present Member, The Ministry Of Health Task Force for PET / Cyclotron
Introduction to Muscat, Oman
UNIVERSITY COMMITTEES
1982
Consultant, Foundation Committee to Begin New Medical School,
Sultan Qaboos University, Muscat, Oman
1999 - 2004
International Advisory Board Member, Sultan Qaboos University
Journal for Scientific Research – Medical Sciences, Sultanate of
Oman
2004 – 2011
Member. College Board. College of Medicine and Health Sciences,
Sultan Qaboos University, Muscat, Oman.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 15
2004 – 2007
Member. College Academic Promotions Committee. College of
Medicine & Health Sciences. Sultan Qaboos University, Muscat,
Oman.
2004 – 2008
Member. Hospital Promotions Committee. Sultan Qaboos
University Hospital, Muscat, Oman.
2004 – 2006
Editor-in-Chief, SQU Journal for Scientific Research: Medical
Sciences
2005 – Present Member. Hospital Board. Sultan Qaboos University Hospital.
2006 – Present
Editor-in-Chief Sultan Qaboos University Medical Journal
(SQUMJ)
2005 – 2006
Member. Sultan Qaboos University Committee on Appeals for
Academic Promotions.
2006 – 2008
Member. Sultan Qaboos University Hospital Promotion and Change
of Status Committee.
2006 - Present Chairman, Medical Advisory Board, Sultan Qaboos University
Hospital, Muscat, Oman
2007
Chairman, Ad hoc Committee on Award of Academic Titles to
Affiliated Staff and Transfer of SQUH Teaching Clinical Staff to
College of Medicine and Health Sciences.
2008
Chairman, College Advisory Board, College Board, College of
Medicine and Health Sciences.
2008
Chairman, Ad hoc Committee on Selection of Distinguished
Researchers and Teachers (Setting of Criteria and Standards).
2008
Member. Committee for "Best Teacher" & "Best Researcher".
College of Medicine and Health Sciences, SQU. Muscat, Oman.
2008 – 2011
Chairman. Committee on Committee Memberships. Sultan Qaboos
University Hospital, Muscat, Oman.
2008 – Present Member. Accreditation and Quality Assurance Committee. College
of Medicine and Health Sciences, SQU, Muscat, Oman.
2008 – 2010
Member. University Academic Promotions Committee. Sultan
Qaboos University, Muscat, Oman.
2008 – Present Member. Staff / Faculty Publication Skills Development. Sultan
Qaboos University, Muscat, Oman.
2008 – 2011
Chairman. Promotions & Change of Status Committee. SQU
Hospital, Muscat, Oman.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 16
2008 – 2011
Chairman. Radiology and Molecular Imaging Departmental Faculty
Recruitment Committee. SQUH, Muscat, Oman.
2008 - 2011
Chairman. Radiology and Molecular Imaging Departmental
Promotions Committee. SQUH, Muscat, Oman.
2011 - Present Chairman. University Academic Promotions Committee (UAPC).
Sultan Qaboos University, Muscat, Oman
2011 – Present Chairman. College of Medicine and Health Sciences and University
Hospital Staff Unification Committee, Sultan Qaboos University,
Muscat, Oman.
2011- Present
Member. Senior Quality Assurance Committee, Sultan Qaboos
University, Muscat Oman
2012 – Present
Chairman. Committee to Standardise the format of All SQU
Journals produced by the Academic Publication Board, SQU
2012- 2013
Chairman, ad hoc SubCommittee on Revised General Criteria for
Promotion of Medical Staff on Clinical Grades and Change of Status
at SQUH, Muscat, Oman
2012 – Present Member. Committee of the Advisors to the Vice Chancellor on
Health Health Affairs at Sultan Qaboos University, Muscat Oman
2013 – Present Member. Committee of Employees Who Left SQU, Sultan Qaboos
University, Muscat, Oman
2013- Present
Member. Decentralization Committee, Sultan Qaboos University,
Muscat, Oman
HONORS AND AWARDS:
1959 - 1965
Medical School Gold Medal in Forensic Medicine
Medical School Gold Medal in Surgery
Medical School Gold Medal in Anatomy
1959 - 1965
Medical School Silver Medal in Surgery
Medical School Silver Medal in Anatomy
1959 - 1965
Medical School Bronze Medal in Basic Sciences
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 17
1988
Editor's Recognition Award for Distinction in Reviewing - Radiology
1989
Editor's Recognition Award with Special Distinction in Reviewing Radiology
1990
Editor's Recognition Award for Distinction in Reviewing - Radiology
1990
Dean's Teaching Excellence Award, The University of TexasHouston Medical School, Texas
1991
Editor's Recognition Award for Distinction in Reviewing - Radiology
1991
Dean's Teaching Excellence Award, The University of TexasHouston Medical School, Texas
1992
Editor's Recognition Award for Distinction in Reviewing - Radiology
1992
Dean's Teaching Excellence Award, The University of TexasHouston Medical School, Texas
1992
Certificate of Appreciation, Scientific Exhibit Award, Society of
Nuclear Medicine 39th Annual Meeting. Brain SPECT Imaging: A
Multimedia Multimodality Interactive Computer Tutorial. Tran HD,
Barron BJ, Lamki LM, Carson GC, Twiford TW, Zuniga EH.
1993
Editor's Recognition Award for Distinction in Reviewing Radiology
1993
Dean's Teaching Excellence Award, The University of TexasHouston Medical School, Texas
1993
Fellow, American College of Nuclear Medicine (FACNM) –
Awarded
1993
Certificate of Appreciation, Scientific Exhibit Award, Society for
Nuclear Medicine 40th Annual Meeting. Spectrum of Laparoscopic
Cholecystectomy Complications on Hepatobiliary Scintigraphy. Tran
HD, Barron BJ, Lamki LM, Guthrie A, Hines M, Banerjee A
1993
Certificate of Merit, Scientific Exhibit Award, Radiological Society
of North America (RSNA) Annual Meeting. Initial Experience with
Ictal Injection of Stabilized Tc-99m Exametazime (HMPAO):
Patterns and Pitfalls. Barron B, Lamki LM, Wheless J, Tran HD,
Curtis V.
1994
Editor's Recognition Award for Distinction in Reviewing Radiology
1995
Editor's Recognition Award for Distinction in Reviewing Radiology
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 18
1995
Best United States Abstract, Oral Presentation Award, Second
International Conference of Nuclear Cardiology, Palais des Festivals,
Cannes, France. Non-Invasive Detection of Cardiac Allograft
Rejection Preliminary Findings Using In Vivo Imaging with
Radiolabeled Monoclonal Antibody to ICAM-1 and MHC Class II
Antigen. McGhie AI, Radovancevic B, Moore W, Capek P, Clubb F,
Cloy M, Kasi L, Lamki L, Frazier OH, Willerson JT.
1995
Certificate of Merit, Scientific Exhibit Award, American Roentgen
Ray Society Annual Meeting. Clinical Utility of Tc-99m-Antibody
(IMMU-4) in the Evaluation of Breast Cancer. Barron BJ, Lamki L,
Pinero S, Ephron V, Bull J.
1995
Honorable Mention, Scientific Exhibit Award, Society of Nuclear
Medicine 42nd Annual Meeting. How to Diagnose and Stage Primary
Breast Cancer with Scintimammography and SPECT: An Interactive
Multimedia Tutorial. Tran HD, Barron BJ, Lamki LM, Pinero S,
Ingram L, Day S, Reich H, Bull J, Holoye P, MacFadyen B, Robins
D.
1996
Editor's Award - Special Distinction in Reviewing - Radiology
1996
Fellow, American College of Radiology (FACR) - Awarded
1997
Editor's Recognition Award for Distinction in Reviewing Radiology
1997
"RSNA On-the-Air" Radio Interview Selection Award. L. Lamki,
Interviewee. 83rd Scientific Assembly and Annual Meeting of the
Radiological Society of North America (RSNA). Effect of Isradipine
on Brain Perfusion Alterations Induced by Intravenous Cocaine:
Measured by Brain Perfusion Index (BPI) and Quantitative SPECT
for Regional Cerebral Perfusion. Barron B, Johnson B, Lamki LM,
Wagner LK, Fang B, Wells LT, Abramson D, Simms KP, Overton D.
Category I Scientific Exhibit. 83rd Scientific Assembly and Annual
Meeting of the Radiological Society of North America (RSNA).
Evaluation of a Comprehensive CQI Program for Radiologists in a
Changing Healthcare Environment--A Story Book. Lamki L, Raval
B, Goldman S.
1997
1997
Outstanding Achievement in Research, Faculty Honors
Convocation Award, The University of Texas-Houston Medical
School, Texas.
1997
Nationally Recognized Honors in Clinical Service, Faculty Honors
Convocation Award, The University of Texas-Houston Medical
School, Texas.
1997-1998
RSNA 1997 CD-ROM Project for Scientific Exhibits Award. 83rd
Scientific Assembly and Annual Meeting of the Radiological Society
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 19
of North America. Improvement in Turnaround Time for the
Radiology Report in a Teaching Hospital. Lamki L, Raval B,
Goldman S.
1998
"Meet the Author" Poster Session Award. The Society of Nuclear
Medicine 45th Annual Meeting. Predictive Value of Gallbladder
Ejection Fraction in the Outcome of Cholecystectomy for Chronic
Biliary Dysfunction: A Follow-Up Study and Comparison with
Pathology Findings. Barron B, Rachal L, Lamki L, Nisbet R,
Stroehlein K, Ephron.
1998
Meet the Author" Poster Session Award. The Society of Nuclear
Medicine 45th Annual Meeting. Tc-99m-LL2 (Monoclonal Antibody
Against Raji Cells) in Evaluation of Patients with B-Cell Lymphoma:
Comparison of Uptake with Histology Findings and Flow Cytometry
Results. Barron B, Lamki L, Stroehlein K, Tamm E, Bull J, Holoye
P, Fang B, Requenez E, Ephron V.
1998
Recognition Award for Reviewing with “Distinction”, Radiology
1999
Outstanding Achievements in Research Award – The University of
Texas-Houston Medical School.
1999
Dean’s Excellence Award – The University of Texas-Houston
Medical School.
1999
Certificate of Award, Society of Nuclear Medicine 46th Annual
Meeting in Los Angeles, CA, June, 1999.
1999
Editor’s Recognition Award for Reviewing with “Distinction”,
Radiology
2000
Nationally Recognized Honors in Research -The University of TexasHouston Health Science Center.
2000
Outstanding Achievements in Research – The University of TexasHouston Medical School. Faculty Honours Day
2000
Outstanding Achievements in Community Service – The University
of Texas-Houston Medical School Faculty Honours Day.
2000
Scientific Exhibit Award, Certificate of Merit: Radiation
Synovectomy in Hemophiliac Patients. A How-to Instructional
Guide with Digital Video Demonstrations. The Radiological Society
of North America 86th Assembly and Annual Meeting, Chicago, IL.,
November, 2000.
2000
Scientific Exhibit Award, Certificate of Merit: Evaluating Cystic
Lung Lesions in Childhood. The Radiological Society of North
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 20
America 86th Assembly and Annual Meeting, Chicago, IL.
November, 2000.
2000
Scientific Exhibit Award, Excellence in Design: Radiation
Synovectomy in Hemophiliac Patients: A How-to Instructional
Guide with Digital Video Demonstrations. The Radiological Society
of North America 86th Assembly and Annual Meeting, Chicago, IL
November, 2000.
2000
Scientific Exhibit Award, Excellence in Design: Radionuclide
Venography as an Adjunct to Ventilation-Perfusion Lung
Scintigraphy in the Detection of Pulmonary Thromboembolic
Disease. The Radiological Society of North America 86th Assembly
and Annual Meeting, Chicago, IL November, 2000.
2001
Outstanding Achievement Award – The University of TexasHouston Medical School Convocation Day, 2001 – Houston, Texas
2002
Appointment by Governor of Texas to Texas Board for Licensing of
Professional Medical Physicists - 4 year appointment.
2002
“TEACHER OF THE YEAR” Award, Department of Radiology,
University of Texas-Houston Medical School – Houston, Texas.
2003
“SpaceCity Houston”, Honored as Ambassador to Houston –
Affiliation and as former President with the American College of
Nuclear Medicine.
2003
Scientific Exhibit Award, Certificate of Merit: Pitfalls in Skeletal
Muscle Uptake on F-18 FDG PET Imaging. The Roentgen Ray
Society Meeting. San Diego, CA, 2003.
LISTED IN:
1)
The Best Doctors in America: Central Region (2nd Edition),
1996-1997 (S. Naifey and G.W. Smith, editors)
Woodward/White, Inc., 1996.
2)
The Best Doctors in America: Central Region (2nd Edition),
1997-1998 (S. Naifey and G.W. Smith, editors)
Woodward/White, Inc., 1997.
3)
Who's Who in Medicine and Healthcare, published by
Marquis Who's Who, New Providence, NJ, 1998.
4)
Houston's Top Doctors of Houston Magazine, October 1998
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 21
SPECIAL INVITATION:
Categorical Seminar VI Faculty: “Monoclonal Antibody Imaging
and Therapy - Technetium-Based Agents”, Society of Nuclear
Medicine Annual Meeting, Cincinnati, OH
1991
EDITORIAL POSITIONS -- JOURNALS:
1978 - 1979
Member/Editorial Committee, Emirates Medical Journal
9/86 - 12/89
Assistant Editor, Journal of Nuclear Medicine
9/84 - 8/86
Associate Editor, Journal of Nuclear Medicine
1999 - 2003
Associate Editor (for Nuclear Medicine), Radiology
2004 – 2006
Editor-in-Chief, SQU Journal for Scientific Research:
Medical Sciences
2006 – Present
Editor-in-Chief, Sultan Qaboos University Medical Journal
(SQUMJ)
EDITORIAL BOARD MEMBER – SCIENTIFIC JOURNALS:
1991 - 1997
Editorial Board Member, The International Journal of
Biological Marker
1992 - 2001
Editorial Board Member, Journal of Nuclear Medicine
1997 - 2004
International Advisory Committee, Sultan Qaboos University
Journal for Scientific Research: Medical Sciences
1997 - 2005
Editorial Advisory Panel, (Nuclear Radiology), American
Journal of Roentgenology (AJR)
2005 – Present
Member, Academic Publication Board (APB), Sultan Qaboos
University, Muscat, Oman.
2006 – Present
Chairman, Editorial Board. Sultan Qaboos University
Medical Journal (SQUMJ).
2009 – Present
Member, Editorial Advisory Board. The Gulf Journal of
Oncology
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 22
PEER REVIEWER:
A) Referee For Scientific Journal Manuscripts :
1984 - Present Reviewer, Journal of Nuclear Medicine
1988 - Present Reviewer, Radiology
1989 - Present Reviewer, Head & Neck
1991 - Present Reviewer, New England Journal of Medicine
1992 - Present Reviewer, American Journal of Roentgenology (AJR)
1993 - Present Reviewer, Cancer
1993 - Present Reviewer, Circulation
1995 - Present Reviewer, Clinical Imaging
2007 – Present Reviewer, Medical Principles & Practice – International Journal
of Kuwait University Health Sciences Center.
B) Book Reviews:
1.
Lamki L: Pulmonary Nuclear Medicine - Techniques of Diagnosis of Lung Disease
(Harold L. Atkins, ed). J Nucl Med 26:435-436, 1985.
2.
Lamki L: Atlas of Nuclear Medicine Artifacts and Variants. J Nucl Med
26(12):1505, 1985.
3.
Lamki L: Nuclear Medicine Annual 1987. J Nucl Med 29:731, 1988.
4.
Lamki L: Clinical Radioimmuno imaging (Zachry D. Grossman and Scott F.
Rosebrough, Ph.D., eds). J Nucl Med 30:138, 1989.
5.
Lamki L: Nuclear Medicine Annual 1988 (L.M. Freeman and H.S. Weismann, eds.).
J Nucl Med 30:2064-2065, 1989.
6.
Lamki L: Clinical SPECT Imaging. AJR, in press.
7.
Lamki L: Manual of Nuclear Medicine Imaging AJR (Christopher C. Kuni, Rene P.
duCret, eds), in press.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 23
8.
Lamki, L.: L. Clinical Positron Emission Tomography: Correlation With
Morphological Cross-Sectional Imaging (Gustav K. von Schulthess, ed. Lippincott
Williams & Wilkins, 2000). Amer. Nucl. Roent. 176:74, 2001.
9.
Lamki L.: “Nuclear Hepatology” (G. T. Krishnamurthy, S. Krishnamurthy)
Springer-Verlag Berlin Heidelberg, New York, 2000. J Nucl Med. 42(5):824-825,
2001.
10.
Lamki, L.: Nuclear Medicine, The Requisites 2nd Edition. James H. Thrall, M.D.
and Harvey A. Ziessman, M.D. Mosby St. Louis, Mo. 2001.
11.
Lamk, L: Nuclear Medicine in Tropical and Infectious Diseases. Francisco Jose
Hossri Nogueira Braga Publisher: Kluwer Academic Publisher - Norwell, MA
Published in the J Nucl Med. 2004.
SERVICE:
A) National Grant Review Panels, NIH Study Sections, Committees:
1988
Committee Member, National Cancer Institute (NCI/NIH) Grants
Review Branch (RFA 87-CA-33), National Institutes of Health.
1988
Reviewer, Ad Hoc Committee, Veterans Administration (VA) Merit
Review Board.
1990
Member, Special Review Committee to Review Program Grant
Application 2 PO1 CA 2768-04 for National Cancer Institute /
National Institutes of Health (NCI/NIH)
1990
Consultant Field Reader to Review Grant Application for Office of
Orphan Products Development, Food and Drug Administration (FDA)
1990
Member, Special Review Committee to Review Program Grant
Application 1 PO1 CA 54417-01 for National Cancer Institute /
National Institutes of Health (NCI/NIH)
1992
Member, Special Emphasis Panel for Reviewing and Site Visit for
Program Project #2PO1 CA47997-04, “Biology and Therapy of
Hepatic Metastasis from Colorectal Cancer” for the National Cancer
Institute / National Institutes of Health (NCI/NIH)
1998-1999
Reviewer, National Institutes of Health Center for Scientific
Review, Diagnostic Radiology Study Section, Washington, DC
1999-2003
Member, Diagnostic Radiology Study Section, Center for Scientific
Review, National Institute of Health (NIH), Department of Health
and Human Services
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 24
B) Service On Hospital / University Committees:
i) Etobicoke General Hospital Committees, Toronto, Canada:
1972 - 1975
Member, Audit and Tissue Committee, Etobicoke General
Hospital, Toronto, Canada
1972 - 1975
Member, Pharmacy and Therapeutics Committee, Etobicoke
General Hospital, Toronto, Canada
1972 - 1975
Member, Medical Records Committee, Etobicoke General
Hospital, Toronto, Canada
ii) Central Hospital Committees, Abu Dhabi, U. A. E:
1975 - 1977
Chairman, Medical Records Committee to Establish Medical
Records Dept., Central Hospital, Abu Dhabi, United Arab
Emirates
1977
Chairman, Hospital Committee to Establish Coronary Care
Unit at Central Hospital, Abu Dhabi, United Arab Emirates
1977 - 1978
Chairman, Hospital Committee to Establish Endocrine Clinic,
Al Jazeira Hospital, Abu Dhabi, United Arab Emirates
1977 - 1980
Head of Nuclear Medicine Department, Al-Jazeira Hospital,
Abu Dhabi, United Arab Emirates
(I established the Department in 1977)
iii) Victoria Hospital Committees,
University Of Western Ontario, London, Canada:
1980 - 1983
Member, Medical Audit and Tissue Committee, Victoria
Hospital, University of Western Ontario, London, Canada
1980 - 1983
Member, Isotope Committee, Victoria Hospital, University of
Western Ontario, London, Canada
1981 - 1983
Assistant Chief, Department of Nuclear Medicine, Victoria
Hospital, University of Western Ontario, London, Canada
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 25
iv) M.D. Anderson Cancer Center Committees
University Of Texas Houston, Texas:
1985 - 1989
Member, Transfusion Subcommittee, University of Texas M.D.
Anderson Cancer Center
1985 - 1989
Member, Medical Practice Committee, University of Texas
M.D. Anderson Cancer Center
1985 - 1990
Member, Pharmacy and Therapeutics Committee, University of
Texas M.D. Anderson Cancer Center
1988 - 1990
Member (Alternate), Research Committee, University of Texas
M.D. Anderson Cancer Center
1988 - 1990
Member, Infection Control Committee, University of Texas
M.D. Anderson Cancer Center
1989 - 1990
Chairman, Nuclear Physicians Conduct of Care Committee,
Department of Nuclear Medicine, University of Texas M.D.
Anderson Cancer Center
1989 - 1990
Director, Protocol Research, Department of Nuclear Medicine
University of Texas M.D. Anderson Cancer Center
v) University Of Texas-Houston Health Science Center:
1990 - 1993
Member, Quality of Excellence Committee, The Outpatient
Clinics
1990 - 1993
Senator, Faculty Senate
1990 - 1994
Member, Radiation Safety Committee
1990 - 2000
Member, Committee for the Protection of Human Subjects,
(University of Texas Health Science Center’s IRB)
1991 – 1994
Member, Radioactive Drug Research Committee
1992 - 1993
Member, PDRC (PET) Advisory Board
vi) University Of Texas-Houston Medical School (UTHMS):
1991 - 2004
Committee for Faculty Promotion and Tenure, Department of
Radiology
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 26
1995 - 2000
Member, Medical Student Admissions Committee
The University of Texas-Houston Medical School
1996 - 2004
Member, Department of Radiology (UT) Grant Review
Committee, Department of Radiology
2001 – 2002
Faculty Appointments, Promotions and Tenure Committee
The University of Texas-Houston Medical School
2001 – 2004
Member, Radiation Safety Committee, The University of
Texas-Houston Medical School
vii) University Of Texas Med School Affiliated Hospital Committees:
1990 - 1995
Member, Medical Staff Quality Review Committee, Hermann
Hospital
1990 - 2004
Chairman, Hermann Hospital Radiology Continuous Quality
Improvement Physicians Peer Review Committee, Department
of Radiology
1990 - 2004
Chairman, Hermann Hospital Radiology Continuous Quality
Improvement Medical Technologist/Administrative
Committee, Department of Radiology
1991 - 1993
Member, Radiation Safety Committee, Hermann Hospital
1993 - 1995
Ex-Officio Member, Hermann Hospital Radiation Safety
Committee
1995 - 2004
Chairman, Hermann Hospital Radiology Continuous Quality
Improvement Steering Committee, Department of Radiology
viii) Sultan Qaboos University & Sultan Qaboos University Hospital
2004 – 2011
Member, College Board, College of Medicine and Health
Sciences, Sultan Qaboos University, Oman
2004 – 2011
Member, Accreditation and Quality Assurance Committee,
College Board, College of Medicine and Health Sciences,
Sultan Qaboos University, Oman
2004 – Present
Member, Hospital Board, Sultan Qaboos University Hospital,
Oman
2004 – Dec. 2005
Member, Medical Advisory Committee, Sultan Qaboos
University Hospital, Oman
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 27
Jan 2006 – Present
Chairman, Medical Advisory Committee, Sultan Qaboos
University Hospital, Oman
2013
Chairman, Medical Advisory ad hoc Committee on MAC
Remits, Sultan Qaboos University Hospital, Muscat, Oman
2004 – 2005
Member, Pharmacy & Therapeutics Committee, Sultan
Qaboos University Hospital, Oman
2004 – 2005
Member, Radiation Safety Committee, Sultan
Qaboos University Hospital, Oman
2004 – 2005
Member, Student Performance Committee, Sultan
Qaboos University, Oman
2004 – 2006
Member, Oman Medical Specialty Board (OMSB), Sultan
Qaboos University, Oman
2005 - Present
Chairman, Radiology Scientific Committee, Oman Medical
Specialty Board (OMSB)
2005 – 2006
Chairman, Sultan Qaboos University Committee on Appeals
for Academic Promotions
2004 – Present
Member, Hospital Promotions Committee, Sultan
Qaboos University Hospital, Oman
2006 – 2008
Member, College Academic Promotions Committee, Sultan
Qaboos University, Oman
2008 – 2010
Member. University Academic Promotions Committee. Sultan
Qaboos University, Muscat, Oman
2010 - Present
Member. College Faculty Recruitment Committee. Sultan
Qaboos University, Muscat, Oman
2010 – 2011
Member, College Academic Promotions Committee, Sultan
Qaboos University, Oman
2011 – Present
Chairman. University Academic Promotions Committee.
Sultan Qaboos University, Muscat, Oman
2011 – Present
Member. Higher Quality Committee of Sultan Qaboos
University, Muscat, Oman
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 28
C) Service To Local, State, National, International Medical Community:
1977-1980
Member, Hospital Board, Al Jazeira Hospital Abu Dhabi,
United Arab Emirates
1978-1979
Member, Ministerial Committee to Create “Law on the Use of
Ionizing Radiation” for the United Arab Emirates, U.A.E.
1979
Chairman, Symposium Committee for Ministry of Health of
the United Arab Emirates to Organize international Symposia
on Endocrinology and Nuclear Medicine, Abu Dhabi, United
Arab Emirates
1982
Consultant, Foundation Committee to Begin New Medical
School, Qaboos University, Muscat, Oman
1985
Co-Chairman, 29th Annual Clinical Conference, The
University of Texas System Cancer Center M.D. Anderson
Hospital and Tumor Institute, Houston, TX
1985, 1986
Consultant to establish the Nuclear Medicine Department,
Royal Hospital, Muscat, Oman, 1985, 1986, 1990, 1993.
1986
Consultant to establish the Nuclear Medicine Department,
Royal Hospital, Muscat, Oman
1993
Consultant to establish the Nuclear Medicine Department,
Royal Hospital, Muscat, Oman
1996- 2004
Advisor, Muslim Health Professional Society (MYPS) for
Muslim Students
2005 - Present
Board Member, Institute of Health Sciences, Muscat, Oman
2007 Feb – Present
Member, Committee of Ministry of Higher Education, Oman,
for Reviewing Private Colleges and Universities.
2007 Mar - Present
Chairman, Ministry of Higher Education Subcommittee for
Evaluation of Private Medical Schools in Oman.
2007 Feb – Present
Member, Executive Board of Oman Medical Specialty Board
which is responsible for Post-graduate Med Training in Oman
2007 Mar – Present
Chairman, Accreditation Committee of Oman Medical
Specialty Board (OMSB).
2009 – Present
Chairman, Quality Assurance for Postgraduate Medical
Education of Oman Medical Specialty Board (OMSB)
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 29
2010 – Present
Member, Education Advisory Committee for Oman Medical
Specialty Board (OMSB)
2011 – Present
Member, Liaison Committee for Oman Medical Specialty
Board (OMSB) and Affiliated Training Centers
TEACHING RESPONSIBILITIES:
A) Medical Student/Resident/Fellows/Other Teaching
1978-1979
Tutorials for British MRCP Examination. Candidates in Abu
Dhabi, United Arab Emirates
1973 - 1975
Seminars in Endocrinology for Medical Students. Wellesley
Hospital, Toronto, Canada
1980 - 1984
Family Physicians Nuclear Medicine Refresher Courses.
Victoria Hospital, London, Ontario, Canada, Family Physician
Continuing Education
1989 - 2004
Teach approximately 40 to 60 Radiology Residents and
Fellows annually, University of Texas Medical School.
1989 - 2004
Teach Medical Students (approximately 200) in Radiology
Core Curriculum, The University of Texas-Houston Medical
School
1989 - 2004
Teach Radiology Elective Medical Students (10-12 every 2 or 3
months), University of Texas Medical School
1990 - 1995
Taught Nuclear Cardiology to Cardiology Fellows (2 every
month), The University of Texas-Houston Medical School
1990 - 2004
Nuclear Cardiology Preceptor for Texas State License purposes
in Nuclear Cardiology, The University of Texas-Houston
Medical School and Hermann Hospital, Houston, TX.
1990 - 2004
Develop and Supervise Didactic Lecture Curriculum in Nuclear
Medicine for Radiology Residents, The University of TexasHouston Medical School
1996 May
School of Public Health Graduate Coursework on Quality
Assurance for Masters, Ph.D., and Hospital Administration.
2006 April
Ethics Seminar for Medical Students: Talk on 'Ethical Issues in
Diagnostic Techniques in Rich and Poor Nations'
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 30
2005 – August
2004 – Present
Started Residency Program in Radiology at Sultan Qaboos
University. To Date 18 Residents have graduated with FRCR
(UK), and 39 Residents actively enrolled in the program
Teaching Residents in Radiology, Nuclear Medicine, Quality
Assurance, Peer Review, Critical Appraisal, and Research
Methodology, Plagiarism, Publication of Scientific
Manuscripts.
2005 – Present
Workshop on Publication of Scientific Papers (three to four
times a year) to Faculty Staff of Sultan Qaboos University
under the Dean of Postgraduate Studies and the College of
Agriculture
2010 – Present
Feedback on Scientific presentations to all OMSB Residents
during the Annual OMSB Research Day
B) Teaching Technology Students
1980 - 1983
Nuclear Medicine Technology Student Seminars. London,
Ontario, Canada
1984 - 1998
Didactic Lectures to Technology Students, Houston
Community College Nuclear Medicine Courses
1989 - 2004
Daily supervision and clinical teaching of the Houston
Community College technology students at Hermann Hospital
Department of Radiology, Division of Nuclear Medicine
1990 - 1996
Annual Lectures (2-3) to the St. Luke's Hospital Nuclear
Technologists Training Program
1984 - 2004
Annual Nuclear Medicine Didactic Lectures (3-4 yearly) to
Nuclear Medicine Technologists at The University of Texas
M.D. Anderson Cancer Center, Texas
C) Research Mentor and Teaching Clinical Observers
1990 - 2004
Mentor to Summer and Year-Around Research Scholarship and
Volunteer Student Researchers.
2 - 8 Medical Students, 3 - 8 Pre-Med Summer Research
Students, 2 - 6 High School Summer Research Students, 1-2
International M.D. Students.
1989 - 2004
Mentor to periodic Research Students, Fellows, Volunteers, or
Observers in the Division of Nuclear Medicine. Each from 1-6
months.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 31
1991 - 1996
Nuclear Medicine Mentor to Neurology Clinical Fellows (1-2
annually) from the Department of Neurology, The University of
Texas-Houston Medical School, doing research in
Neurology/Brain SPECT Interphase.
GRANT SUPPORT:
1984 - 1989
Hybritech, Inc.
Clinical research on Indium-111 labeled monoclonal antibodies.
Principal Investigator:
Dr. J.L. Murray.
Principal Investigator for some protocols.
Co-Investigator for other protocols.
Project . . .
CIM1/cim2
Protocol. .
DM87-076 & DM88-072
Amount. .
$100,000 - $150,000 per year
1986 - 1988
Amersham, Inc.
Clinical trials of Strontium-89 (89Sr) therapy in the management of
bone pain from metastatic lesion of prostatic and breast cancer.
Principal Investigator:
T.P. Haynie, M.D.
Co-Principal Investigator: Lamk Lamki, M.D.
Project . . .
NUM1/num6
Protocol. .
NUM86-01
Amount . . $110,400
1987 - 1988
NeoRx Corp.
Clinical research on Tc-99m labeled melanoma monoclonal
antibodies.
Principal Investigator:
J.L. Murray, M.D.
Co-Principal Investigator: Lamk M. Lamki, M.D.
Project . . .
CIM1/cim2
Protocol . .
DM87-013
Amount . . $40,140
1988 - 1989
NeoRx Corp.
Phase II study of Tc-99m labeled anti-small cell lung cancer
monoclonal antibody.
Principal Investigator:
Bonnie Glisson
Co-Principal Investigator: Lamk M. Lamki, M.D.
Project . . .
CIM/cim2
Protocol . .
DM88-18
Amount . . $50,000
1987 - 1989
Cytogen Corp.
Clinical trials of In-111-GYK-DTPA monoclonal antibody B72.3 for
detection of breast cancer.
Principal Investigator: A. Buzdar, M.D.
Co-Principal Investigator: Lamk M. Lamki, M.D.
Project . . .
CIM1/cim2
Protocol . .
DM87-095
Amount . .
$19,800
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 32
1987 - 1989
NIH Grant
Imaging tissue distribution studies of human anti-colorectal
carcinoma monoclonal antibody in patients with localized and
disseminated malignancy.
Principal Investigator:
B. Levine, M.D.
Co-Principal Investigator: Lamk M. Lamki, M.D.
Project . . .
CIM1/cim2
Protocol . .
DM88-076
Amount . . $20,000
1988 - 1989
Cytogen Corp.
Phase I/II trials of intraperitoneal MoAB B72.3-GYK-DTPA 90Y in
patients with ovarian carcinoma.
Principal Investigator:
J. Kavanagh, M.D.
Co-Principal Investigator: Lamk M. Lamki, M.D.
Project . . .
CIM 1/cim2
Protocol . .
DM88-010
Amount . . $24,000
1988 - 1990
NIH Contract
Phase I clinical trials of biological response modifiers: (1)
Monoclonal antibody in combination with interferon or interleukin-2.
(2) Monoclonal antibodies and monoclonal immunoconjugates in
cancer patients.
Principal Investigator:
J.L. Murray, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
NCI-CM-73729-18
Protocol . .
RFP12 & F-RFP
Amount . .
$186,000
1988 - 1990
American-Cyanamid Corporation (Lederle Labs).
131
I-Lym-1 Moab for therapy of diffuse aggressive lymphoma.
Principal Investigator:
Charles LeMaistre, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HEM2/lym1
Protocol . .
DM88-096
Amount . . $310,625
1989 - 1994
NCI Contract NCI-CM-73729-18
Radioimmunoconjugate and Phase I/II Study.
Principal Investigator:
James L. Murray, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
CIM1/cim2
Protocol . .
ID89-020 & ID89-021
Amount . . $2,628,234 (over 5 years)
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 33
1991 - 1992
R.W. Johnson Pharmaceutical Research Institute
Phase III safety and efficacy study of 111-In-RWJ 28299-134[111InDTPA-immune serum globulin, human (Intravenous)] in patients
with suspected inflammation or infection.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS92-054
Protocol . .
RWJ-M3
Amount . . $50,000
1992 - 1993
Amersham HEALTHCARE
Evaluation of the stabilized Tc-99m Exametazime (Ceretec) in the
detection of seizure foci.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-92-178
Protocol . .
MPI 92-02, Pr93-101
Amount . . (Patient billed plus pharmaceuticals
from the company)
1992 - 1995
Amersham HEALTHCARE
Localization of epileptic foci in brain SPECT studies utilizing a
stable formulation of Tc-99m Exametazime (Ceretec).
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-92-178
Protocol . .
MPIU Pr93101v2.3
Amount . . (Patient billed with radiopharmaceuticals
from company) $192,000 additional as
of 3/95
1993 - 1994
NeoRx Corporation
A clinical study to compare imaging of non-small cell lung cancer
with a Technetium-labeled monoclonal antibody produced by
different manufacturers.
Principal Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-058
Protocol . .
9206-HHH, BB-IND #2633
Amount . . $1000 (plus radiopharmaceuticals from
company)
1993 - 1994
NeoRx Corporation
A multicenter clinical study using Technetium-labeled monoclonal
antibody for imaging patients with small cell lung cancer.
Principal Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-051
Protocol . .
9205, BB-IND #2633
Amount . . $3950 (plus radiopharmaceuticals from
Co.)
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 34
1993 - 1994
Immunomedics, Inc.
Evaluation of the safety and efficacy of 99m-Tc-labeled antigranulocyte antibody Fab’ fragment (IMMU-MN3) for the diagnosis
of osteomyelitis in patients with diabetic foot ulcers.
Principal Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-052
Protocol . .
IM-D-MN3-07, IND number BB3579
Amount . . $11,874 (plus radiopharmaceuticals
from company)
1993 – 1997
Immunomedics, Inc.
Evaluation of the safety and efficacy of 99m-Tc-labeled antigranulocyte antibody Fab’ fragment (IMMU-MN3) for the diagnosis
of long bone osteomyelitis.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-067
Protocol . .
IM-D-MN3-08
Amount . . $9800.00 (plus radiopharmaceuticals
from company)
1993 - 1995
Immunomedics, Inc.
Detection of breast carcinoma by diagnostic imaging of
Fab’ fragment of the anti-CEA antibody IMMU-4 labeled with Tc99m.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-027
Protocol . .
1011B, IND number BB-3851
Amount . . $40,989.00
1993 - 1994
DuPont Merck Pharmaceutical Company
Assessment of the clinical value of Neurolite (Tc-99m Bicisate)
imaging in patients with either suspected dementia, epilepsy or
cerebrovascular diseases.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-098
Protocol . .
DuP 198-021
Amount . . $11,200 (plus radiopharmaceuticals)
1993 - 1994
DuPont Merck Pharmaceutical Company
Evaluation of 99m-Tc Bicisate in healthy elderly volunteers and
patients with mild to moderate dementia of the Alzheimer type.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-124
Protocol . .
DuP 198-017
Amount . . $64,233
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 35
1980 - 1994
131-I-Metaiodobenzylguanadine (I-MIBG) sulfate for diagnosis and
localization of pheochromocytomas and neuroblastomas prior to
metastasis.
Principal Investigator (5/91):
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-93-047
(formerly HSC-MS-84-099)
Protocol . .
IND #24,880
Amount . . (Fee for service covered by patient)
1994 – 1999
IMMUNOMEDICS, Inc.
Evaluation of the safety, efficacy, and cost-effectiveness of
LeukoScan-TM (99m-Tc-labeled anti-granulocyte antibody Fab’
fragment - IMMU-MN3) in the detection of acute non-classic
appendicitis.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-94-228
Protocol . .
IM-D-MN3-16
Amount . . ~$140,000.00
(1 more patient will be done)
1993 - 1995
American Heart Association (Texas Affiliate)
Non-Invasive detection of rejection of heterotopic cardiac allografts
using radiolabeled antibodies to MHC antigens and ICAM-1.
Principal Investigator:
A. Iaian McGhie, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-AWC-93-035
Protocol . .
Not applicable
Amount . . $16,320.00 (patient billed)
1993 - 1995
MEDCO Research, Inc.
Phase III Study of 123-I-IPPA as an imaging agent for the assessment
of viable myocardium and the ability to predict functional
improvement following coronary artery bypass surgery.
Principal Investigator:
Iaian McGhie, M.D.
Co-Investigators:
Lamk M. Lamki, M.D.
James Willerson, M.D.
Project . . .
HSC-MS-93-147
Protocol . .
IV-04, IND #39,936
Amount . .
1994 - 1995
DuPont Merck, Inc.
Diagnostic accuracy of Technetium-99m Sestamibi scintigraphic
images in identifying malignant breast lesions in subjects with
mammographically detected non-palpable breast abnormalities.
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project
HSC-MS-94-023
Protocol . .
DuP 843-044
Amount . . $1,500
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 36
1994 - 1995
DuPont Merck, Inc.
Diagnostic accuracy of Tc-99m Sestamibi scintigraphic images in
identifying malignant breast lesions in subjects with breast
abnormalities detected by palpation.
Principal Investigator: Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-94-024
Protocol . .
DuP 843-045
Amount . . $10,500
3/01 – 2/02
Novartis Pharmaceuticals Company
A Phase I, Open-Label, Dose-Escalating Study to Evaluate the
Biological Activity & Pharmacokinetics of PKI166 in Patients With
Advanced Cancers Accessible for Biopsy
Principle Investigator: Lamk M. Lamki, M.D.
Co-Investigator: Bruce J. Barron, M.D.
Project. . . . .HSC-MS-00-090
Protocol . . . .DM99-385
Amount. . . . $600 X 34 scans = $20,400
1994 -1996
IMMUNOMEDICS, Inc.
Detection of CEA-producing carcinoma by diagnostic imaging of
Fab’ fragment of the anti-CEA antibody IMMU-4 labeled with Tc99m.
Principal Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-94-035
Protocol . .
1017A
Amount . . Patient Payment for Service
1994 -1997
NIH/CRC Grant
Epidemiologic, generic and treatment issues in diffuse infiltrating
lymphocytosis syndrome (DILS).
Principal Investigator:
John D. Reveille, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-94-177
Protocol . .
R-5-94-177
Amount . . $60,000 over 5 years
1995 - 1996
Knoll Pharmaceutical Company
Evaluation of the antihypertensive and anti-proteinuric effects of
Verapamil, Trandolapril, and their combination in patients with Type
II diabetes mellitus.
Principal Investigator:
James Gray, M.D.
Principal Investigator/Nuclear: Bruce J. Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-95-049
Protocol . .
TV-43-CP
Amount . . $5,860
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 37
1995 - 1996
Bracco Diagnostics, Inc.
A Phase II clinical investigation of the safety and effectiveness of
99m-Tc-BMS 189121 in the identification of areas of ischemia in the
brain.
Principal Investigator:
Bruce J. Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-94-066
Protocol . .
45,043-3
Amount . .
$40,000
1996 – 2000
Immunomedics, Inc.
The utility of 99mTc-IMMU-LL2 Fab’ SH fragment imaging in the
detection of residual disease after chemotherapy and/or radiotherapy
in patients with intermediate and high grade non-Hodgkin’s
lymphoma.
Principal Investigator:
Lamk M. Lamki, M.D.
Co-Principal Investigator: Bruce J. Barron, M.D.
Project . . .
HSC-MS-96-185
Protocol . .
IM-D-LL2-05
Amount . . $56,000 per study
1996 -1997
Immunomedics, Inc.
The utility of 99mTc-IMMU-LL2 Fab’ SH fragment imaging in the
detection of residual disease after chemotherapy and/or radiotherapy
in patients with intermediate and high grade non-Hodgkin’s
lymphoma.
Principal Investigator:
Lamk M. Lamki, M.D.
Co-Principal Investigator: Bruce J. Barron, M.D.
Project . . .
HSC-MS-96-184
Protocol . .
IM-D-LL2-06
Amount . . $40,000
1995 – 1996
Immunomedics, Inc.
Detection of colorectal carcinoma by multiple diagnostic imaging of
Fab' fragment of the anti-CEA antibody IMMU-4 labeled with Tc99m (CEA-Scan-TM)
Principal Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-95-178
Protocol . .
1018B
Amount
$13,000 plus radiopharmaceuticals
1995 – 1998
Diatech, Inc.
Phase III Clinical Trials Evaluating the Safety and Efficacy of
Technetium Tc-99m P280 in the Detection and Localization of Acute
Venous Thrombosis by Gamma Scintigraphy Compared with
Contrast Venography
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-95-227
Protocol . .
280-21
Amount . . $5,000
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 38
1996 – 1998
Diatech, Inc.
Phase II Clinical Trial Evaluating the Safety and Efficacy of
Technetium Tc-99m P748 in the Detection and Localization of
Pulmonary Embolism by Gamma Scintigraphy - Dose-Ranging
Principal Investigator:
Bruce Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
NSC-MS-95-228
Protocol . .
IND #748-21
Amount . . $27,000 plus cost of arteriogram
1996 - 1998
ATP Advanced Technical Program 1995
SPECT Studies of Cocaine-Dependent Patients
Principal Investigator:
Bankole Johnson, M.D., Ph.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-95-028-4
Protocol . .
IND #
Amount . . $141,531
1996 - 1997
A Study to Evaluate the Pharmacology of Optimark in Patients with
CNS and Liver Pathology
Principal Investigator:
Bruce J. Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-96-087
Protocol . .
1177-95-04.02 (Study #489-H)
Amount . . $94,771.70
1997 - 1998
DuPont Merck Pharmaceutical Company
A Multicenter Trial to Characterize Lesions Which Were Not
Detected by Physical Examination or Mammography but Which
Were Identified by Technetium Tc-99m Sestamibi Scintigraphic
Images of DUP 843-044 and DUP 843-045
Principal Investigator:
Bruce J. Barron, M.D.
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-96-186
Protocol . .
843-048
Amount . . $2,448 (per 4 patients)
1998 – 1999
Palatin International
Atypical Appendicitis and Tc-99m Anti-Granulocyte Antibodies
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HCS-MS-99-266
Protocol . .
Amount . .
$25,000.00
3/00 – 9/00
Palatin International
Leutech – Diabetic Foot and Tc-99m Anti-Granulocyte Antibodies
Co-Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-00-049
Amount . .
$34,500.00
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 39
1999 – 2002
Coulter Pharmaceutical
Radioiodine Labeled Antibody Therapy for Lymphoma
Principal Investigator:
Lamk M. Lamki, M.D.
Project . . .
HSC-MS-98-253
Amount . .
$7,000.00
2000 – 2004
Giliad Sciences, Inc.
Research Study Gilead 903
Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing
Tenofovir Disoproxil Fumarate Administered in Combination With
Lamivudine and Efavirenz Versus Stavudine, Lamivudine, and
Efavirenz;
Principlal Investigator: Ben Barnett;
Co-Investigator: Lamk M. L amki, M.D
2000 – 2004
Pharmacia & Upjohn
Phase III Study of Depot Medroxyprogesterone Acetate Subcutaneous
Injection (SMPA-SC) in Women with Endometriosis in the United
States and Canada 839-FEH-0012-268
Non-UT Study Principal Investigator:: Sandra A. Carson, M.D.
Co-Principal Investigator (UT): Lamk Lamki, M.D., FRCPC
Amount: $5,227.50 for 5 complete subjects (5 scans each) for
performance of DEXA bone mineral density scans and processing and
mailing of data.
PENDING GRANTS WHEN I LEFT UNIV. OF TEXAS:
1.
NIH Proposal for NCI PA: Comparison of diagnostic value of combined NaF (18)
and FDG versus standard FDG PET and MDP Bone Scan Imaging in OncologyRelated PET Imaging.
2.
Immunomedics Prostate Therapy
3.
Immunomedics Hepatocellular CA Therapy
4.
NIH Proposal for Radiologic Evaluation of the Effectiveness of an Alternative
Approach to the Treatment of Breast Cancer with FDG-PET
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 40
PUBLICATIONS:
A.
ORIGINAL ARTICLES in Refereed Journals:
1.
Lamki L: Hyperparathyroidism Nomenclature. Lancet 1:888 (letter), 1969.
2.
Volpe R, Edmonds M, Lamki L, Clarke PV, Row VV: The Pathogenesis of Graves’
Disease: A Disorder of Delayed Hypersensitivity? Mayo Clin Proc 47(11):824-834,
1972.
3.
Lamki L, Row V, Volpe R: Cell-Mediated Immunity in Graves’ Disease and in
Hashimoto’s Thyroiditis as Shown by the Demonstration of Migration Inhibition
Factor (MIF). J Clin Endoc Metab 36(2):358-364, 1973.
4.
Lamki L, Ezrin C, Koven I, Steiner G: L-Thyroxine in the Treatment of Obesity
Without Increase in Loss of Lean Body Mass. Metab 22(4):617-622, 1973.
5.
Munro RE, Lamki L, Row VV, Volpe R: Cell-Mediated Immunity in the
Exophthalmos of Graves’ Disease as Demonstrated by the Migration Inhibition Factor
(MIF) Test. J Clin Endoc Metab 37(2):286-292, 1973.
6.
7.
Edmonds M, Lamki L, Killinger DW, Volpe R: Autoimmune Thyroiditis, Adrenalitis
and Oophoritis. Amer J Med 54(6):782-787, 1973.
Kinare AS, Lamki N, Lamki L, Husain I: Clinico-Pathological, Radiological &
Radionuclide Methods in the Evaluation and Staging of Bilharzial Uropathy. Emirates
Med J 1(1):31-40, 1979.
8.
Lamki L: Prolactin: An Overview. Emirates Med J 1(1):49-53, 1979.
9.
Lamki L, Gatee O, Awadalla I: The Endocrine Pattern of Male Infertility in the UAE
and Response to Bromocriptine. Emirates Med J 1(2):108-114, 1980.
10.
Kazim E, Gatee O, Lamki L, Al Rais S: A Survey of Thyroid Disease in Abu Dhabi.
Emirates Med J 1(2):141-147, 1980.
11.
Lamki L, Shafik M, Lamki N: HIDA Cholescintiscan: A Report of 54 Cases and
Comparison with Conventional Cholangiography. Emirates Med J 1(2):171-176,
1980.
12.
Lamki LM, Lamki N: HIDA and Pseudosplenomegaly in Hydatid Cyst and Amoebic
Abscess of Liver. Clin Nucl Med 6(2):81-84, 1981.
13.
Lamki LM, Lamki N: Radionuclide Studies of Chronic Schistosomal Uropathy.
Radiology 140(2):471-474, 1981. Reprinted in Urol Digest, June 1983, p 10-11.
14.
Boxen I, Lamki L: 67Gallium in the Sac. Clin Nucl Med 6(10):495, 1981.
15.
Sullivan SN, Lamki L, Corcoran P: Inhibition of Gastric Emptying by Enkephalin
Analogue. Lancet 2(8237):86-87, 1981.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 41
16.
Lamki L: A Dichotomy in Hepatic Uptake of 99mTc IDA and 99mTc Colloid. Sem
Nucl Med 12(1):92-94, 1982.
17.
Lamki L, Cohen P, Driedger A: Malignant Pleural Effusion and 99mTc MDP
Accumulation. Clin Nucl Med 7(7):331-333, 1982.
18.
Lamki L, Willis RB: Radionuclide Findings of Pyomyositis. Clin Nucl Med
7(10):465-467, 1982.
19.
Lamki LM, Wyatt JK: Renal Vein Thrombosis as a Cause of Excess Renal
Accumulation of Bone Seeking Agents. Clin Nucl Med 8(6):267-268, 1983.
20.
Lamki L, Holliday R: Gallium Uptake by a Rare Primary Hepatic Malignancy. Clin
Nucl Med 8(3):129-130, 1983.
Lamki L, Sullivan S: A Study of Gastrointestinal Opiate Receptors: The Role of the
Mu Receptor on Gastric Emptying: Concise Communication. J Nucl Med 24(8):689692, 1983.
21.
22.
Sullivan SN, Bloom SR, Adrian TE, Lamki L, McDonald T, Corcoran P: The Effect
of a Synthetic Enkephalin Analogue on Postprandial Gastrointestinal and Pancreatic
Hormone Secretion. Am J Gastroent 78(5):287-290, 1983.
23.
Hogan D, Lamki L, Cape R: Gastric Emptying and Aging. J Clin Exp Gerontol
6:145-152, 1984.
24.
Lamki L: Tc-DMSA Uptake by Metastatic Carcinoma of the Prostate. J Nucl Med
25:733, 1984.
25.
Lamki L: Radionuclide Esophageal Transit (RET) Study: The Effect of Body
Posture. Clin Nucl Med 10(2):108-110, 1985.
26.
Lamki L: Baker’s Cyst, Radionuclide Arthrographic Findings. Clin Nucl Med
10(3):147-152, 1985.
27.
Murray JL, Rosenblum MG, Sobol RE, Bartholomew RM, Plager CE, Haynie TP,
Jahns MG, Glenn HJ, Lamki L, Benjamin RS, Papadopoulos N, Boddie AW, Frincke
JM, David GS, Carlo DJ, Hersh EM: Radioimmunoimaging in Malignant Melanoma
with 111In-Labeled Monoclonal Antibody 96.5. Cancer Res 45(5):2376-2381, 1985.
28.
Lamki L: Bone Scintigraphy: Current Trends and Future Prospects (Editorial). J Nucl
Med 26(3 Part 1):312-314, 1985.
29.
Linton AL, Richmond JM, Clark WF, Lindsay RM, Driedger AA, Lamki LM:
Gallium67 Scintigraphy in the Diagnosis of Acute Renal Disease. Clin Nephrol
24(2):84-87, 1985. Reprinted in "Chapter 12 - The Genitourinary System". In:
Yearbook of Nuclear Medicine 1987 (PB Hoffer, JC Gore, A Gottschalk, D Sostman,
BL Zaret, eds) Mosby Yearbook, Inc., St. Louis, MO. pp. 295-296.
30.
Lamki LM, Spence JD, MacDonald AC, Roulston M: Differential Glomerular
Filtration Rate in Diagnosis of Renovascular Hypertension and Follow-Up of Balloon
Angioplasty. Clin Nucl Med 11(3):188-193, 1986.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 42
31.
Sullivan SN, Lee MG, Bloom SR, Lamki L, Dupre J: Reduction by Morphine of
Human Postprandial Insulin Release is Secondary to Inhibition of Gastrointestinal
Motility. Diabetes 35(3):324-328, 1986.
32.
Wong DG, Spence JD, Lamki L, Freeman D, McDonald JWD: Effect of NonSteroidal Anti-Inflammatory Drugs on Control of Hypertension by Beta-Blockers and
Diuretics. Lancet 1(8488):997-1001, 1986.
33.
Holbert BL, Lamki LM, Holbert JM: Clinical Image - Uptake of Bone Scanning
Agent in Neurofibromatosis. Clin Nucl Med 12:66-67, 1987.
34.
Murray JL, Rosenblum MG, Lamki LM, Glenn HJ, Krizan Z, Hersh EM, Plager CE,
Bartholomew RM, Unger MW, Carlo DJ: Clinical Parameters Related to Optimal
Tumor Localization of Indium-111-Labeled Mouse Antimelanoma Monoclonal
Antibody ZME-018. J Nucl Med 28(1):25-33, 1987.
35.
Murray JL, Rosenblum MG, Lamki L, Haynie TP, Glenn HJ, Plager CE, Unger MW,
Carlo DJ, Hersh EM: Radioimmunoimaging in Malignant Melanoma Patients with
the Use of Indium-111-Labeled Antimelanoma Monoclonal Antibody (ZME-018) to
High-Molecular-Weight Antigen. NCI Monogr, Number 3, 3-9, 1987.
36.
Babaian RJ, Murray JL, Lamki LM, Haynie TP, Hersh, EM, Rosenblum MG, Glenn
HJ, Unger MW, Carlo DJ, von Eschenbach AC: Radioimmunological Imaging of
Metastatic Prostatic Cancer with 111Indium-Labeled Monoclonal Antibody PAY 276.
J Urol 137(3):439-443, 1987.
37.
Schwegel DK, Lamki LM: Scintigraphic Appearance of Extraosseous Uptake of
Technetium-99m MDP Following Liposuction Therapy. Clin Nucl Med 12(7):558,
1987.
38.
Rosenblum MG, Murray JL, Lamki L, David G, Carlo D: Comparative Clinical
Pharmacology of [111In]-Labeled Murine Monoclonal Antibodies. Cancer Chemother
Pharmacol 20(1):41-47, 1987.
Haynie TP, Lamki LM: Nuclear Imaging in Adrenal Medullary Tumors. Cancer Bull
39(6):295-300, 1987.
39.
40.
Rosenblum MG, Lamki LM, Murray JL, Carlo DJ, Gutterman JU: InterferonInduced Changes in Pharmacokinetics and Tumor Uptake of 111In-labeled
Antimelanoma Antibody 96.5 in Melanoma Patients. J Natl Cancer Inst 80(3):160165, 1988.
41.
Patt YZ, Lamki LM, Haynie TP, Unger MW, Rosenblum MG, Shirkhoda A, Murray
JL: Improved Tumor Localization with Increasing Dose of Indium-111-Labeled AntiCarcinoembryonic Antigen Monoclonal Antibody ZCE-025 in Metastatic Colorectal
Cancer. J Clin Oncol 6(8):1220-1230, 1988.
42.
Murray JL, Lamki LM, Shanken LJ, Blake ME, Plager CE, Benjamin RS,
Schweighardt S, Unger MW, Rosenblum MG: Immunospecific Saturable Clearance
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 43
Mechanisms for Indium-111-Labeled Anti-Melanoma Monoclonal Antibody 96.5 in
Humans. Cancer Res 48(15):4417-4422, 1988.
43.
Lamki LM, Murray JL, Rosenblum MG, Patt YZ, Babaian R, Unger MW: Effect of
Unlabeled Monoclonal Antibody (MoAb) on Biodistribution of 111Indium Labeled
MoAb. Nucl Med Commun 9(8):553-564, 1988.
44.
Kumar R, David R, Sayle BA, Lamki LM: Adrenal Scintigraphy. Semin Roentgenol
23(4):243-249, 1988.
45.
Lamki LM, Kasi LP, Haynie TP: Localization of Indium-111 Leukocytes in
Noninfected Neoplasms. J Nucl Med 29(12):1921-1926, 1988.
46.
Salk D, and the Multicenter Study Group: Technetium-Labeled Monoclonal
Antibodies for Imaging Metastatic Melanoma: Results of a Multicenter Clinical
Study. Sem in Oncol 15(6):608-618, 1988.
47.
Frontiera M, Murray JL, Lamki L, Thomas J, Satterlee W, Schmelter R, Rosenblum
MG, Khazaeli MG, Unger MW, Robinson WA, et al.: Sequential Use of Indium-111
Labeled Monoclonal Antibodies 96.5 and ZME-018 Does Not Increase Detection
Sensitivity of Metastatic Melanoma. Clin Nucl Med 14(5):357-366, 1989.
48.
Babaian RJ, Lamki LM: Radioimmunoscintigraphy of Prostate Cancer. Sem Nucl
Med 19(4):309-321, 1989.
49.
Murray JL, Kleinerman ES, Cunningham JE, Tatom JR, Andrejcio K, Lepe-Zuniga J,
Lamki LM, Rosenblum MG, Frost H, Gutterman JU, Fidler IJ, Krakoff IH: Phase I
Trial of Liposomal Muramyl Tripeptide Phosphatidylethanolamine in Cancer Patients.
J Clin Oncol 7(12):1915-1925, 1989.
50.
Patt YZ, Charnsangavej C, Boddie A, Cleary K, Carrasco CH, Soski M, Claghorn L,
Lambert M, Lamki L, G, Mavligit G: Treatment of Hepatocellular Carcinoma with
Hepatic Arterial Floxuridine, Doxorubicin, and Mitomycon C (FUDRAM): Factors
Associated with Long Term Survival. Regional Cancer Treatment 2:98-104, 1989.
51.
Lamki LM, Patt YZ, Rosenblum MG, Shanken LJ, Thompson LB, Schweighardt SA,
Frincke JM, Murray JL: Metastatic Colorectal Cancer: Radioimmunoscintigraphy
with a Stabilized In-111-Labeled F(ab’)2 Fragment of an Anti-CEA Monoclonal
Antibody. Radiology 174(1):147-151, 1990. Reprinted in "Chapter 8 - Oncology". In:
Yearbook of Nuclear Medicine 1991 (PB Hoffer, JC Gore, A Gottschalk, D Sostman,
BL Zaret, IG Zubal, eds) Mosby Yearbook, Inc., St. Louis, MO, 1991. pp. 185-187.
52.
Lamki LM, Zukiwski AA, Shanken LJ, Legha SS, Benjamin RS, Plager CE, Salk
DF, Schroff RW, Murray JL: Radioimaging of Melanoma Using 99mTc-Labeled Fab
Fragment Reactive with a High Molecular Weight Melanoma Antigen. Cancer Res
50(3 Suppl):904s-908s, 1990.
53.
Lamki LM, Haynie TP: The Role of Adrenal Imaging in Surgical Management. J
Surg Oncol 43(3):139-147, 1990.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 44
54.
Hagemeister FB, Fesus SM, Lamki LM, Haynie TP: Role of the Gallium Scan in
Hodgkin’s Disease. Cancer 65(5):1090-1096, 1990. Reprinted in "Chapter 8 Oncology". In: Yearbook of Nuclear Medicine 1991 (PB Hoffer, JC Gore, A
Gottschalk, D Sostman, BL Zaret, IG Zubal, eds) Mosby Yearbook, Inc., St. Louis,
MO. pp. 179-180.
55.
Abdel-Nabi HH, Levine G, Lamki LM, Murray JL, Tauxe WN, Shah AN, Patt YZ,
Doerr RJ, Klein HA, Gona J, Jayakumari G, Rosenblum MG, Unger MJ, Smith LM,
Schweighardt SA, Merchant EB: Detection of Colorectal Carcinoma Metastases with
In-111-Labeled Monoclonal Antibody CCR 086: Results of Multi-Institutional Trial.
Radiology 176(1):117-122, 1990. Reprinted in "Chapter 8 - Oncology". In:
Yearbook of Nuclear Medicine 1992 (PB Hoffer, JC Gore, A Gottschalk, D Sostman,
BL Zaret eds) Mosby Yearbook, Inc., St. Louis, MO. pp. 187-188.
56.
Patt YZ, Lamki LM, Shanken J, Jessup JM, Charnsangavej C, Ajani JJ, Levin B,
Merchant B, Halverson C, Murray JL: Imaging with Indium-111-Labeled
Anticarcinomembryonic Antigen Monoclonal Antibody ZCE-025 CEAkerTM of
Recurrent Colorectal or CEA-Producing Cancer in Patients with Rising Serum
Carcino-Embryonic Antigen Levels and Occult Metastases. J Clin Oncol 8(7):12461254, 1990.
57.
Lamki LM, Haynie TP: Radioisotopic Adrenal Imaging. Postgraduate Surg 2:115123, 1990.
58.
Lamki LM, Haynie TP, Podoloff DA, Kim EE. Quality Assurance in a Nuclear
Medicine Department. Radiology 177(3):609-614, 1990.
59.
Lamki LM, Buzdar AU, Singletary SE, Rosenblum MG, Bhadkamkar VA, Esparza
L, Podoloff DA, Zukiwski A, Hortobagyi GN, Murray JL: Indium-111 Labeled B72.3
Monoclonal Antibody in the Detection and Staging of Breast Cancer: A Phase I
Study. J Nucl Med 32(7):1326-1332, 1991. Reprinted in "Chapter 5 - Oncology". In:
Yearbook of Nuclear Medicine 1993 (PB Hoffer, JC Gore, A Gottschalk, Z Rattner,
BL Zaret, IG Zubal, eds) Mosby Yearbook, Inc., St. Louis, MO. pp 155-156.
60.
Lamki LM, Buzdar AU, Singletary SE, Rosenblum MG, Bhadkamkar V, Esparza L,
Podoloff DA, Zukiwski A, Hortobagyi GN, Murray JL: Indium-111 Labeled B72.3
Monoclonal Antibody in the Detection and Staging of Breast Cancer: A Phase I
Study. J Nucl Med 32(7):1326-1332, 1991. Reprinted in "Chapter 5 - Oncology". In:
Yearbook of Nuclear Medicine 1993 (PB Hoffer, JC Gore, A Gottschalk, Z Rattner,
BL Zaret, IG Zubal, eds) Mosby Yearbook, Inc., St. Louis, MO. pp 155-156.
61.
Mavligit GM, Zukiwski AA, Salem PA, Lamki LM, Wallace S: Regression of
Hepatic Metastases from Gastrointestinal Leiomyosarcoma After Hepatic Arterial
Chemo-embolization. Cancer 68(2):321-323, 1991.
62.
Rosenblum MG, Kavanagh JJ, Burke TW, Warton JT, Cunningham JE, Silva EG,
Thompson L, Cheung L, Lamki L, Murray JL: Clinical Pharmacology, Metabolism
and Tissue Distribution of 90Y-Labeled B72-3 after Intraperitoneal Administration.
JNCI 83(22):1629-1636, 1991.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 45
63.
Abello R, Lamki L: Ga-67 Uptake by Metastatic Carcinoma of the Penis. Clin Nucl
Med 17(1):23-26, 1992.
64.
Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, Barron BJ:
Should Hypertension be Treated After Acute Stroke? A Randomized Controlled Trial
Using Single Photon Emission Computed Tomography. Arch Neurol 50(8):855-862,
1993.
65.
Hanson SK, Grotta JC, Rhoades H, Tran HD, Lamki LM, Barron BJ, Taylor WJ:
Value of Single-Photon Emission-Computed Tomography in Acute Stroke
Therapeutic Trials. Stroke 24(9):1322-1329, 1993. Reprinted in "Chapter 9 - Central
Nervous System". In: Yearbook of Nuclear Medicine 1995 (A Gottschalk, MD
Blafox, JG McAfee, BL Zaret, IG Zubal, Hoffer PB, eds) Mosby Yearbook, Inc., St.
Louis, MO. pp. 254-257.
66.
Patt YZ, Podoloff DA, Curley S, Smith R, Badkhamkar VA, Lamki LM, Jessup
MM, Hohn DC: Monoclonal Antibody Imaging in Patients with Colorectal Cancer
and Increasing Levels of Serum Carcinoembryonic Antigens. Experience with ZCE025 and IMMU-4 Monoclonal Antibodies and Proposed Directions for Clinical
Trials. Cancer 71(12 Suppl):4293-4297, 1993.
67.
Barron BJ, Tran HD, Lamki LM: Scintigraphic Findings of Osteomyelitis After
Intraosseous Infusion in a Child. Clin Nucl Med 19(4):307-308, 1994.
68.
Chen P, Lamki L Raval B: Indium-111 Leukocyte Appearance of Salmonella
Mycotic Aneurysm - A Case Report. Clin Nucl Med 19(7):646-648, 1994.
69.
Barron BJ, Robinson L, Tran HD, Lamki L: Scintigraphic Manifestations of “Sternal
Cupping”: Report of Two Unusual Cases. J Nucl Med 35:1167-1169, 1994.
70.
Brophey M, Lamki L, Barron B, Chen P, Gokaslan A: The Scintigraphic Presentation
of Pott’s Disease. Clin Nucl Med 20(2):191-193, 1995.
71.
Brophey M, Lamki L, Barron B, Shah S: Prominent Small Bowel Gallium Uptake
Associated with Yersinial and Tuberculous Enterocolitis. Clin Nucl Med 20(2):107110, 1995. Reprinted in Postgraduate Radiology, 1995. Reprinted in "Chapter 3 Infection and Inflammation". In: Yearbook of Nuclear Medicine 1996 (A Gottschalk,
MD Blaufox, JG McAfee, F Wackers, IG Zubal, eds) Mosby Yearbook, Inc., St.
Louis, MO. pp. 94-95.
72.
Kasi LP, Lamki LM, Saranti S, Podoloff DA, Freedman RS: Indium-111 Labeled
0Leukocytes in Evaluation of Active Specific Immunotherapy Responses. Intl J
Gynecol Cancer 5:226-232, 1995.
73.
Lamki L: Tissue Characterization in Nuclear Oncology: Its Time Has Come
(editorial; comment). J Nucl Med 36(2):207-210, 1995.
74.
Zeck OF, Fang B, Mullani N, Lamki LM, Gould KL, Ha S, Walsh JW: PET and
SPECT Imaging for Stereotactic Localization. Stereotact Funct Neurosurg 64(1):147154, 1995.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 46
75.
Barron BJ, Robins DB, Lamki LM, Daniels W, Chopra L, Black CT: Intussusception
Secondary to Meckel’s Diverticulum: Detection with Tc-99m-MoAb to Granulocytes
(LeukoScan®). Clin Nucl Med 21(11):834-837, 1996.
76.
Sills C, Villar-Cordova C, Pasteur W, Ramirez A, Lamki L, Barron BJ, Mullani N,
Grotta J: Demonstration of Hypoperfusion Surrounding Intercerebral Hematoma in
Humans, J Stroke Cerebrovas Diseases 6(1):17-24, 1996.
77.
Johnson B, Lamki L, Barron B, Spiga R, Chen R, OverMeish R, Khilnani N: Brain
Blood Flow Abnormalities Associated with Oral Cocaine Use. Iri J Psych Med
14(2):72-73, 1997.
78.
Lamki L, Barron B: What Role, If Any, Does Nuclear Medicine Play in the
Evaluation of Non-Hypertensive Renal Artery Stenosis? Questions and Answers. AJR
168:1615-1616, 1997.
79.
McGhie AI, Radovancevic B, Capek P, Moore WH, Cloy M, Blust JS, Kasi L, Lamki
L, Clubb FJ, Frazier OH, Willerson JT: MHC Class II Antigen Expression in
Rejecting Cardiac Allografts: Detection Using In Vivo Imaging with Radiolabeled
Monoclonal Antibody. Circulation, 96(5, Sept 2):1605-1611, 1997.
80.
N. Mulani, D. Brandon, B. Barron, L. Lamki, L. Gould: The Standard Uptake Value
(SUV). Is It Necessary for Diagnosing Malignant Tissue by F-18-FDG PET?
Clinical Positron Imaging, Volume 1, Number 4, pp. 243-243(1), Autumn 1998.
81.
Barron BJ, Imam S, Lamki L, Redwine MD, Nightingale JA, Kahan B: Augmented
Enterocystoplasty for Neurogenic Bladder Associated with Renal Transplantation:
Appearance on Tc-99m-MAG Renal Transplant Scan, Clin Nucl Med 23(3):156-159,
1998.
82.
Johnson BA, Lamki L, Fang B, Barron B, Wagner L, Wells L, Kenny P, Overton D,
Dhother S, Abramson D, Chen R, Kramer L: Demonstration of Dose-Dependent
Global and Regional Cocaine-Induced Reductions in Brain Blood Flow Using a
Novel Approach to Quantitative Single Photon Emission Tomography.
Neuropsychopharmacology 18(5):377-384, 1998.
83.
Johnson B, Fang B, Barron B, Lamki L, Wagner L, Wells L, Kenny P, Overton D,
Dhother S, Abramson D, Chen YR, Kramer L: Isradipine Prevents Global and
Regional Cocaine-Induced Changes in Brain Blood Flow. Psychopharmacology
136(4):335-341, 1998.
84.
Willerson J, Chen P, Lamki L: A Case of Diarrhea and Positive Octreoscan.
Circulation.
85.
Johnson D, Sandler M, Okabe T, Blumenstein B, Balaban E, Frankel E, Walker B,
Spaulding M, Gona J, Einhorn L, Wellman H, Keppon M, Purnell G, Lamki L,
Glisson B: Monoclonal Antibody Imaging: A New Diagnostic Staging Procedure for
Small Cell Lung Cancer. J Clin Oncology.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 47
86.
Slaton JW, Browne BJ, Lamki LM, Barron BJ, Verani R, Kahan BD: Changes in
99m
Tc-DTPA Perfusion Scans Predict Acute Rejection in Renal Allografts. Clinl Nucl
Med.
87.
Slaton JW, Browne BJ, Lamki LM, Barron BJ, Verani R, Kahan BD: Delayed
Function in Renal Allografts Predicted by Initial 99mTc-MAG3 Clearance Rate,
American Journal of Kidney Diseases.
88.
B. Baron, C. Hanna, A.M. Passalaqua, L. Lamki, W.A. Wegener, D.M. Goldberg:
Rapid Diagnostic Imaging of Acute, Non-classic Appendicits by Leukoscintigraphy
with Sulesomab, a Tc-99m Labeled Antigranulocyte antibody Fab' Fragment.
LeukoScan Appendicitis Clinical Trial Group. Surgery. 1999 Mar; 125(3):288-96
89.
Goldenberg David M., Abdel-Nabi, Hani, Sullivan Cynthia L., Serafini, Aldo, Seldin,
David, et al. Carcinoembryonic Antigen Immunoscintigraphy Complements
Mammography in the Diagnosis of Breast Cancer. Cancer :89(1), 104-115,2000
90.
Lamk, L.M.: Therapy with radionuclies: Clinical acceptance is overdue. Medical
Sciences, sultan Qaboos University (2000), 2, 69-73.
91.
Ambrose, C.G., Gogola G.R., Brennan, M., Barron, B., Lamki, L. The Effects of
Indomethacin and Ibuprofen on Hormone-Deficient Bone Density Loss in an
Ovariectomized Mature Rate Model. Bone Journal.
92.
Reveille, J.D., Aguilar, M.B., Cohen, P.R., Barron, B.J., Lamki, L.M., Williams,
F.M.. The effect of Protease Inhibitors on the presentation of the Diffuse Infiltrative
Lymphocytosis Syndrome (DILS). Arthritis and Rheumatism – 2000.
93.
Goldenberg, D, Abdel-Nabi, H., Sullivan, C., Serafini, A., Seldin,D., Barron, B.L,
Lamki, L., et al: Carcinoembryonic Antigen Immunoscintigraphy Complements
Mammography in the Diagnosis of Breast Carcinoma. CANCER, Jul 1; 89(1):10415. 2000.
94.
Mullani, N., Herbst, R., Abbrussese, J., Charnsangavej, C., Kim, E., Tran, H., Barron,
B., Lamki, L. Antiangiogenic Treatment with Endostatin Results in Uncoupling
Blood Flow and Glucose Metabolism in Human Tumors. Clin Positron Imaging,
2000 Jul; 3(4) 151-.
95.
Gayed, I., Lamki, L.M., Barron, B.J., Elshazly, S.: Technetium-99m Sestamibi
Uptake in a Maxillary Brown Tumor. Clin Nuc Med. Jan; 26(1): 65-7, 2001.
96.
Granato, M., Elshazly, S., Lamki, L., Barron, B.J.: Potential Pitfall in Parathyroid
Sestamibi Imaging from a Cardiac Pacemaker. Clin Nuc Med. Jan; 26 (1) 74-5,
2001.
97.
Radaideh, M.M., Lamki, L.M., Barron, B.J., Elshazly, S.M.: Radionuclide lung
imaging in respiratory decompression sickness: potential role in the diagnosis and
evaluation of hyperbaric therapy. Clin Nucl Med. 2001 Apr; 26(4):320-4.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 48
98.
Mullani, N., Herbst, R., Abbruzzese, J., Barron, B., Lamki, L., Charnsangavej, C.
9:30-9:45. First Pass FDG Measured Blood Flow in Tumors: A Comparison 0-15
Labeled Water Measured Blood Flow. Clin Positron Imaging, 2000 Jul; 2(4) 153-.
99.
Bhosale, P., Barron, B., Lamki, L.: The “SAPHO” syndrome: a case report of a
patient with unusual bone scan findings. Clin Nucl Med. 2001 Jul; 26(7):619-21.
100.
Ambrose, C.G., Gogola G.R., Brennan, M., Barron, B., Lamki, L. The Effects of
Indomethacin and Ibuprofen on Hormone-Deficient Bone Density Loss in an
Ovariectomized Mature Rate Model. Bone Journal.
101.
Gupta, R.G., Barron B., Lamki, L.: Visualizationof the kidneys on Xe-133
ventilation images of a ventilation-perfusion scan. Clin Nucl Med. 2001 Nov;
26(11):973-4.
102.
Joseph, U., Barron, B., Lamki, L.: Rim Sign in Tc-99m Sulfur Colloid Hepatic
Scintigraphy. Clin Nuc. Med, May, 2005
103.
Lamki, L., Barron, B., Ibrahim, S.: Tc-99m-WBC in Diagnosis of Osteomyelitis in
Diabetic Foot Ulcers. Ost. Bone & Joint, 2005
104.
L. Lamki. Ever changing Medical Education and Communication. Message from
the Editor-in-Chief (Editorial). SQU Medical Journal 7(1):1, 2007
105.
L. Lamki. Our Efforts are reflected in our Health. Message from the Editor-in-Chief
(Editorial). SQU Medical Journal 7(2):1, 2007
106.
L. Lamki. Message from the Editor-in-Chief (Editorial): Vaccines and
Vaccinations – The Battle goes on. SQU Medical Journal 7(3):189, 2007.
107.
L. Lamki. Message from the Editor-in-Chief (Editorial):
Change and Human Health. SQU Med J 8(2):125, 2008.
108.
L. Lamki. Message from the Editor-in-Chief (Editorial): The World Financial
Crisis and Human Health. SQU Med J 8(3):259, 2008.
109.
L. Lamki. “Plagiarism and Other Types of Publication Misconduct” (editorial).
SQU Med J 9(1):1, 2009.
110.
L. Lamki. “Peer Review of Physicians' Performance, Is it a necessary quality
assurance activity?” (editorial). SQU Med J 9(2):109, 2009.
111.
L. Lamki. “Evaluation Tools in Postgraduate Medical Education: Do we need
"Made in Oman" tools?”. SQU Med J (9)3:219-223, 2009.
112.
L. Lamki: “Life Loss and Disability from Traffic Accidents: It is Imperative We
All Act Now” (editorial). SQU Med J 10(1):1-5, 2010.
113.
L. Lamki: Stress in Medical Profession and its Roots in Medical School (editorial).
SQU Med J 10(2):156-159, 2010.
Physicians, Climate
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 49
114.
L. Lamki: “UN Millennium Development Goals and Oman, Kudos to Oman on its
40th National Day” (editorial). SQU Med J 10(3):301-305, 2010.
115.
L. Lamki: “Radiation Exposure from Medical Imaging: A Wake-up Call for
Oman!” (editorial). SQU Med J 11(1):1-4, 2011.
116.
L. Lamki: “Complementary and Alternative Medicine: Where do we stand in the
21st century?” (editorial). SQU Med J 11(2):161-164, 2011.
117.
L. Lamki. “Acute Coronary Syndrome, Diabetes, and Hypertension: Oman must
pay more attention to chronic non-communicable diseases” (editorial). SQU Med J
11(3):318-321, 2011.
118.
L. Lamki: “Medical Tourism: Beneficence or maleficence?” (editorial). SQU Med
J 11(4):444-447, 2011.
119.
L. Lamki. “Child Rights: What can we do in Oman?” (editorial). SQU Med J
12(1):1-4, 2012.
120.
L. Lamki. “Deaths from Sickle Cell Disease in Intensive Care Units: Can we do
better?” (editorial). SQU Med J 12(2):133-136, 2012.
121.
L. Lamki. “Dyslexia, Its impact on the individual, Parents and Society” (editorial).
SQU Med J 12 (3): 269-272, 2012.
122.
L. Lamki. “Ethics in Scientific Publication. Plagiarism and other Scientific
Misconduct” (editorial) Oman Medical Journal 28 (6):379-381; 2013
123.
Sulayma Albarwani, Muna Al-Saadoon, Omar Al-Rawas, Saif Al-Yaarubi, Rashid
Al-Abri, Lamk Al-Lamki, Musbah O. Tanira. “Reflections on the Academic
Accreditation of the MD Programme of the College of Medicine & Health Sciences,
Sultan Qaboos University, Oman” (editorial). SQU Med J. 14 (1), 16th Jan 2014
(in press)
B.
INVITED ARTICLES in Peer-Reviewed Journals:
1.
Haynie TP, Lamki LM: Nuclear Imaging in Adrenal Medullary Tumors. Cancer Bull
39:295-300, 1987.
2.
Lamki LM, Kasi LP, Kim EE, Podoloff DA, Haynie TP: Radioimmunoscintigraphy
of Cancer. Cancer Bull 40(3):143-150, 1988.
3.
Podoloff DA, Kim EE, Lamki LM, Haynie TP: Single-Photon Emission Computed
Tomography (SPECT) in Cancer Diagnosis. Cancer Bull 40(3):151-157, 1988.
4.
Kim EE, Tilbury RS, Haynie TP, Podoloff DA, Lamki LM, Dodd GD Jr: Positron
Emission Tomography in Clinical Oncology. Cancer Bull 40(3):158-164, 1988.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 50
5.
Patt YZ, Murray JL, Lamki LM: Indium-111 Anti-Carcinoembryonic Antigen ZCE025 in the Detection of Metastatic Colorectal Cancer. Cancer Bull 40(4):218-221,
1988.
6.
Abello R, Lamki L: Anticuerpos Monoclonales en Otros Tumores. Curso De
Medicina Nuclear Clinica: Departmento de Medicina de la Universitat Autonoma de
Barcelona 1-19, 1990.
7.
Lamki LM: Radioimmunoscintigraphy of Cancer: Problems, Pitfalls and Prospects.
Nucl Med Annual 113-150, 1990.
8.
Kim E, Lamki LM, Podoloff D, Yang D: RSNA 91 Meeting Notes: Nuclear
Medicine. Radiology 182:609-610, 1992.
9.
Kim E, Lamki L, Podoloff D: RSNA 92 Meeting Notes in Nuclear Medicine.
Radiology 186:612-613, 1993.
10.
Kim EE, Lamki L, Podoloff DA, Wong F: RSNA 93 Meeting Notes in Nuclear
Medicine. Radiology 190(2):616-617, 1994.
11.
Kim EE, Lamki LM, Podoloff DA, Yang DJ: RSNA 94 Meeting Notes: Nuclear
Medicine. Radiology 194(2):606-608, 1995.
12.
Kim EE, Lamki LM, Podoloff DA, Yang DJ: RSNA 95 Meeting Notes: Nuclear
Medicine. Radiology 198(2):614-616, 1996.
13.
Lamki LM: Positron Emission Tomography (PET) in Oncology: General Acceptance
of Its Role is Overdue. Cancer 78(10):2039-2042, 1996. (Invited Editorial)
14.
Lamki LM: Positron Emission Tomography, Bronchogenic Carcinoma, and the
Adrenals: A Commentary. AJR, 168:1361-1362, 1997. (Invited Commentary)
15.
Lamki L, Barron B: Questions and Answers: What Role, If Any, Does Nuclear
Medicine Play in the Evaluation of Non-Hypertensive Renal Artery Stenosis? AJR
168:1615-1616, 1997 (Invited Commentary).
16.
Oldham SA, Barron B, Munden RF, Lamki N, Lamki L: The Radiology of the
Thoracic Manifestations of AIDS. Critical Reviews in Diagnostic Imaging 39(4):259338, 1998 (Invited Review Article).
C.
PUBLISHED Abstracts From Refereed Conference Presentations:
1.
Lamki L, Ezrin C, Steiner G: Lean Body Mass Loss During Dieting and Thyroxine
Treatment as Diagnosed by K40 Whole Body Counting and Nitrogen Excretion.
Canadian Diabetic Association Abstr, Vol 1, 1971.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 51
2.
Lamki L, Ezrin C, Koven I, Steiner G: Thyroxine (L-T4) In the Treatment of Obesity
with No increase in Loss of Lean Body Mass (LBM). Clin Res 19:793, 1971.
3.
Lamki L, Ezrin C, Murray S: Unimpaired Thyroidal 131I-TSH Binding in Graves’
Disease. Amer Thyroid Association Abstr, 1:37, 1971.
4.
Lamki L, Row V, Volpe R: Migration Inhibition Factor (MIF) in Graves’ disease and
Hashimoto’s Struma. Proc IV Intl Congr Endo, 1:194, 1972.
5.
Lamki L: The Bone Scan in Orthopaedics. Proc Ortho Gulf Conf/Abu Dhabi, Vol. 1,
1978.
6.
Lamki L: 99mTc DMSA Scan and DTPA Renogram in Obstruction. Proc NephroUrol Symp/Abu Dhabi Vol. 1, 1979.
7.
Lamki L: Comparison of 131I-Hippuran and 99mTc-DTPA Renograms. Proc NephroUrol Symp/Abu Dhabi, Vol. 1, 1979.
8.
Kazim W, Gatee O, Lamki L: Survey of Thyroid Disease in Abu Dhabi. Proc Symp
Endo Dis - Tropics, Vol. 1, 1979.
9.
Lamki L, Shafik M, Lamki N: HIDA in Gallbladder Disease. Emirates Med J
2(S):20, 1980.
10.
Lamki L: HIDA in Pseudosplenomegaly. Emirates Med J 2(S):20, 1980.
11.
Lamki L, Gatee O, Awadalla I: Pattern of Male Infertility in the U.A.E. and
Response to Bromoscriptine. Emirates Med J 2(S):14, 1980.
12.
Lamki L, Lamki N: HIDA in Diagnosis of Pseudosplenomegaly. Proc Can Assn
Rad/CANM/CAP 1:216, 1980.
13.
Lamki L, Lamki N: Radioisotope Study of Chronic Bilharzial Uropathy. Proc Can
Assn Rad/CANM/CAP 1:223, 1980.
14.
Lamki LM, Driedger AA, Linton AL, Clark WF, Turnbull DI, Lindsay RM: Renal
Uptake of 67Gallium in Drug-Induced Interstitial Nephritis and Other Causes of Acute
Renal Failure. Am J Roentgenol 136:451, 1981.
15.
Vestrup J, Lamki L, Sibbald W, Driedger AA: Skeletal Muscle Imaging with 99mTc
Pyrophosphate. Proc Can Assn Rad/CANM/CAP 1:169, 1981.
16.
Lamki L: Nuclear Medicine in Assessment of Acute Renal Failure. Proc Can Assn
Rad/CANM/CAP 1:177, 1981.
17.
Driedger AA, Vestrup J, Sibbald, WJ, Lamki L: Radionuclide Angiography and
Blood Pool Imaging in Determination of Brain Death. Proc Can Assn
Rad/CANM/CAP 1:185, 1981.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 52
18.
Lamki L, Sullivan SN, Corcoran P: The Effect of a Synthetic Enkephalin Analogue
on Gastric Emptying Time as Studied by Radionuclide Method. SNM EGL Abs 1:1213, 1981.
19.
Lamki L, Sullivan SN: The Use of Gastric Emptying in the Study of Specific Opiate
Receptors of the Gastrointestinal Tract (GIT). SNM EGL Abs Vol. 1, 1982.
20.
Sullivan SN, Lamki L, Bloom SR: The Effects of an Enkephalin Analog on Gastric
Function and the Secretion of Gastrointestinal Hormones. Annales of Royal College
of Phys and Surg Clinicians 15(4):291, 1982.
21.
Lamki L, Spence JD, MacDonald AC, Roulston M: Differential Renal Function in
Diagnosis of Renovascular Hypertension and Follow-Up of Balloon Angioplasty. J
Nucl Med 24:129-130, 1983.
22.
Lamki L, Spence JD, MacDonald AC, Roulston M: Differential Glomerular
Filtration Rate (Diff GPR) in Renovascular Hypertension Diagnosis and Follow-Up
of Balloon Angioplasty. Annales CRMCC 16(4):364, 1983 (Abs. #232).
23.
Lamki L, Driedger AA: Aerosol Ventilation Scintigraphy (VS) in Spontaneously
Breathing and Mechanically Ventilated Patients. Annales CRMCC 16(4):366, 1983
(Abs. #238).
24.
Lee M, Sullivan S, Lamki L, Dupre J: Ophoid Regulation of Insulin Secretion?
Victoria Hospital Res Bull, Vol. 1, 1993.
25.
Spence JD, Wong DG, Lamki L: MK-421 is a New Angiotesin Converting Enzyme
Inhibitor Which Was Designed to Avoid the Adverse Effects of Captopril, by
Omitting the Sulfhydryl Group. Clin and Invest Med 6(2):36, 1983.
26.
Wong DG, Spence JD, McDonald JWD, Lamki L: Non-steroidal Anti-Inflammatory
Drugs (NSAID) Vs. Placebo in Hypertension Treated with Diuretic and Beta-Blocker.
Amer Soc for Clin Pharm Therapy Abs, Vol. 1, 1983.
27.
Kim EE, Haynie TP, Wright KC, Charnsangavej C, Gianturco C, Lamki L, Wallace
S: Pulsatile Versus Steady Infusions for Hepatic Artery Chemotherapy. J Nucl Med
25:41, 1984.
28.
Ewer MS, Ali MK, Chawla SP, Carrasco CH, Lamki L, Mackay B, Balakrishnan PV,
Johnston DA, Benjamin RS: A Comparison of Resting and Exercise Ejection
Fractions with Cardiac Biopsy Grades in Patients Receiving Adriamycin. Proc of Am
Soc of Clin Oncol 4:27, 1985 (Abs. #C-101).
29.
Lamki L, Haynie TP, Murray JL, Rosenblum M, Glenn H, Jahns M, Hersh EM: NonTumor Distribution of ZME-018 Anti-Melanoma Monoclonal Antibody Compared to
Anti-P97 in Melanoma Patients. J Nucl Med 26(P):112, 1985.
30.
Murray JL, Lamki L, Haynie TP, Glenn HJ, Hersh EM: Comparison of Two
Radionuclide Doses in Melanoma Imaging with Anti-P97 Monoclonal Antibody. J
Nucl Med 26(P):113, 1985.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 53
31.
Murray JL, Rosenblum M, Lamki L, Haynie TP, Glenn HJ, Jahns M, Plager C, Hersh
EM, Unger MW, Carlo DJ: Radio-Imaging Findings and Pharmacokinetics of
111
Indium ZME-018 Monoclonal Antibody (MOAB) in Malignant Melanoma. J Nucl
Med 26(P):289, 1985 (Abs. #1138).
32.
Lamki L: Tc-99m DTPA Findings in “Acute Tubular Necrosis”. Proc Intl Cong Rad,
Vol. 1, 1985.
33.
Murray JL, Rosenblum MG, Lamki L, Haynie TP, Glenn HJ, Jahns M, Plager C,
Hersh EM, Unger MW, Carlo DJ: Radioimmunoimaging in Malignant Melanoma
Patients Using 111Indium-Labeled ZME-018 Anti-Melanoma Monoclonal Antibody.
Cancer Drug Delivery 2(3):217, 1985.
34.
Rosenblum MG, Murray JL, Lamki L, Haynie TP, Hersh EM: Comparative Clinical
Pharmacology of the Two Antimelanoma Antibodies ZME-018 and 96.5 Labeled
with 111Indium. Cancer Drug Delivery 2(3):234, 1985.
35.
Lamki LM, von Eschenbach AC, Haynie TP, Hersh EM, Rosenblum M, Glenn HJ:
Radioimmuno-Imaging Findings of Metastatic Prostatic Carcinoma Using Indium111-Labeled Prostatic Acid Phosphatase Monoclonal Antibody PAY-276. Radiology
157(P):333, 1985.
36.
Lamki LM, Babaian RJ, Murray JL, Haynie TP, Glenn HJ, Hersh EM: Detection of
Metastatic Prostatic Cancer Using Indium-111 Labeled Monoclonal Antibody PAY276. J Nucl Med 27(2):316, 1986.
37.
Lamki LM: Update - Status of Monoclonal Antibody Imaging. Clin Nucl Med
11:242, 1986.
38.
Murray JL, Rosenblum MG, Lamki LM, Talpaz M, Gutterman JU, Carlo DJ:
Enhancement of Tumor Uptake of 111Indium (111In)-Labeled Anti-Melanoma
Monoclonal Antibody (MoAb) 96.5 in Melanoma Patients Receiving Partially
Purified Alpha Interferon (aIFN). ASCO/AACR Proc, Vol. 1, 1986.
39.
Rosenblum MG, Murray JL, Lamki LM, David G, Frincke J, Carlo D, Haynie TP,
Hersh EM: Comparative Pharmacokinetics of 111In-Labeled Murine Antimelanoma
Monoclonal Antibodies (MOAB) 96.5 and ZME-018. AACR Proc 1:15, 1986.
40.
Patt YZ, Murray JL, Lamki LM, Trahan P, Haynie T, Carlo DJ, Unger MW, Hersh
EM: 111In Radiolabeled Anti-CEAR Monoclonal Antibodies (MoAb-CEA) for
Localization of Metastatic Colorectal Cancer (CRC). Proc Am Assoc Cancer Res 1:1,
1986.
41.
Lamki LM, Haynie TP, Murray JL, Babaian R, Patt YZ, Merchant B: The Effect of
Increasing Unlabelled Monoclonal Antibody (MoAb) Doses on Metastases Detection
and on Body Distribution of Various 111In MoAbs. Br J Cancer 54(3):535, 1986.
42.
Lamki LM, Babaian RJ, Murray JL, Haynie TP, Glenn HJ, Hersh EM: Nuclear
Medicine. J Nucl Med 27(2):316, 1986.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 54
43.
Lamki LM, Freedman R, Kasi LP, Haynie TP, Glenn HJ, Jahns MF: Indium-111
Leukocytes Monitoring of Biological Response Modifiers Immunotherapy with Viral
Oncolysate in Ovarian Cancer. J Nucl Med 27(6):942, 1986.
44.
Lamki LM, Lopez-Berestein G, Kasi LP, Haynie TP, Glenn HJ: Localization of Tc99m Multilamellar Liposomes at Sites of Fungal Infection: Potential Use in
Amphotericin B Therapy. J Nucl Med 27:1016, 1986.
45.
Lamki LM, Patt YZ, Murray JL, Haynie TP, Glenn HJ, Hersh EM, Unger MW,
Carlo DJ: Scintigraphic Findings of Colonic Cancer Using Indium-111 Labeled AntiCEA Monoclonal Antibody (ZCE-025) Combined with Unlabeled Antibody. J Nucl
Med 27:1021, 1986.
46.
Lamki LM, Babaian R, Murray JL, Haynie TP, Von Eschenbach AC, Hersh E, Unger
M, Carlo DJ: The Effect of Increasing “Cold” Antibody Dose on Prostative Cancer
Metastases Detection and on Body Distribution of PAY-276 Monoclonal Antibody
(MoAb). J Nucl Med 27:1021, 1986.
47.
Lamki LM, Rosenblum MG, Murray JL, Haynie TP, Unger M: The Effect of
Varying Doses of Nonimmunoreactive Subspecies of 96.5 Antimelanoma Monoclonal
Antibody on Pharmacokinetics and Body Distribution of In-111 Labeled 96.5 in a
Chase-Pulse Study. Radiology 161(P):322, 1986.
48.
Babaian- RJ, Murray JL, Lamki L, Rosenblum MG, Haynie TP, Glenn HJ, Under
MW, Carlo DJ, Hersh EM, von Eschenbach AC: Urology and Nuclear Medicine. J
Urol 135(4 Part 2):111A, 1986.
49.
Lamki LM, Haynie TP, Murray JL, Babaian R, Patt YZ, Merchant B: The Effect of
Increasing Unlabeled Monoclonal Antibody (MoAb) Doses on Metastases Detection
and on Body Distribution of Various In-111 MoAbs. Proc WFNMB, Vol. 1, 1987
50.
Lamki LM, Murray JL, Rosenblum MG, Unger M, Merchant B, Haynie TP: Liver
Uptake of In-111 Labeled Anti-Melanoma Monoclonal Antibody (MoAb) 96.5 is
Partially Due to the Presence of Specific Binding Sites. J Nucl Med 28(2):264, 1987.
51.
Lamki LM, Kasi L, Haynie TP: Pitfalls in the Use of In-111 Leukocytes for
Investigation of Fever of Unknown Origin in the Oncology Patient. J Nucl Med
28(4):648, 1987.
52.
Lamki LM, Murray JL, Rosenblum MG, Unger M, Haynie TP: Localization of
Tumor-Specific Monoclonal Antibody In-111 96.5c in the Liver is not Blocked by
Escalating Doses of Non-Immunoreactive 96.5a. J Nucl Med 28(4):651, 1987.
53.
Murray JL, Lamki LM, Rosenblum MG, Carlo DJ, Unger MW: Effect of Escalating
Doses of Non-Immunoreactive (NIR) MoAb 96.5A on Liver Uptake of TumorSpecific 111In-MoAb 96.5c. Proc Am Assoc Cancer Res Annu Meet 28:384 (#1523),
1987.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 55
54.
Patt YZ, Lamki L, Haynie TP, Unger MW, Murray JL: Improved 111In Monoclonal
Anti-CEA ZCE-025 (MoAb) Localization in Colorectal Cancer (CRC) Liver
Metastases by the Addition of Unlabeled ZCE-25. Cancer Res 28:1546, 1987.
55.
Lamki LM, Kasi LP, Hester JP, Haynie TP: Potential Role of 111In Donor Platelets in
the Management of the Oncology Patient. Radiology 165(P):33-34, 1987.
56.
Light ET, Garza AL, Lamki LM, Podoloff DA: Experience with Dual-Headed
Digital Camera for Dynamic Flow Studies. J Nucl Med 29:272, 1988.
57.
Haynie TP, Lamki LM: Nuclear Imaging in Adrenal Medullary Tumors. J Nucl Med
29:276, 1988.
58.
Kim EE, Abello R, Haynie TP, Lamki LM, Podoloff DA: Complementary Roles of
Radionuclide Scintigraphy and Magnetic Resonance Imaging in Evaluating
Parathyroid Adenomas and Paragangliomas. J Nucl Med 29(2):277, 1988.
59.
Lamki LM, Murray JL, Patt YZ, Shanken LJ, Unger MW: Occult Metastatic
Adenocarcinoma of Colon Detected by Monoclonal Antibody ACE 025 in Patients
with Elevated Serum CEA. J Nucl Med 29(2):277, 1988.
60.
Lamki LM, Kasi LP, Haynie TP, Hester JP: Factors That Influence Survival and
Sequestration of Indium-111 Donor Platelets in Patients with Neoplasms. J Nucl Med
29(5):787, 1988.
61.
Lamki LM, Patt YZ, Murray JL, Shanken LJ, Merchant B: The Role of In-111 AntiCEA Monoclonal Antibody in the Detection of Occult Metastatic Cancer in Patients
with Rising Serum CEA. J Nucl Med 29(5):833-834, 1988.
62.
Lamki LM, Patt YZ, Murray JL, Shanken LJ, Rosenblum M, Unger MW: The Effect
of Unlabeled F(ab’)2 Fragment of Anti-CEA MoAb on the Detection of Metastatic
Colorectal Cancer and Biodistribution of In-111 Labeled F(ab’). J Nucl Med
29(5):834, 1988.
63.
Lamki LM, Haynie TP, Balch CM, Bhadkamkar VA, Podoloff DA, Kim EE: The
Contribution of Tc-99m Sulfur Colloid Lymphoscintigraphy to Surgical Management
of Primary Trunkal Melanoma on Intermediate Thickness. J Nucl Med 29(5):854,
1988.
64.
Lamki LM, Murray JL, Patt YZ, Shanken LJ, Unger MW: Comparison of Single
Photon Emission Computed Tomography (SPECT) and Planar Imaging in the
Detection of Metastatic Colorectal Cancer Using Anti-CEA Monoclonal Antibody
ZCE-025 and Its F(ab’)2 Fragment. J Nucl Med 29(5):886, 1988.
65.
Podoloff DA, Broussard W, Kim EE, Lamki LM, Haynie TP: Utility of Qualitative
and Quantitative Parameters Used to Evaluate Hepatic Perfusion in Cancer Patients. J
Nucl Med 29(5):894-895, 1988.
66.
Kasi LP, Lamki LM, Podoloff DA: The Potential of Imaging Abscesses with Tc-99m
Multilamellar Liposomes. J Nucl Med 29(5):888, 1988.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 56
67.
Freedman RS, Bowen JM, Wallace S, Edward C, Wharton EJ, Ioanides C, Atkinson
N, Lamki L, Podolof D: Pre-Irradiation Intralymphatic Viral Oncolysate (ILVO) in
Cervix Carcinoma Patients with Metastatic Lymph Node Involvement - A Phase 1a
Study. AACR Proc 29:207, 1988.
68.
Lamki LM, Murray JL, Zukiwski A, Shanken LJ, Podoloff D, et al: Detection of
Metastatic Ocular and Cutaneous Melanoma with Tc-99m Labeled Monoclonal
Antibody Fab Fragments. Radiology 169:165, 1988.
69.
Podoloff DA, Lamki LM, Kim EE, Haynie TP: Utility of Diuretic Renography in
Patients with Urinary Diversion Procedures Secondary to Pelvic Malignancies.
Radiology 169:288, 1988.
70.
Podoloff DA, Lamki LM, Vadhan-Raj S, Kim EE, Haynie TP: Bone Marrow Scans
in Patients Treated with Granulocyte Macrophage Colony Stimulating Factor.
Radiology 169:1311, 1988.
71.
Podoloff DA, Kim EE, Broussard W, Lamki LM, Haynie TP: Non-uniformity of
Sulfur Colloid Distribution on SPECT Imaging in Patients with Hodgkin's Disease
and Non-Hodgkin Lymphomas. Radiology 169:1316, 1988.
72.
Kim EE, Abello R, Podoloff DA, Lamki LM, Haynie TP, Mavligit E: Evaluation of
Response to Interferon Therapy in Hairy-Cell Leukemia by Tc-99m Colloid
Liver/Spleen Scans. J Nucl Med 30(2):2Ab, 1989.
73.
Murray JL, Lamki LM, Buzdar AU, Esparza L, Theriault RL, Holmes F, Singletary
SE, Ro JY, Zukiwiski AA, Maguire RT, Hortobagyi GT, Rosenblum MG: Imaging,
Radiolocalization Index (RI), and Pharmacokinetics of Monoclonal Antibody (MAb)
B72.3-GYK-DTPA-111In in Patients (PTS) with Primary Breast Cancer (BC). ACCR
Proc 30:403, 1989.
74.
Podoloff D, Lamki L, Kim E, Vadhan-Raj S, Haynie T: Tc-99m Sulfur Colloid Bone
Marrow Imaging in Patients (PTS) with Bone Marrow Failure (BMF) Before and
After a Single Cycle of Granulocyte Macrophage Colony Stimulating Factor (GMCFS). J Nucl Med 30(5):738, 1989.
75.
Abello R, Kim CS, Kim EE, Podoloff DA, Lamki LM, Haynie TP: Relationship of
Chemotherapy and Hot Skull on the Radionuclide Bone Scans in Cancer Patients. J
Nucl Med 30(5):858, 1989.
76.
Podoloff DA, Broussard W, Kim EE, Lamki LM, Keating MJ, Haynie TP: Diffuse
Non-uniformity on SPECT Liver Studies in Patients with Leukemia. J Nucl Med
30(5):905 (2Ab/3Ab), 1989.
77.
Lamki LM, Buzdar A, Singletary A, Rosenblum M, Podoloff D, Esperanza L,
Bhadkamkar V, McGuire R, Murray JL: Breast Cancer Detection: Pharmocokinetics
and Tissue Localization Studies Using In-111-GYK-DTPA-B72.3 Monoclonal
Antibody (MoAb). J Nucl Med 30(5):819, 1989.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 57
78.
Lamki LM, Glisson B, Murray JL, Podoloff D, Bhadkamkar V, Salk D, de Blaquiere
P. Radioimmunoscintigraphy of Small Cell Lung Carcinoma (SCC) Using Tc-99m
Labeled Monoclonal Antibody FAB Fragment. J Nucl Med 30(5):819, 1989.
79.
Lamki LM, Haynie TP, Dexeus F, Johnson D, Logothetis C, von Eschenbach A:
Strontium-89 (Sr-89) in the Palliative Therapy of Painful Bone Metastases: A Phase II
Clinical Study. J Nucl Med 30(5):836 (2Ab), 1989.
80.
Lamki LM, Haynie TP, Balch CM, Bhadkamkar VA, Podoloff DA, Kim EE:
Lymphoscintigraphy in the Surgical Management of Patients with Truncal Melanoma:
Comparison of Tc Sulfur Colloid with Tc Human Serum Albumin. J Nucl Med
30(5):844, 1989.
81.
Lamki LM, Glisson B, Podoloff D, Bhadkamkar V, Murray JL, Szentes L, Salk D.
Evaluation of a Tc-99m-Labeled Monoclonal Antibody Fab Fragment for Staging
Small Cell Lung Cancer and Evaluating Response to Therapy. Radiology 173(P):418,
1989.
82.
Lamki LM, Glisson B, Murray JL, Podoloff D, Bhadkamkar VA, Salk D,
deBlaquiere P. Radioimmunoscintigraphy of Small Cell Lung Carcinoma (SCC)
Using Tc-99m Labeled Monoclonal Antibody Fab Fragment. J Nucl Med 30(S), 1989
(Abs 81).
83.
Lamki LM, Zukiwski AA, Shanken LJ, Legha SS, Benjamin RS, Plager CE, Salk
DF, Schroff RW, Murray JL: Radioimaging of Melanoma Using 99mTc-Labeled Fab
Fragment Reactive with a High Molecular Weight Melanoma Antigen. Cancer Res
50(3):904s-908s, 1990.
84.
Lamki LM, Kavanagh J, Rosenblum MG, Murray JL, Podoloff D, Burke T,
Bhadkamkar V, Thompson L, Shanken J, Cunningham J, Kim EE, MacGuire RT,
Haynie TP: Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Yttrium-90GYK-DTPA-B72.3 Antibody: Tissue Distribution, Pharmacokinetics, Toxicity and
Bremsstrahlung. J Nucl Med 31(5):724, 1990.
85.
Kim EE, Chung SK, Tilbury RS, Podoloff DA, Lamki LM, Haynie TP, Yung A:
Evaluation of Residual or Recurrent Brain Tumors with PET Using 18F-FDG. J Nucl
Med 31(5):800, 1990.
86.
Kim EE, Chung SK, Tilbury R, Mullani N, Podoloff DA, Lamki LM, Haynie TP,
Yung A, Ajani J: Differentiation of Residual or Recurrent Tumors from PostTreatment Changes with PET Using F-18 FDG. J Nucl Med 31(5):803, 1990.
87.
Kasi LP, Grimm EA, Lamki LM, Moser RP: Homing Patterns of Adoptively
Transferred Autologous Lymphocytes in Brain Tumors. J Nucl Med 31(5):818, 1990.
88.
Lamki LM, Patt YZ, Murray JL, Hohn DC, Podoloff DA, Kim EE, Frincke J,
Merchant B, Haynie TP: Superiority of In-111 Monoclonal Antibody to CT and Other
Conventional Imaging Studies in the Diagnosis of Recurrence of Colorectal Cancer.
Radiology 177(P):258, 1990.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 58
89.
Podoloff DA, Pacheo EJ, North LB, Lamki LM, Kim EE, Haynie TP, Cabanillas FF:
Comparison of Gallium SPECT and CT with Clinical Outcome During Therapy:
Analysis of Discordant Results in Hodgkin and Non-Hodgkin Thoracic Lymphoma.
Radiology 177(P):258, 1990.
90.
McGinness J, Lamki L, Michaels W, Olson d, Sloan K: The Role of EEG and
SPECT in Anticonvulsant Therapy in Psychiatry. Proc N Clin Drug Eval Unit, Vol. 1,
1991.
91.
Podoloff DA, Haynie TP, Kim EE, Lamki LM, Forman AD, Benjamin RS, Samaan
NA: Thallium-201 SPECT Tumor Imaging in Differentiation of Recurrent Metastatic
Disease from Post-Therapy Complication. J Nucl Med 32:962, 1991.
92.
Podoloff DA, Murray VA, Bhadkamar LP, Kasi LM, Lamki LM, Kim EE, Haynie
TP: Radioimmunolocalization (RIL) of an Antiganglioside Antibody Directed Against
GD2 Ganglioside: Imaging Considerations. J Nucl Med 32:970, 1991.
93.
Podoloff DA, Murray JL, Bhadkamkar VA, Kasi LP, Lamki LM, Kim EE, Haynie
TP: Radioimmunolocalization (RIL) of an Antiganglioside: Imaging Considerations.
Clin Nucl Med 16:220, 1991.
94.
Podoloff DA, Murray JL, Bhadkamkar VA, Kasi LP, Lamki LM, Kim EE, Haynie
TP. Radioimmunolocalization (RIL) of an Anti-Ganglioside Antibody Directed
Against GD2 Ganglioside Imaging Considerations. J Nucl Med 32(S):970, 1991.
95.
Tran HD, Barron BJ, Lamki LM, Carson GC, Twiford TW: Brain Imaging: A
Multimedia Modality Interactive Tutorial, InfoRAD Exhibit. Radiology 181(P):370,
1991.
96.
Lamki LM, Barron BJ, Tran HD, Taylor WJ: Quantification of Brain SPECT with
Tc-99m HMPAO in “Normal” Cases, Stroke, Epilepsy, and Closed Head Injury.
Radiology 182(2):611, 1992.
97.
Barron BJ, Tran HD, Browner BD, Lyssy K, Lamki LM: Impact of Adding Co-57
Transmission Imaging and Tc-99m Sulfur Colloid to the Standard Technique of Tc99m MDP/In-111-Labeled White Blood Cell Scanning for the Diagnosis of
Osteomyelitis in Trauma Patients. Radiology 182(2):612, 1992.
98.
Tran HD, Barron BJ, Browner B, Lyssy K, Lamki LM: Evaluation of the Utility of
Adding Co-57 Transmission and Marrow Scintigraphy to 3-Phase Bone and Labeled
Leukocyte Imaging in the Diagnosis of Osteomyelitis in Violated Bone. Clin Nucl
Med 17(3):255, 1992.
99.
Lamki LM, Tran HD, Barron BJ, Taylor WJ: Brain SPECT Quantification Using Tc99m HMPAO in “Normal”, Closed Head Injury, Cerebro-Vascular Accident, and
Epilepsy Patients. Clin Nucl Med 17(3):256, 1992.
100.
Tran HD, Barron BJ, Lamki LM, Carson GC, Twiford TW, Zuniga EH: Brain
SPECT: A Multimedia Multimodality Interactive Computer Tutorial. Clin Nucl Med
17(3):258, 1992.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 59
101.
Lamki L, Hanson S, Tran H, Barron B, Grotta J: Potential Value of Serial Brain
SPECT and Transcranial Doppler (TCD) in the First 24 Hours Following Acute
Ischemic Stroke Therapy. J Nucl Med 33(5):968, 1992.
102.
Tran HD, Barron BJ, Lamki LM, Carson GC, Twiford TW, Zuniga EH: Brain
SPECT Imaging: A Multimedia Multimodality Interactive Computer Tutorial
(Certificate of Merit). J Nucl Med 33(5):1071, 1992.
103.
Lamki L, Hanson S, Tran H, Barron B, Grotta J: Potential Value of Serial Brain
SPECT and Transcranial Doppler (TCD) in the Last 24 Hours Following Acute
Ischemic Stroke Therapy. J Nucl Med 33(5):606, 1992.
104.
Barron B, Tran H, Browner B, Lyssy K, Lamki L: The Impact of Adding Cobalt-57
Transmission Imaging and Tc-99m-Sulfur Colloid (SC) Marrow Scan to the Standard
Tc-99m-MDP In-111-WBC Scan Diagnosis of Osteomyelitis in Trauma Patients.
ARRS Proc 1:45, 1992 (Paper #17).
105.
Lamki L, Tran H, Barron B, Taylor WJ: High Resolution Brain SPECT
Quantification Using Tc-99m HMPAO in “Normal” Closed Head Injury, Stroke, and
Epilepsy Patients. ARRS Proc 1:206, 1992 (Paper #196).
106.
Tran H, Barron B, Lamki LM, Carson GC, Twiford TW: Brain Imaging: A
Multimedia Multimodality Interactive Tutorial. ARRS Proc 1:230, 1992.
107.
Patt YZ, Podoloff DA, Curley S, Smith R, Badkhamkar VA, Lamki LM, Jessup
MM, Hohn DC: Monoclonal Antibody Imaging in Patients with Colorectal Cancer
and Increasing Levels of Serum Carcinoembryonic Antigen. Experience with ACE025 and IMMU-4 Monoclonal Antibodies and Proposed Directions for Clinical
Trials. ACS Abs Vol. 1, 1992.
108.
Willmore LJ, Wheless JW, Curtis VL, Barron BJ, Tran HD, Fletcher JM, Lamki LM.
SPECT Abnormalities in Patients with Non-Epileptic Seizures. Epilepsia 33(3):553554, 1992.
109.
Wheless JW, Galan A, Barron B, Tran JD, Willmore LJ, Curtis VL, Lamki LM:
Nonepileptic Seizures: Diagnostic Verification with Ictal and Interictal SPECT.
Epilepsia 34(2):140, 1993.
110.
Barron B, Tran H, Lamki L, Lyssy K, Browner B, Banerjee A, Fife C: In-111
Labeled Polyclonal Pooled Human IgG Imaging for Osteomyelitis: Improved
Specificity by Tc-99m-DTPA Subtraction Imaging. Clin Nucl Med 18(2):172, 1993.
111.
Lamki LM, Barron BJ, Tran HD: Pitfalls and Artifacts in High Resolution Tc-99mExametazime Brain SPECT Imaging and Some Solutions. Clin Nucl Med 18(2):174,
1993.
112.
Tran H, Lamki L, Barron B, Wheless J, Willmore J, Curtis V: Tc-99m-Exametazime
Evaluation on Non-Epileptic (Pseudo) Seizures. Clin Nucl Med 18(2):176, 1993.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 60
113.
MacFadyen B, McGhie A, Clubb F Jr, Molinari B, Lamki L, Frischmeyer K,
Radovancevic B, McAllister H Jr, Buja LM, Willerson J: Cardiac Major
Histocompatibility Complex Class II Antigen Expression in a Canine Model of
Heterotopic Cardiac Allograft Transplantation. FASEB J 7(3):57, 1993.
114.
Tran HD, Barron BJ, Lamki LM: Pitfalls and Artifacts in High-Resolution Tc-99m
Exametazime Brain SPECT Imaging and Some Solutions. ARRS Proc 1:113, 1993
(Abs. 222).
115.
Lisk D, Grotta J, Lamki L, Tran H, Taylor J, Molony D, Barron B: Should
Hypertension be Treated After Acute Stroke? A Randomized Controlled Trial Using
Single Photon Emission Computed Tomography. Am Neurol 34:253-254, 1993.
116.
Hanson S, Grotta J, Rhoades H, Tran H, Lamki L, Barron B, Taylor W: SPECT: Is It
Useful for Selecting Patients for Reperfusion Therapy After Acute Stroke? Canc J
Neurol Sci, 4S:S84, 1993.
117.
Lisk D, Grotta J, Lamki L, Tran H, Taylor J, Molony D, Barron B: Should
Hypertension Be Treated After Acute Stroke? A Randomized Controlled Trial Using
SPECT. Cancer J Neurol Sci, 4S:246, 1993.
118.
Lisk D, Grotta J, Lamki L, Tran H, Taylor J, Molony D, Barron B: Should
Hypertension Be Treated After Acute Stroke? Arch Neurol 50:855-862, 1993.
119.
Lamki LM, Barron BJ, Tran HD, Wheless J, Curtis V: Tc-99m Exametazime
Evaluation of Nonepileptic (Pseudo) Seizures. Radiology 186(2):617, 1993.
120.
Barron BJ, Tran HD, Lamki LM, Lyssy K, Fife CE, Browner BD: In-111-Labeled
Polyclonal Pooled Human IgG Imaging for Osteomyelitis: Improved Specificity by
Tc-99m-DTPA Subtraction Imaging. Radiology 186(2):615, 1993.
121.
Korkmaz M, Delpassand E, Kim EE, Kasi L, Podoloff D, Haynie T, Lamki L, Hester
J: Correlation of Indium-111 Platelet Splenic Sequestration Studies and Clinical
Outcomes in Cancer Patients. J Nucl Med 34(5):119P, 1993 (Abs. #477).
122.
Williams JS, Vang M, Tran HD, Barron BJ, Lamki LM: Lung Ventilation/Perfusion
Imaging - The Clinical Perspective: A MacIntosh Interactive Multimedia Tutorial. J
Nucl Med 34(5):256P, 1993 (Exhibit Abs #1205).
123.
Tran HD, Barron BJ, Lamki LM, Guthrie A, Hines M, Banerjee A: The Spectrum of
Laparoscopic Cholecystectomy Complications on Hepatobiliary (Certificate of
Appreciation). J Nucl Med 34(5):260P, 1993 (Viewbox #1223).
124.
Tran HD, Barron BJ, Lamki LM: A Gamut of Pitfalls in High-Resolution Brain
SPECT Imaging with Suggestions for Improvement. J Nucl Med 34(5):260P, 1993
(Viewbox #1224).
125.
Lamki LM, Tran HD, Barron B: Gamut of Pitfalls in High-Resolution Brain SPECT
Imaging with Suggestions for Improvement. Radiology 198(P):390, 1993.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 61
126.
Barron B, Lamki LM, Wheless J, Tran HD, Curtis V: Initial Experience with Ictal
Injection of Stabilized Tc-99m Exametazime (HMPAO): Patterns and Pitfalls
(Certificate of Merit). Radiology 198(P):1994 (Exhibit Abs. 349NR).
127.
Barron BJ, Tran HD, Lamki LM, Guthrie AM, Hines MD: Spectrum of Laparoscopic
Cholecystectomy Complications Seen at Hepatobiliary Scintigraphy. Radiology
198(P):416, 1994.
128.
Lamki L, Barron B, Curtis V, Wheless J, Lesser J, Willmore J: Preliminary
Experience with Tc-99m ECD (Bicisate, Neurolite) Brain SPECT: Distribution in
Normal Subjects, Alzheimer's and Epilepsy. Clin Nucl Med 19(3):260, 1994.
129.
Barron B, Lamki L, Wheless J, Curtis V, Willmore J: Ictal Injection of Tc-99mStabilized Exametazime: Initial Experience and Clinical Correlation. Clin Nucl Med
19(3):260, 1994.
130.
Fang B, Payne M, Lamki L, Barron B, Brophey M: Patterns of Motion Artifacts in
Tc-HMPAO and Tc-ECD Brain SPECT: Their Identification and Suggestions for
Solutions. Clin Nucl Med 19(3):261, 1994.
131.
Brophey M, Lamki L, Barron B: 99mTc-HMPAO Labeled Leukocyte Scintigraphy:
Recognition of Bone Marrow Uptake Patterns and Benefits from an Altered Protocol.
Clin Nucl Med 19(3):264, 1994.
132.
Alexander T, Fang B, Lamki L, Barron B, Brophey M: An Exposition of Various
Filter Choices for Tc-99m-HMPAO Tc-ECD Brain SPECT Reconstruction. Clin Nucl
Med 19(3):267, 1994.
133.
Fang B, Payne M, Wagner L, Lamki L, Barron B, Brophey M: Motion Artifacts in
Tc-HMPAO and Tc-ECD Brain SPECT: Pattern Identification and Suggestions for
Improvement. J Nucl Med 35(5), 1994.
134.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Freeman T, Cassidy J, Kramer L,
Lilly R, Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Mild
to Moderate Head Injury Presenting with Significant Memory Loss. Eur J Nucl Med
21S(10):33, 1994 (#122).
135.
Lamki L, Barron B, Lesser J, Kumar S, Ephron V, Jacobe R: Linopirdine (LP) in the
Treatment of Dementia of Alzheimer’s Type (DAT): Preliminary Results of
Sequential Brain SPECT with Tc-99m-ECD and Comparison with Normal Interscan
Changes. Eur J Nucl Med 21S(10):557, 1994 (#198).
136.
Barron BJ, Lamki LM, Brophey M: Normal and Abnormal Patterns of Tc-99mHMPAO-Leukocyte Scanning in Soft Tissue Infections: Potential for Eliminating
Need for Bone Scan. Eur J Nucl Med 21S(10):S159 (#627), 1994.
137.
Barron BJ, Hovsepian M, Lamki L, Kramer L, Wheless J, Grotta J: Brain SPECT
Findings in Non-Psychiatric and Non-Atherosclerotic Neurological Syndromes: A
Pictorial Essay. Eur J Nucl Med 21S(10):S178 (#701), 1994.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 62
138.
Lamki LM, Wheless JW, Barron BB, Curtis VL, Ephron VJ, Willmore JL: Ictal and
Interictal Brain SPECT with Tc-99m Bicisate in the Preoperative Evaluation of a
Epileptic Foci: Comparison with Findings in Control Subjects. Radiology 193(P):124,
1994.
139.
Barron BJ, Hovsepian M, Lamki L, Kalisky Z, Freeman T, Vang M, Patel N,
Yeakley J, Kramer L, Lilly R, Cassidy J, Walker M, Plenger P: Brain SPECT
Findings in Patients with Memory Loss Secondary to Mild to Moderate Closed Head.
Radiology 193(P):240 (Abs. #696), 1994.
140.
Barron BJ, Hovsepian MM, Lamki LM, Kalisky Z, Freeman T, Vang M, Patel N,
Yeakley J, Kramer L, Lilly R, Cassidy J, Walker M, Plenger P: Brain SPECT
Findings in Patients with Memory Loss Secondary to Mild to Moderate Closed Head
Injury: Pictorial Display. Radiology 193(P):451, 1994.
141.
Barron B, Lamki LM, Pinero S, Shepard P, Bull JM, Holoye P, Ephron VJ,
MacFadyen B, Ingram L, Oggero K, Duke J: Clinical Use of Tc-99m AntiCarcinoembryonic Antigen Antibody in the Evaluation of the Breast. Radiology
193(P):424, 1994 (Ex440BR).
142.
Barron BJ, Champagne J, Lamki LM: Screening for “Appropriateness” of Nuclear
Medicine Requests: Is It Cost-Effective? Radiology 193(P):399, 1994 (Ex204ED).
143.
Lamki LM, Raval B, Goldman SM: Impact of the Radiologists’ Continuous Quality
Improvement Program on the Referring Physicians and the Institution. Radiology
193(P):431, 1994.
144.
Cohen AM, Oldham SA, Lamki LM, Barron BJ, Raval BK: Pulmonary Disease in
HIV Infection: The Changing Spectrum. Radiology 193(P):417, 1994.
145.
Fang B, Wagner LK, Lamki LM, Barron BJ, Alexander T: Display of the Effect of
Various Filter Selections for Tc-99m HMPAO and Tc-ECD Brain SPECT. Radiology
193(P):426, 1994 (Ex464PH).
146.
Barron BJ, Hovsepian M, Lamki L, Kramer L, Wheless J, Kalisky Z, Willmore J,
Curtis V, Grotta J: Brain SPECt Findings in Non-Psychiatric and Non-Atherosclerotic
Neurological Syndromes: a Pictorial Essay. Neuro Res Sess Vol 1(P), 1994.
147.
Walsh JW, Zeck OF, Fang B, Mullani N, Lamki LM, Gould L, Ha C-S: PET and
SPECT Imaging for Stereotactic Localization. Stereotact Funct Neurosurg 64(1):147154, 1995.
148.
Lamki L, Barron B, Pinero S, Shepard P, Bull J, Holoye P, Ephron V, MacFadyen B,
Ingram L, Oggero K, Duke J: Tc-99m-Anti-CEA Monoclonal Antibody (IMMU-4) in
the Initial Staging of Breast Cancer. Clin Nucl Med 20(1):89, 1995.
149.
Lamki L, Barron B, Lesser J, Kumar S, Ephron V, Jacobe R: Sequential Brain
SPECT with Tc-99m-ECD in the Treatment of Dementia of Alzheimer’s Type (DAT)
with Linopirdine (LP): Comparison with Normal Interscan Changes. Clin Nucl Med
20(1):90, 1995.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 63
150.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Cassidy J, Freeman T, Lilly R,
Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Memory Loss
Secondary to Moderate to Severe Closed Head Injury (CHI). Clin Nucl Med 20(1):93,
1995.
151.
Barron B, Champagne J, Lamki L: Screening for “Appropriateness” of Nuclear
Medicine Requests, Is It Cost Effective? Clin Nucl Med 20(1):93, 1995.
152.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Cassidy J, Freeman T, Lilly R,
Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Memory Loss
Secondary to Moderate to Severe Closed Head Injury (CHI). Clin Nucl Med 20(1):93,
1995.
153.
McGhie AI, Radovancevic B, Moore W, Capek P, Clubb F, Cloy M, Kasi L, Lamki
L, Frazier OH, Willerson JT: Non-Invasive Detection of Cardiac Allograft Rejection
Preliminary Findings Using in Vivo Imaging with Radiolabeled Monoclonal Antibody
to ICAM-1 and MHC class Ii Antigen. Proc Intl Con Nucl Card Vol. 1, 1995. (Best
United States Abstract).
154.
Cohen AM, Lamki L, Barron B, Raval B: Pulmonary Disease in HIV Infection: The
Changing Spectrum. Am J Roentgenol 164(3S):111.
155.
Lamki L, Barron B, Lesser J, Kumar S, Ephron V, Jacobe R: Sequential Brain
SPECT with Tc-99m-ECD in the Treatment of Dementia of Alzheimer’s Type (DAT)
with Linopirdine (LP): Comparison with Normal Interscan Changes. Am J
Roentgenol 164(3S):153 (OP #36-332).
156.
Barron BJ, Lamki L, Pinero S, Ephron V, Bull J: Clinical Utility of Tc-99mAntibody (IMMU-4) in the Evaluation of Breast Cancer (Certificate of Merit). Am J
Roentgenol 164(3S):182 (Ex#217).
157.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Cassidy J, Freeman T, Lilly R,
Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Memory Loss
Secondary to Moderate to Severe Closed Head Injury (CHI). Am J Roentgenol
164(3S):223 (Ex#765).
158.
Barron BJ, Hovsepian M, Lamki L, Kramer L, Wheless J, Kalisky Z, Willmore J,
Curtis V, Grotta J: Brain SPECT Findings in Non-Psychiatric and NonAtherosclerotic Neurological Syndromes: A Pictorial Essay. Am J Roentgenol
164(3S):226 (Ex#780).
159.
Lamki L, Raval B, Goldman S: The Impact of the Radiologists’ Continuous Quality
Improvement (CQI) Program on the Referring Physicians and the Institution. Am J
Roentgenol 164(3S):260, 1995 (Ex#1203).
160.
Slaton JW, Browne BJ, Lamki L, Kahan BD: 99m-TC-MAG-3 Clearance Predicts
Delayed Graft Function after Cadaveric Renal Transplantation. Am Soc Trans Phys
Abs Vol. 1, 1985.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 64
161.
Browne BJ, Slaton JW, Lamki L, Verani R, Kahan BD: 99m-Tc-DTPA Perfusion
Predicts Acute Rejection but Fails to Differentiate Pathologic Grade in Renal
Allografts. Am Soc Trans Phys Abs Vol. 1, 1995.
162.
Tran HD, Barron BJ, Lamki LM, Pinero S, Ingram L, Day S, Reich H, Bull J, Holoye
P, MacFadyen B, Robins D: How to Diagnose and Stage Primary Breast Cancer with
Scintimammography and SPECT: An Interactive Multimedia Tutorial (Honorable
Mention Award). J Nucl Med 36(5):271P, 1995.
163.
McGhie AI, Radovancevic B, Moore W, Capek P, Clubb F, Kasi L, Lamki L, Frazier
OH, Willerson JT: Non-Invasive Detection of Cardiac Allograft Rejection
Preliminary Findings Using In Vivo Imaging with Radiolabeled Monoclonal
Antibody to ICAM-1 and MHC Class II Antigen. J Nucl Med 36(5):102P, 1995.
164.
Yeakley JW, Aboulesh El, Lamki LM, Grotta JC, Kramer LA: MR of Hyperacute
Spinal Epidurla blood Patch for Treatment of "Spontaneous" Intracranial
Hypotension. Proc W Neuro Soc Vol. 1, 1995.
165.
Lamki L, McGhie AI, Moore W, Radovancevic B, Capek P, Clubb F, Kasi L, Frazier
OH, Willerson JT: Early Detection of Cardiac Allograft Rejection: Preliminary
Results with Radiolabeled Monoclonal Antibody to MHC Class II Antigen and to
Intercellular Adhesive Molecule. Radiology 197(P):146, 1995.
166.
Lamki L, Slaton J, Barron B, Browne B, Kahan B: Tc-99m-MAG3 Clearance within
3 Hours of Renal Transplantation is a Good Predictor of Delayed Graft Function and
Risk of Cyclosporine Toxicity. Radiology 197(P):215, 1995.
167.
Barron BJ, Lamki LM, Wheless JW, Curtis VL, Ephron VJ, Willmore LJ: Initial
Experience with Ictal and Interictal Injections of Tc-99m-Stabilized Exametazime for
Pre-Surgery Seizure Focus Localization in Childhood Epilepsy: Utility of Brain
SPECT. Radiology 197(P):268, 1995 (PP#863).
168.
Rodgers BM, Barron BJ, Lamki LM: Imaging in Osteomyelitis: An Algorithmic
Approach. Radiology 197(P):215, 1995 (SE#227SK).
169.
Mcghie AI, Radovancevic B, Capek P, Moore WH, Cloy M, Grisset J, Blust JS, Kasi
L, Lamki L Clubb F, Frazier OH, Willerson, JT: Upregulation of MHC Class Ii
Antigen Expression in Rejecting Cardiac Allografts: Detection Using In Vivo
Imaging with Radiolabeled Monoclonal Antibody. AHA Sess Abs: Vol. 1, 1995 and
Circulation October 1995.
170.
Lamki L, Slaton JW, Barron B, Browne BJ, Kahan BD: Nuclear Evaluation of Renal
Allograft: Prediction of Delayed Graft Function by Tc-99m-MAG3 and of Acute
Rejection by Tc-99m DTPA. Clin Nucl Med 21(2):171, 1996.
171.
Grilley KA, Lamki L, Barron BJ, Wheless J, Willmore J, Mulhern OR, Zeck OF,
Betrand S, Emery R: Ictal Injections in an Epilepsy Monitoring Unit (EMU) for Brain
SPECT: Problems Encountered in Establishing the Program and Their Solutions. Clin
Nucl Med 21(2):169, 1996.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 65
172.
Barron BJ, Lamki LM, Zelitt D, Duke JH, Lally KP, Ephron VJ: Tc-99m-MN3 Fab'
Fragment of AntiAcute Appendicitis. Clin Nucl Med 21(2):171, 1996.
173.
Padmanabhan-Ayyar G, Barron B, Ravichandran G, Lamki L: Tc-99m-ECD Brain
SPECT in Attention Deficit Hyperactivity Disorder (ADHD): Utility in Directing
Appropriate Therapy. Clin Nucl Med 21(2):169, 1996.
174.
McGhie I, Lamki L, Moore W, Radovancevic B, Capek P, Clubb P, Kasi L, Grilley
K, Frazier OH, Willerson JT: Immunoscintigraphic Diagnosis of Cardiac Allograft
Rejection Using In Vivo Imaging with Radiolabeled Monoclonal Antibodies to MHC
Class II Antigens and to Intercellular Adhesive Molecule ICAM-I. Clin Nucl Med
21(2):171, 1996.
175.
Ephron V, Barron B, Lamki L, Grilley K, Rahmanian P: The Unique Challenges
Facing the Research Nurse in Primary Nuclear Medicine Clinical Trials. Clin Nucl
Med 21(2):170, 1996.
176.
Villar-Cordova C, Sills C, Lamki L, Barron B, Pasteur W, Ramirez A, Mullani N,
Grotta J: Brain SPECT Demonstration of Hypoperfusion Surrounding Intracerebral
Hematomas in Humans. Clin Nucl Med 21(2):169, 1996.
177.
Fang B, Lamki L, Barron B, Williams T, Johnson B, Wagner LK: Problems
Encountered in Quantification of Brain Perfusion Index (BPI) Derived from Brain
Flow Acquisition with Tc-HMPAO and Tc-ECD. Clin Nucl Med 21(2):169, 1996.
178.
Abouleish E, Yeakley JW, Grotta JC, Lamki L, Kramer L: Epidural blood Patch for
Treatment of Spontaneous Intracranial Hypotension. Proc World Cong Anesthesiol,
Vol. 1, 1996.
179.
Barron B, Grotta J, Lamki L, Villar-Cordova C, Ephron V, Patel D: Preliminary
Experience with Technetium-99m BMS-181321, a Nitroimidazole, in the Detection
of Cerebral Ischemia Associated with Acute Stroke. J Nucl Med 37S(5):272P, 1996.
180.
Barron BJ, Lamki LM, Zelitt D, Duke JH, Lally KP, Caplan R, Ephron VJ: Clinical
Utility of Tc-99m-MN3 Fab’ Fragment of Anti-Granulocyte Antibody (Leukoscan®)
in the Diagnosis of Atypical Acute Appendicitis. J Nucl Med 37S(5):162P, 1996
(WPP#708).
181.
Lamki L, Slaton JW, Barron B, Browne BJ, Kahan BD: Renal Allograft: Initial Tc99m MAG3 Clearance at 3 Hrs Can Predict Delayed Graft Function (DGF) and Tc99m-DTPA Perfusion Score During Follow-Up Correlates with Rejection. J Nucl
Med 37S(5):292P, 1996 (PS#13060).
182.
Ravichandran GK, Barron B, Lamki LM, Padmanabhan-Ayyar G: Brain SPECT in
attention deficit hyperactivity disorder (ADHD): Utility in Directing Appropriate
Therapy. Proc World Cong Psych, 1:31, 1996 (PSG1294).
183.
Goldenberg DM, Pinsky CM, Datz FL, Harwood SJ, Quenzer RW, Hung C, Barron
BJ, Lamki L: Phase-III Trial Results of Leukoscan in the Imaging of Infection and
Inflammation. Eur J Nucl Med 23(9):1181 (PP#Pmo599).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 66
184.
Barron BJ, Lamki LM, LePage P, Hanna C, Lally KP, Ephron VJ: Use of Tc-99mMN3 Fab’ Fragment of Antigranulocyte Antibody Imaging (LeukoscanR) in the
Diagnosis of Lower Abdominal Inflammation/Infection: Clinical Utility in the
Management of Acute Atypical Appendicitis. Radiology 201(P):364, 1996.
185.
Barron BJ, Grotta J, Lamki LM, Villar-Cordova C, Ephron VJ, Nunn AD: Utility of
Tc-99m-BMS-181321, A Nitroimidazole in the Detection of Cerebral Ischemia
Associated with Acute Stroke: Preliminary Experience. Radiology 201(P):402, 1996.
186.
Lamki LM, Kahan BD, Barron BJ, Slaton JW, Browne BJ: Tc-99m MAG3
Clearance at 3 Hrs is a Good Predictor of Delayed Renal Graft Function (DGF) While
Tc-99m-DTPA Perfusion Score During Follow-Up Can Predict Rejection. Radiology
201(P):436, 1996.
187.
Lamki LM, Padmanabhan-Ayyar G, Ravichandran GK, Barron BJ: Attention-Deficit
Hyperactivity Disorder: Utility of Tc-99m ECD Brain SPECT in Diagnosis and
Directing Appropriate Therapy. Radiology 201(P):450, 1996.
188.
Johnson B, Barron B, Lamki N, Wagner L, Fang B, Simms D, Kenny P, Overton D,
Wells, L, Chen R, Abramson D, Minkowitz H, Shafer A, Lamki L: Brain Perfusion
Abnormalities After Acute IV Cocaine Challenge in Abusers Shown by Quantitative
SPECT and Brain Perfusion Index (BPI). Clin Nucl Med 22(3):199, 1997.
189.
Lamki N, Roberts A, Lamki L, Barron B, Chueh S-C, Ephron V, Kahan BD: Tc99m-MAG3 Clearance by Camera Method in Renal Allografts: Its Relationship to
Function at Various Periods. Clin Nucl Med 22(3):200, 1997.
190.
Odita J, Ross PJ, Barron BJ, Lamki LM, Cross CA, Burau KD: Determination of the
Effect of Teenage Pregnancy on Bone Mineral Content. Clin Nucl Med 22(3):200,
1997.
191.
Johnson B, Barron B, Lamki N, Wagner L, Fang B, Simms D, Kenny P, Overton D,
Wells L, Chen R, Abramson D, Minkowitz H, Shafer A, Lamki L: The Effect of
Acute IV Cocaine Challenge in Abusers on Brain Perfusion as Shown by Quantitative
SPECT and Brain Perfusion Index (BPI). J Nucl Med 38(5):274P-275P, 1997
(PS#1156).
192.
Odita JC, Ross PJ, Barron BJ, Lamki LM, Cross CA, Burau KD: The Impact of
Teenage Pregnancy on Bone Mineral Content. J Nucl Med 38(5):292P-293P, 1997
(MAPS#1229).
193.
Barron B, Lamki L, Hanna C, Passalaqua A, Wegener W, Pinsky CM,
Hammershaimb L, Marks DH, Goldenberg DM: Efficacy and Safety of Sulesomab
(Leukoscan) in the Diagnosis of Acute Non-Classic Appendicitis. J Nucl Med
38(5):25P, 1997 (SP#85).
194.
Johnson BA, Lamki L, Simms D, Chen R, Fang B, Barron B, Wells LT, Abramson
D, Dhother S, Meisch R, Oderinde V: Reversal of Cocaine-Induced Changes in Brain
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 67
Blood Flow by Isradipine. National Institute on Drug Abuse Monograph Series, NIH
Publication #98-4305 178:96, 1998.
195.
Lamki L, Johnson BA, Simms D, Fang B, Barron B, Wagner L, Bordnick PS, Chen
R, Meisch R, Vogelson L, Maugans W, Overton D: Cocaine-Related Changes in
Brain Blood Flow. National Institute on Drug Abuse Monograph Series, NIH
Publication #98-4305 178:151, 1998.
196.
Overton D, Kenny P, Wells LT, Dhother S, Simms D, Lamki L, Barron B, Wagner L,
Fang B, Chen R, Meisch R, Ratkos LM, Johnson BA: Cardiovascular Effects of
Cocaine. National Institute on Drug Abuse Monograph Series, NIH Publication #984305 178:207, 1998.
197.
Saad YD, Lamki LM (sponsor): Role of Lymphoscintigraphy in Traumatic Pediatric
Chylothorax. UTHSC Summer Research Program Student Abstracts 1:33, 1997
198.
Adham WK, Lamki LM (sponsor): Impact of Brain SPECT Imaging on the
Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD).
UTHSC Summer Research Program Student Abstracts 1:49, 1997.
199.
Overton D, Kenny P, Wells L, Dhother S, Simms D, Lamki L, Barron B, Wagner L,
Fang B, Chen R, Meisch R, Ratkos L, Johnson BA: Cardiovascular Effects of
Cocaine, Proc ACDDD 1:13, 1997.
200.
Bordnick P, Wells L, Lamki L, Barron B, Fang B, Wagner L, Dhother S, Kramer L,
Abramson D, Huang D, Ratkos L, Vogelson L, Johnson B: Neuropsychological
Effects of Chronic Cocaine Use. Proc CINP/CMN 1:14, 1997.
201.
Lamki L, Raval B, Goldman S. Evaluation of a Comprehensive CQI Program for
Radiologists in a Changing Healthcare Environment--A Story Book (CATEGORY I
Scientific Exhibit). Radiology 205(P):589, 1997.
202.
Barron B, Holoye P, Lamki L, Bull J, Redwine MD, Ephron V: Tc-99m-L12
Monoclonal Antibody in the Initial Staging and Restaging of Patients with B-Cell
Non-Hodgkin’s Lymphoma. Initial Experience and Pitfalls: A Pictorial Essay.
Radiology 205(P):666.
203.
Barron B, Johnson B, Lamki LM, Wagner LK, Fang B, Wells LT, Abramson D,
Simms KP, Overton D: Effect of Isradipine on Brain Perfusion Alterations Induced by
Intravenous Cocaine: Measured by Brain Perfusion Index (BPI) and Quantitative
SPECT for Regional Cerebral Perfusion. Radiology 205(P):314, 1997. Selected for
"RSNA On-the-Air" Radio Interview for distribution to local radio stations.
Interview done by L. Lamki.
204.
Zelitt DL, Raval BK, Dinwiddie S, Lamki LM, Goldman SG: Improvement in
Turnaround Time for the Radiology Report in a Teaching Hospital. Radiology
205(P):693, 1997.
205.
Johnson BA, Wagner L, Lamki L Fang B, Barron B, Wells LT, Kramer L, Bordnick
PS, Chen R, Abramson D, Dhother S, Vogelson L: Reliability of a Novel Quantitative
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 68
SPECT Technique for Measuring Low, High, and Normal Blood Flow States in the
Brain. Proc CA Neuropsychopharm, Vol l, 1997.
206.
Lamki L, Barron BJ, Dandia F, Ephron V, Fang, B: Utility of "Clamping" Procedure
in Computer Analysis of SPECT Images of Tc-99m Labeled Monoclonal Antibody
Studies. Clin Nucl Med 23(2):130, 1998.
207.
Barron BJ, Lamki L, Tamm E, Bull J, Holoye P, Fang B, Requenez E, Ephron V:
Utility of Tc-99m-LL2 (Monoclonal Antibody Against Raji Cells) in the Evaluation
of Patients with a B-Cell Lymphoma. Clin Nucl Med 23(2):129, 1998.
208.
Barron BJ, Andijar R, Lamki L, Fang B: Tc-99m-ECD (Neurolite) Cerebral Blood
Flow in the Determination of Brain Death: A Pictorial Essay of Complicating Factors.
Clin Nucl Med 23(2):131, 1998.
209.
Huynh SL, Amin RS, Barron B, Nikolaidis P, Lamki L: Nuclear Imaging of
Meckel’s Diverticulum: A Pictorial Essay of Pitfalls. AJR 170(4):130, 1998.
210.
Tamm E, Barron BJ, Lamki LM, Roarke M, Bull J, Holoye P, Requenez E, Ephron
V: Potential Clinical Utility of TC-99M-LL2, Anti-Raji Cell Monoclonal Antibody in
the Follow-Up and Staging of Patients with B-Cell Lymphoma. AJR 170(4):130,
1998.
211.
Lamki L, Raval B, Goldman S: The Impact of Changing Health-Care Environment
on Nuclear and Radiology Continuous Quality Improvement (CQI) Activities -Response of a Teaching Hospital Department. JNM 39(5):276P, 1998 (SE#1307).
212.
Huynh S, Amin R, Barron B, Dhekne R, Lamki L: Pitfalls of Nuclear Imaging of
Meckel's Diverticulum: A Pictorial Essay. J Nucl Med 39(5):276P, 1998 (SE#1308).
213.
Barron B, Rachal L, Lamki L, Nisbet R, Stroehlein K, Ephron V: Predictive Value of
Gallbladder Ejection Fraction in the Outcome of Cholecystectomy for Chronic Biliary
Dysfunction: A Follow-Up Study and Comparison with Pathology Findings ("Meet
the Author" Poster Session). J Nucl Med 39(5):273P, 1998 (MAPS#1198).
214.
Barron B, Lamki L, Stroehlein K, Tamm E, Bull J, Holoye P, Fang B, Requenez E,
Ephron V: Tc-99m-LL2 (Monoclonal Antibody Against Raji Cells) in Evaluation of
Patients with B-Cell Lymphoma: Comparison of Uptake with Histology Findings and
Flow Cytometry Results. ("Meet the Author" Poster Session) J Nucl Med
39(5):244P, 1998 (MAPS#1076).
215.
Lamki L, Barron B, Stroehlein K, Tamm E, Bull J, Holoye P, Fang B, Requenez E,
Ephron V: Tc-99m-LL2 (Monoclonal Antibody Against RAJI Cells) in the Initial
Staging and Follow-Up of B-Cell Lymphoma; Utility After Therapy. Eur Journal Nucl
Med 25(8):1014, 1998 (PP PS124).
216.
Lamki L, Dandia F, Barron B, Ephron V, Fang B: Correcting for SPECT Artifacts
During Tc-99m Labeled Monoclonal Antibodies Imaging by Clamping of the High
Counts Regions: A Novel Approach. Eur J Nucl Med 25(8):922, 1998 (OC OS-343).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 69
217.
Nabi HA, Goldenberg DM, Lamki L, Barron B, and the Immunomedics Study
Group: The Role of Carcinoembryonic Antigen (CEA) Imaging in the Diagnosis of
Breast Carcinoma. Eur J Nucl Med 25(8):872, 1998.
218.
Mullani, NA, van Horn, G, Lamki, L, Barron, B, Gould, K: Brain Blood Flow and
Metabolism Imaging of Parkinson’s Disease patients Pre and Post Pallidotomy –
Preliminary Results. 44th Annual Meeting of the Southwestern Chapter, Society of
Nuclear Medicine, Santa Fe, NM, March, 1999. Clin Nucl Med 24(3):213, 1999.
219.
Barron, BJ, Lamki, L, Kipper, S, Stroehlein, K, Ephron, V: Newer Imaging Methods
for the Diagnosis of Acute Appendicitis: A Review. 44th Annual Meeting of the
Southwestern Chapter, Society of Nuclear Medicine, Santa Fe, NM, March 1999. Clin
Nucl Med 24(3):214, 1999.
220.
Lamki, L.M., Bhosale, P., Barron, B.J., Stroehlein, K., Grilley, K.: Tc-99mHMPAO-WBC Four-Phase Imaging in the Diagnosis of Osteomyelitis (OM) in
Patients with Diabetic Foot Ulcers: Comparison with Biopsy Findings. Society of
Nuclear Medicine, Los Angeles, Ca., June, 1999 J Nucl Med 40(5): 201P, 1999.
221.
Barron, B, Lamki, L, Wheless, J, Bhosale P, Papanicolau, A., Simos, P, Su, J:
Localization of Epileptogenic Foci: The Utility of Magnetoencephalography (MEG)
and Brain SPECT. 44th Annual Meeting of the Southwestern Chapter, Society of
Nuclear Medicine, Santa Fe, NM, March 1999. Clin Nucl Med 24(3):214, 1999.
222.
Lamki, L.M., Bhosale, P., Barron, B.J., Stroehlein, K. and Grilley, K.: Tc-99m HMPAOWBC Four-Phase Imaging in the Diagnosis of Osteomyelitis (OM) in Patients with Diabetic
Foot Ulcers: Comparison with Biopsy Findings. RSNA Abstract Book of the 85th Annual
Meeting in Chicago, IL. P539, #0671MK, 1999.
223.
Barron, B.J., Mitchell, T.A., Lamki, L.M., Chin, H., Huynh, S. L., Mullani, N.A., et al:
FDG PET Imaging of Lung Cancer: A Pictorial Essay of Patterns and Pitfalls. RSNA
Abstract Book of the 85th Annual Meeting in Chicago, Il., P495 #0013CECH, 1999.
224.
Mitchell, T.A., Barron, B.J., Oldham, S.A., Lamki, L.M., Chen, P.C., Tamm, E.P., et al:
Correlation of VQ Scans, Doppler Ultrasound and Chest Radiographs with CT Angiography
in Patients with Clinical Suspicion of Pulmonary Embolus: A Suggested Algorithm for
Patient Management. RSNA Abstract of the 85th Annual Meeting in Chicago, Il., P562,
#1031CH, 1999.
225.
Huynh, S.L., Barron, B.J., Lamki, L.M., Raval, B.K., Nakolaidis, P., Stroehlein, K., et al: A
Review of Imaging Methods for the Diagnosis of Acute Appendicitis and the Role of
Radiolabeled Leukocytes and Monoclonal Antibodies: RSNA Abstract of the 85th Annual
Meeting in Chicago, Il., P496, #0023CEGI, 1999.
226.
Mullani, N.A., Van Horm, G., Papanicolaou, A., Hassenbush, P., Lamki, L.M., Barron, B.J.,
et al: Brain Blood Flow and Metabolism Imaging of Parkinson’s Disease Post, Pre and
Postpallidotomy-Preliminary Results. RSNA Abstract Book of the 85th Annual Meeting in
Chicago, Il., P296, #855, 1999.
227.
Barron, B.J., Censullo, M.L., Lamki, L.M., Hoots, K., Clyburn, T.: Radiation
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 70
Synovectomy in Hemophiliac Patients: A How-to Instructional Guide with Digital
Video Demonstrations. Radiology Supl. 217(P) 621, 2000.
228.
Lamki, L. M., Barron, B.J., Mullani, N., Joseph, U., Ehret, E. Delayed Additional
PET Images Improve Lesion Detection Rate In Oncology Patients. Jour. Nuc. Med
Abstract Book 4 3(5), 155P, No. 562, May 2002.
229.
Barron, B.J., Nguyen, H., Lamki, L.M., Mullani, N., Joseph, U., Dilone, a., Ehret, E.
Non-Coronary Cardiovascular Findings o n Whole-Body Oncologic 18F-FDG PET
Scans. Journ. Nuc. Med. Abstract Book 43(5), 187, No. 773, May 2002.
230.
Barron, B.J., Lamki, L.M., Mullani, N., Joseph, U., Ehret, E., and Fang, B.: Imaging
in Oncologic Patients. Molecular Imaging and Biology 4(4), S47 Supplement 1,
July/August 2002.
D.
Book Chapters:
1.
Lamki LM, Kim EE, Haynie TP: Tumor Immunoscintigraphy Using Monoclonal
Antibodies. In: “Monoclonal Antibodies in Cancer: Advances in Diagnosis and
Treatment” (JA Roth, ed.) Futura Publishing Co., Inc., Mount Kisco, NY, 1986, pp.
259-288.
2.
Lamki LM: The Interpretation of Diagnostic Tests: A Clarification of Terminology.
In: “Nuclear Diagnostic Imaging” (EE Kim, TP Haynie, eds.) McMillan Publishers,
NY, 1987, pp. 3-16.
3.
Lamki LM: Nuclear Medicine in Gynecologic Oncology: Recent Practice (Chapter
34). In: “Gynecologic Cancer: Diagnosis and Treatment Strategies” (FN Rutledge,
RS Freedman, DM Gershenson, eds.) Annual Clinical Conference on Cancer, Vol.
29, The University of Texas Press, Austin, TX, 1987, pp. 429-437.
4.
Murray JL, Lamki LM, Rosenblum MG, Haynie TP, Glenn HJ, Hersh EM: Clinical
Use of Monoclonal Antibodies in Cancer Therapy and Imaging: Current Status,
Controversies, and Future Direction. Martinis Nijhofs Publishing Co., 1987.
5.
Podoloff DA, Lamki LM: Advances in Nuclear Imaging of Abdominal and Pelvic
Malignancies (Chapter 13). In: “Radiologic Oncology of the Abdomen and Pelvis: A
Text and Atlas” (A Shirkoda, ed.) Year Book Medical Publishers, 1988, pp. 11961243.
6.
Murray JL, Lamki LM, Rosenblum MG: Radioimmunoimaging of Malignant
Melanoma with Monoclonal Antibodies. In: “Cancer Treatment and Research:
Malignant Melanoma: Biology, Diagnosis, and Therapy” (L Nathanson, ed.) Kluwer
Academic Publishers: Dordrecht, Netherlands; Boston, 1988, pp. 123-153.
7.
Rosenblum MG, Lamki LM, Murray Jl: Clinical Pharmacology Studies with Murine
Antimelanoma Monoclonal Antibodies. In: “Human Melanoma, Immunology,
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 71
Diagnostics and Therapy” (S Ferrone, ed.) Springer-Verlag, Heidelberg, 1989, pp.
325-343.
8.
Lamki LM: Radioimmunoscintigraphy of Cancer Problems, Pitfalls, and Prospects.
In: “Nuclear Medicine Annual, 1990” (LM Freeman, ed.) Raven Press, New York,
1990, pp. 113-150.
9.
Lamki LM, Patt YZ, Murray JL: In-111 Monoclonal Antibody Immunoscintigraphy
of Colorectal Cancer. In:”Cancer Treatment and Research: Cancer Imaging with
Radiolabeled Antibodies” (DM Goldenberg, ed.) Kluwer Academic Publishers,
Boston, 1990, pp. 293-312.
10.
Lamki LM: Nuclear Medicine and the High-Risk Newborn. In: "Diagnostic Imaging
of the Premature Infant” (R Dominguez, ed.) Churchill Livingston, Inc., New York,
1991, pp. 35-47.
11.
Lamki L, Logic JR: Defining Lymphatic Drainage Patterns with Cutaneous
Lymphoscintigraphy. In: “Cutaneous Melanoma” (CM Balch, ed.) J.B. Lippincott,
Philadelphia, 1992, pp. 367-375.
12.
Kim EE, Barron BJ, Lamki LM, Podoloff DA: Genitourinary Nuclear Medicine I,
Chapter 64. In: “Diagnostic Nuclear Medicine”, Third Edition, Vol. II (Section XI:
Nephrology) (MP Sandler, ed.) Williams & Wilkins, 1995, pp. 1191-1208.
13.
Barron BJ, Lamki LM, Kim EE: Genitourinary Nuclear Medicine II, Chapter 65. In:
"Diagnostic Nuclear Medicine", Third Edition, Vol. II (Section XI: Nephrology) (MP
Sandler, ed.) Williams & Wilkins, 1995, pp. 1209-1232.
14.
Lamki LM, Barron BJ: Breast Imaging with Radiolabeled Antibodies, Part II,
Chapter 6. In: “Radionuclide Imaging of the Breast” (R Taillefer, I Khalkhali, A
Waxman, H Biersack, eds.), Marcel Dekker, Inc., New York, 1997, pp. 177-234.
15.
Lamki LM, Barron BJ: Radionuclide Imaging, Section E: Breast Carcinoma,
Chapter 21, In Nuclear Oncology, Lippincott, Williams & Wilkins, Philadelphia,
PA., 2001.
16.
Kim, E., Barron, B.J., Lamki, L.M.: Renal Nuclear Medicine. Section 10, Chapter
42 Renal Nuclear Medicine pages 865 – 901 Lippincott, Williams and Wilkins
Philadelphia, PA. 2002.
17.
Schulam, P.G., Kawashima, A., Sandler, C., Barron, B.J., Lamki, L., Goldman,
S.M.: Urinary Tract Imaging Basic Principles. In Walsh PC, ed., Campbell’s
Urology, 8th Edition, W.B. Saunders, Philadelphia, Pa. 2002 – 122-166.
E.
OTHER PROFESSIONAL COMMUNICATIONS:
E.1. ORAL Presentations from 1990
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 72
1.
Lamki LM, Kavanagh J, Rosenblum MG, Murray JL, Podoloff D, Burke T,
Bhadkamkar V, Thompson L, Shanken J, Cunningham J, Kim EE, MacGuire RT,
Haynie TP: Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Yttrium90-GYK-DTPA-B72.3 Antibody: Tissue Distribution, Pharmacokinetics, Toxicity
and Bremsstrahlung. Presented at 37th Annual Meeting of the Society of Nuclear
Medicine, Washington, DC,
a. June 1990. Presented at 37th Annual Meeting of the Society of Nuclear
Medicine,
b. Washington, DC, June 1990.
2.
Kim EE, Chung SK, Tilbury RS, Podoloff DA, Lamki LM, Haynie TP, Yung A:
Evaluation of Residual or Recurrent Brain Tumors with PET Using 18F-FDG.
Presented at 37th Annual Meeting of the Society of Nuclear Medicine, Washington,
DC, June 1990.
3.
Kim EE, Chung SK, Tilbury R, Mullani N, Podoloff DA, Lamki LM, Haynie TP,
Yung A, Ajani J: Differentiation of Residual or Recurrent Tumors from PostTreatment Changes with PET Using F-18 FDG. Presented at 37th Annual Meeting of
the Society of Nuclear Medicine, Washington, DC, June 1990.
4.
Kasi LP, Grimm EA, Lamki LM, Moser RP: Homing Patterns of Adoptively
Transferred Autologous Lymphocytes in Brain Tumors. Presented at 37th Annual
Meeting of the Society of Nuclear Medicine, Washington, DC, June 1990.
5.
Lamki LM, Patt YZ, Murray JL, Hohn DC, Podoloff DA, Kim EE, Frincke J,
Merchant B, Haynie TP: Superiority of In-111 Monoclonal Antibody to CT and
Other Conventional Imaging Studies in the Diagnosis of Recurrence of Colorectal
Cancer. Radiological Society of North America annual Meeting, 1990.
6.
Podoloff DA, Pacheo EJ, North LB, Lamki LM, Kim EE, Haynie TP, Cabanillas FF:
Comparison of Gallium SPECT and CT with Clinical Outcome During Therapy:
Analysis of Discordant Results in Hodgkin and Non-Hodgkin Thoracic Lymphoma.
Radiological Society of North America Annual Meeting, 1990.
7.
McGinness J, Lamki L, Michaels W, Olson D, Sloan K: The Role of EEG and
SPECT in Anticonvulsant Therapy in Psychiatry. New Clinical Drug Evaluation Unit
(NCDEU) Annual Meeting, Key Biscayne, FL, May 1991.
8.
Podoloff DA, Haynie TP, Kim EE, Lamki LM, Forman AD, Benjamin RS, Samaan
NA: Thallium-201 SPECT Tumor Imaging in Differentiation of Recurrent Metastatic
Disease from Post-Therapy Complication. The Society of Nuclear Medicine 38th
Annual Meeting, Cincinnati, OH, June 1991.
9.
Podoloff DA, Murray VA, Bhadkamar LP, Kasi LM, Lamki LM, Kim EE, Haynie
TP: Radioimmunolocalization (RIL) of an Antiganglioside Antibody Directed
Against GD2 Ganglioside: Imaging Considerations. The Society of Nuclear Medicine
38th Annual Meeting, Cincinnati, OH, June 1991.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 73
10.
Podoloff DA, Murray JL, Bhadkamkar VA, Kasi LP, Lamki LM, Kim EE, Haynie
TP: Radioimmunolocalization (RIL) of an Antiganglioside: Imaging Considerations.
Southwestern Chapter of the Society of Nuclear Medicine Annual Meeting, 1991.
11.
Lamki LM, Barron BJ, Tran HD, Taylor WJ: Quantification of Brain SPECT with
Tc-99m HMPAO in “Normal” Cases, Stroke, Epilepsy, and Closed Head Injury.
RSNA, December 1992.
12.
Barron BJ, Tran HD, Browner BD, Lyssy K, Lamki LM: Impact of Adding Co-57
Transmission Imaging and Tc-99m Sulfur Colloid to the Standard Technique of Tc99m MDP/In-111-Labeled White Blood Cell Scanning for the Diagnosis of
Osteomyelitis in Trauma Patients. RSNA, December 1992.
13.
Tran HD, Barron BJ, Browner B, Lyssy K, Lamki LM: Evaluation of the Utility of
Adding Co-57 Transmission and Marrow Scintigraphy to 3-Phase Bone and Labeled
Leukocyte Imaging in the Diagnosis of Osteomyelitis in Violated Bone.
Southwestern Chapter of The Society of Nuclear Medicine, 1992.
14.
Lamki LM, Tran HD, Barron BJ, Taylor WJ: Brain SPECT Quantification Using Tc99m HMPAO in “Normal”, Closed Head Injury, Cerebro-Vascular Accident, and
Epilepsy Patients. Southwestern Chapter of The Society of Nuclear Medicine, 1992.
15.
Lamki L, Hanson S, Tran H, Barron B, Grotta J: Potential Value of Serial Brain
SPECT and Transcranial Doppler (TCD) in the First 24 Hours Following Acute
Ischemic Stroke Therapy. Society of Nuclear Medicine 39th Annual Meeting, Los
Angeles, CA, May 1992.
16.
Barron B, Tran H, Browner B, Lyssy K, Lamki L: The Impact of Adding Cobalt-57
Transmission Imaging and Tc-99m-Sulfur Colloid (SC) Marrow Scan to the
Standard Tc-99m-MDP In-111-WBC Scan Diagnosis of Osteomyelitis in Trauma
Patients. American Roentgen Ray Society, 92nd Annual Meeting, Orlando, FL, May
1992, #17.
17.
Lamki L, Tran H, Barron B, Taylor WJ: High Resolution Brain SPECT
Quantification Using Tc-99m HMPAO in “Normal” Closed Head Injury, Stroke, and
Epilepsy Patients. American Roentgen Ray Society, 92nd Annual Meeting, Orlando,
FL, May 1992, #196.
18.
Patt YZ, Podoloff DA, Curley S, Smith R, Badkhamkar VA, Lamki LM, Jessup
MM, Hohn DC: Monoclonal Antibody Imaging in Patients with Colorectal Cancer
and Increasing Levels of Serum Carcinoembryonic Antigen. Experience with ZCE025 and IMMU-4 Monoclonal Antibodies and Proposed Directions for Clinical
Trials. American Cancer Society Workshop on the Pretreatment Diagnostic
Management of Colorectal Cancer and Follow-Up Management of Recurrent
Disease, San Francisco, California, October 1992.
19.
Willmore LJ, Wheless JW, Curtis VL, Barron BJ, Tran HD, Fletcher JM, Lamki LM.
SPECT Abnormalities in Patients with Non-Epileptic Seizures. Presented at the
Annual Meeting of The American Epilepsy Society in Seattle, WA, December 1992.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 74
20.
Wheless JW, Galan A, Barron B, Tran JD, Willmore LJ, Curtis VL, Lamki LM:
Nonepileptic Seizures: Diagnostic Verification with Ictal and Interictal SPECT.
Presented at the 20th International Epilepsy Congress, Oslo, Norway, July 1993.
21.
Barron B, Tran H, Lamki L, Lyssy K, Browner B, Banerjee A, Fife C: In-111
Labeled Polyclonal Pooled Human IgG Imaging for Osteomyelitis: Improved
Specificity by Tc-99m-DTPA Subtraction Imaging. Society of Nuclear Medicine
Southwestern Chapter 38th Annual Meeting, Dallas, TX, March 1993.
22.
Tran H, Lamki L, Barron B, Wheless J, Willmore J, Curtis V: Tc-99m-Exametazime
Evaluation on Non-Epileptic (Pseudo) Seizures. Society of Nuclear Medicine
Southwestern Chapter 38th Annual Meeting, Dallas, TX, March 1993.
23.
MacFadyen B, McGhie A, Clubb F Jr, Molinari B, Lamki L, Frischmeyer K,
Radovancevic B, McAllister H Jr, Buja LM, Willerson J: Cardiac Major
Histocompatibility Complex Class II Antigen Expression in a Canine Model of
Heterotopic Cardiac Allograft Transplantation. FASEB Annual Meeting, New
Orleans, LA, March 1993.
24.
Lisk D, Grotta J, Lamki L, Tran H, Taylor J, Molony D, Barron B: Should
Hypertension be Treated After Acute Stroke? A Randomized Controlled Trial Using
Single Photon Emission Computed Tomography. Presented at National Neurological
Society Meeting, 1993.
25.
Hanson S, Grotta J, Rhoades H, Tran H, Lamki L, Barron B, Taylor W: SPECT: Is It
Useful for Selecting Patients for Reperfusion Therapy After Acute Stroke? Presented
at National Neurological Society Meeting, 1993.
26.
Lisk D, Grotta J, Lamki L, Tran H, Taylor J, Molony D, Barron B: Should
Hypertension Be Treated After Acute Stroke? A Randomized Controlled Trial Using
SPECT. Presented at National Neurological Society Meeting, 1993.
27.
Lisk D, Grotta J, Lamki L, Tran H, Taylor J, Molony D, Barron B: Should
Hypertension Be Treated After Acute Stroke? Presented at Neurology Annual
Meeting, 1993.
28.
Barron BJ, Tran HD, Lamki LM, Lyssy K, Fife CE, Browner BD: In-111-Labeled
Polyclonal Pooled Human IgG Imaging for Osteomyelitis: Improved Specificity by
Tc-99m-DTPA Subtraction Imaging. RSNA, 1993.
29.
Korkmaz M, Delpassand E, Kim EE, Kasi L, Podoloff D, Haynie T, Lamki L, Hester
J: Correlation of Indium-111 Platelet Splenic Sequestration Studies and Clinical
Outcomes in Cancer Patients. Society for Nuclear Medicine Proceedings of the 40th
Annual Meeting, Toronto, Ontario, Canada, June 1993 (#477).
30.
Lamki L, Barron B, Curtis V, Wheless J, Lesser J, Willmore J: Preliminary
Experience with Tc-99m ECD (Bicisate, Neurolite) Brain SPECT: Distribution in
Normal Subjects, Alzheimers and Epilepsy. Southwestern Chapter, Society of
Nuclear Medicine Annual Meeting, Albuquerque, NM, April 1994.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 75
31.
Barron B, Lamki L, Wheless J, Curtis V, Willmore J: Ictal Injection of Tc-99mStabilized Exametazime: Initial Experience and Clinical Correlation. Southwestern
Chapter, Society of Nuclear Medicine Annual Meeting, Albuquerque, NM, April
1994.
32.
Fang B, Payne M, Lamki L, Barron B, Brophey M: Patterns of Motion Artifacts in
Tc-HMPAO and Tc-ECD Brain SPECT: Their Identification and Suggestions for
Solutions. Southwestern Chapter, Society of Nuclear Medicine Annual Meeting,
Albuquerque, NM, April 1994.
33.
Brophey M, Lamki L, Barron B: 99mTc-HMPAO Labeled Leukocyte Scintigraphy:
Recognition of Bone Marrow Uptake Patterns and Benefits from an Altered Protocol.
Southwestern Chapter, Society of Nuclear Medicine Annual Meeting, Albuquerque,
NM, April 1994.
34.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Freeman T, Cassidy J, Kramer L,
Lilly R, Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Mild
to Moderate Head Injury Presenting with Significant Memory Loss. 6th World
Congress of the World Federation of Nuclear Medicine and Biology, Sydney,
Australia, October, 1994.
35.
Lamki L, Barron B, Lesser J, Kumar S, Ephron V, Jacobe R: Linopirdine (LP) in the
Treatment of Dementia of Alzheimer’s Type (DAT): Preliminary Results of
Sequential Brain SPECT with Tc-99m-ECD and Comparison with Normal Interscan
Changes. 6th World Congress of the World Federation of Nuclear Medicine and
Biology, Sydney, Australia, October 1994.
36.
Barron BJ, Lamki LM, Brophey M: Normal and Abnormal Patterns of Tc-99mHMPAO-Leukocyte Scanning in Soft Tissue Infections: Potential for Eliminating
Need for Bone Scan. 6th World Congress of the World Federation of Nuclear
Medicine and Biology, Sydney, Australia, October 1994.
37.
Lamki LM, Wheless JW, Barron BB, Curtis VL, Ephron VJ, Willmore JL: Ictal and
Interictal Brain SPECT with Tc-99m Bicisate in the Preoperative Evaluation of
a. Epileptic Foci: Comparison with Findings in Control Subjects. 80th RSNA
Scientific Assembly and Annual Meeting, Chicago, IL, November 1994.
38.
Barron BJ, Hovsepian M, Lamki L, Kalisky Z, Freeman T, Vang M, Patel N,
Yeakley J, Kramer L, Lilly R, Cassidy J, Walker M, Plenger P: Brain SPECT
Findings in Patients with Memory Loss Secondary to Mild to Moderate Closed Head
Injury. 80th RSNA Scientific Assembly and Annual Meeting, Chicago, IL,
November 1994.
39.
Walsh JW, Zeck OF, Fang B, Mullani N, Lamki LM, Gould L, Ha C-S: PET and
SPECT Imaging for Stereotactic Localization. Presented at Sixth International
Leksell Gamma Knife Society Meeting, Kyoto, Japan, May 1994. Stereotact Funct
Neurosurg 64(1):147-154, 1995.
40.
Lamki L, Barron B, Pinero S, Shepard P, Bull J, Holoye P, Ephron V, MacFadyen B,
Ingram L, Oggero K, Duke J: Tc-99m-Anti-CEA Monoclonal Antibody (IMMU-4)
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 76
in the Initial Staging of Breast Cancer. 40th Annual Meeting of the Southwestern
Chapter, Society of Nuclear Medicine, San Antonio, TX, March 1995.
41.
Lamki L, Barron B, Lesser J, Kumar S, Ephron V, Jacobe R: Sequential Brain
SPECT with Tc-99m-ECD in the Treatment of Dementia of Alzheimer’s Type
(DAT) with Linopirdine (LP): Comparison with Normal Interscan Changes. 40th
Annual Meeting of the Southwestern Chapter, Society of Nuclear Medicine, San
Antonio, TX, March 1995.
42.
McGhie AI, Radovancevic B, Moore W, Capek P, Clubb F, Cloy M, Kasi L, Lamki
L, Frazier OH, Willerson JT: Non-Invasive Detection of Cardiac Allograft Rejection
Preliminary Findings Using In Vivo Imaging with Radiolabeled Monoclonal
Antibody to ICAM-1 and MHC Class II Antigen. Presented at 2nd International
Conference of Nuclear Cardiology, Palais des Festivals, Cannes, France, April 1995
(Best United States Abstract).
43.
Lamki L, Barron B, Lesser J, Kumar S, Ephron V, Jacobe R: Sequential Brain
SPECT with Tc-99m-ECD in the Treatment of Dementia of Alzheimer’s Type
(DAT) with Linopirdine (LP): Comparison with Normal Interscan Changes.
American Roentgen Ray Society, 1995 Annual Meeting, Washington, DC, May
1995.
44.
McGhie AI, Radovancevic B, Moore W, Capek P, Clubb F, Kasi L, Lamki L, Frazier
OH, Willerson JT: Non-Invasive Detection of Cardiac Allograft Rejection
Preliminary Findings Using In Vivo Imaging with Radiolabeled Monoclonal
Antibody to ICAM-1 and MHC Class II Antigen. Presented at Society of Nuclear
Medicine 42nd Annual Meeting, Minneapolis, MN, June 1995.
45.
Yeakley JW, Aboulesh EI, Lamki LM, Grotta JC, Kramer LA: MR of Hyperacute
Spinal Epidural Blood Patch for Treatment of "Spontaneous" Intracranial
Hypotension. Presented at Western Neuroradiological Society, Vancouver, Canada,
September 1995.
46.
Lamki L, McGhie AI, Moore W, Radovancevic B, Capek P, Clubb F, Kasi L, Frazier
OH, Willerson JT: Early Detection of Cardiac Allograft Rejection: Preliminary
Results with Radiolabeled Monoclonal Antibody to MHC Class II Antigen and to
Intercellular Adhesive Molecule. 81st Scientific Assembly and Annual Meeting of
the Radiological Society of North America, Chicago, IL, November 1995 (#109).
47.
Lamki L, Slaton J, Barron B, Browne B, Kahan B: Tc-99m-MAG3 Clearance within
3 Hours of Renal Transplantation is a Good Predictor of Delayed Graft Function and
Risk of Cyclosporine Toxicity. 81st Scientific Assembly and Annual Meeting of the
Radiological Society of North America, Chicago, IL, November 1995 (#536).
48.
Barron BJ, Lamki LM, Wheless JW, Curtis VL, Ephron VJ, Willmore LJ: Initial
Experience with Ictal and Interictal Injections of Tc-99m-Stabilized Exametazime for
Pre-Surgery Seizure Focus Localization in Childhood Epilepsy: Utility of Brain
SPECT. 81st Scientific Assembly and Annual Meeting of the Radiological Society of
North America, Chicago, IL, November 1995 (#863).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 77
49.
Rodgers BM, Barron BJ, Lamki LM: Imaging in Osteomyelitis: An Algorithmic
Approach. 81st Scientific Assembly and Annual Meeting of the Radiological Society
of North America, Chicago, IL, November 1995 (Scientific Exhibit #227SK).
50.
McGhie AI, Radovancevic B, Capek P, Moore WH, Cloy M, Grisset J, Blust JS, Kasi
L, Lamki L, Clubb F, Frazier OH, Willerson, JT: Upregulation of MHC Class II
Antigen Expression in Rejecting Cardiac Allografts: Detection Using In Vivo
Imaging with Radiolabeled Monoclonal Antibody. American Heart Association 68th
Scientific Sessions, Anaheim, CA, November 1995.
51.
Lamki L, Slaton JW, Barron B, Browne BJ, Kahan BD: Nuclear Evaluation of Renal
Allograft: Prediction of Delayed Graft Function by Tc-99m-MAG3 and of Acute
Rejection by Tc-99m DTPA. 41st Annual Meeting of the Southwestern Chapter of
the Society of Nuclear Medicine, Austin, TX, March 1996.
52.
Grilley KA, Lamki L, Barron BJ, Wheless J, Willmore J, Mulhern OR, Zeck OF,
Betrand S, Emery R: Ictal Injections in an Epilepsy Monitoring Unit (EMU) for
Brain SPECT: Problems Encountered in Establishing the Program and Their
Solutions. 41st Annual Meeting of the Southwestern Chapter of the Society of
Nuclear Medicine, Austin, TX, March 1996.
53.
Barron BJ, Lamki LM, Zelitt D, Duke JH, Lally KP, Ephron VJ: Tc-99m-MN3 Fab'
Fragment of AntiAcute Appendicitis. 41st Annual Meeting of the Southwestern Chapter of the Society
of Nuclear Medicine, Austin, TX, March 1996.
54.
Padmanabhan-Ayyar G, Barron B, Ravichandran G, Lamki L: Tc-99m-ECD Brain
SPECT in Attention Deficit Hyperactivity Disorder (ADHD): Utility in Directing
Appropriate Therapy. 41st Annual Meeting of the Southwestern Chapter of the
Society of Nuclear Medicine, Austin, TX, March 1996.
55.
McGhie I, Lamki L, Moore W, Radovancevic B, Capek P, Clubb P, Kasi L, Grilley
K, Frazier OH, Willerson JT: Immunoscintigraphic Diagnosis of Cardiac Allograft
Rejection Using In Vivo Imaging with Radiolabeled Monoclonal Antibodies to MHC
Class II Antigens and to Intercellular Adhesive Molecule ICAM-I. 41st Annual
Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Austin,
TX, March 1996.
56.
Ephron V, Barron B, Lamki L, Grilley K, Rahmanian P: The Unique Challenges
Facing the Research Nurse in Primary Nuclear Medicine Clinical Trials. 41st Annual
Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Austin,
TX, March 1996.
57.
Villar-Cordova C, Sills C, Lamki L, Barron B, Pasteur W, Ramirez A, Mullani N,
Grotta J: Brain SPECT Demonstration of Hypoperfusion Surrounding Intracerebral
Hematomas in Humans. 41st Annual Meeting of the Southwestern Chapter of the
Society of Nuclear Medicine, Austin, TX, March 1996.
58.
Fang B, Lamki L, Barron B, Williams T, Johnson B, Wagner LK: Problems
Encountered in Quantification of Brain Perfusion Index (BPI) Derived from Brain
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 78
Flow Acquisition with Tc-HMPAO and Tc-ECD. 41st Annual Meeting of the
Southwestern Chapter of the Society of Nuclear Medicine, Austin, TX, March 1996.
59.
Abouleish E, Yeakley JW, Grotta JC, Lamki L, Kramer L: Epidural Blood Patch for
Treatment of Spontaneous Intracranial Hypotension. 11Th World Congress of
Anaesthesiologists, Sydney, Australia, April 1996.
60.
Barron BJ, Lamki LM, LePage P, Hanna C, Lally KP, Ephron VJ: Use of Tc-99mMN3 Fab’ Fragment of Antigranulocyte Antibody Imaging (LeukoscanR) in the
Diagnosis of Lower Abdominal Inflammation/Infection: Clinical Utility in the
Management of Acute Atypical Appendicitis. 82nd Scientific Assembly and Annual
Meeting of the Radiological Society of North America, Chicago, IL, December 1996.
61.
Barron BJ, Grotta J, Lamki LM, Villar-Cordova C, Ephron VJ, Nunn AD: Utility of
Tc-99m-BMS-181321, A Nitroimidazole in the Detection of Cerebral Ischemia
Associated with Acute Stroke: Preliminary Experience. 82nd Scientific Assembly
and Annual Meeting of the Radiological Society of North America, Chicago, IL,
December 1996 (#1484).
62.
Lamki LM, Kahan BD, Barron BJ, Slaton JW, Browne BJ: Tc-99m MAG3
Clearance at 3 Hrs is a Good Predictor of Delayed Renal Graft Function (DGF)
While Tc-99m-DTPA Perfusion Score During Follow-Up Can Predict Rejection.
82nd Scientific Assembly and Annual Meeting of the Radiological Society of North
America, Chicago, IL, December 1996 (#1660).
63.
Lamki LM, Padmanabhan-Ayyar G, Ravichandran GK, Barron BJ: Attention-Deficit
Hyperactivity Disorder: Utility of Tc-99m ECD Brain SPECT in Diagnosis and
Directing Appropriate Therapy. 82nd Scientific Assembly and Annual Meeting of the
Radiological Society of North America, Chicago, IL, December 1996 (Accepted as
Alternate Oral Presentation).
64.
Johnson B, Barron B, Lamki N, Wagner L, Fang B, Simms D, Kenny P, Overton D,
Wells, L, Chen R, Abramson D, Minkowitz H, Shafer A, Lamki L: Brain Perfusion
a. Abnormalities After Acute IV Cocaine Challenge in Abusers Shown by
Quantitative SPECT and Brain Perfusion Index (BPI). 42nd Annual Meeting
of the Southwestern Chapter Society of Nuclear Medicine & Cardiac Nuclear
Medicine Symposium, New Orleans, LA, April 1997.
65.
Lamki N, Roberts A, Lamki L, Barron B, Chueh S-C, Ephron V, Kahan BD: Tc99m-MAG3 Clearance by Camera Method in Renal Allografts: Its Relationship to
Function at Various Periods. 42nd Annual Meeting of the Southwestern Chapter
Society of Nuclear Medicine & Cardiac Nuclear Medicine Symposium, New
Orleans, LA, April 1997.
66.
Odita J, Ross PJ, Barron BJ, Lamki LM, Cross CA, Burau KD: Determination of the
Effect of Teenage Pregnancy on Bone Mineral Content. 42nd Annual Meeting of the
Southwestern Chapter Society of Nuclear Medicine & Cardiac Nuclear Medicine
Symposium, New Orleans, LA, April 1997.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 79
67.
Barron B, Lamki L, Hanna C, Passalaqua A, Wegener W, Pinsky CM,
Hammershaimb L, Marks DH, Goldenberg DM: Efficacy and Safety of Sulesomab
(Leukoscan) in the Diagnosis of Acute Non-Classic Appendicitis. The Society of
Nuclear Medicine 44th Annual Meeting, San Antonio, TX, June 1997 (#85).
68.
Johnson BA, Lamki L, Simms D, Chen R, Fang B, Barron B, Wells LT, Abramson
D, Dhother S, Meisch R, Oderinde V: Reversal of Cocaine-Induced Changes in
Brain Blood Flow by Isradipine, Problems of Drug Dendence 1997, Fifty-Ninth
Annual College on Problems of Drug Dependence Meeting, Nashville, TN, June
1997.
69.
Lamki L, Johnson BA, Simms D, Fang B, Barron B, Wagner L, Bordnick PS, Chen
R, Meisch R, Vogelson L, Maugans W, Overton D: Cocaine-Related Changes in
Brain Blood Flow, Problems of Drug Dependence 1997, Fifty-Ninth Annual College
on Problems of Drug Dependence Meeting, Nashville, TN, June 1997.
70.
Overton D, Kenny P, Wells LT, Dhother S, Simms D, Lamki L, Barron B, Wagner L,
Fang B, Chen R, Meisch R, Ratkos LM, Johnson BA: Cardiovascular Effects of
Cocaine, Problems of Drug Dendence 1997, Fifty-Ninth Annual College on
Problems of Drug Dependence Meeting, Nashville, TN, June 1997.
71.
Overton D, Kenny P, Wells L, Dhother S, Simms D, Lamki L, Barron B, Wagner L,
Fang B, Chen R, Meisch R, Ratkos L, Johnson BA: Cardiovascular Effects of
Cocaine, Fifty-Ninth Annual College on Problems of Drug Dependence Meeting,
Nashville, TN, June 1997.
72.
Bordnick P, Wells L, Lamki L, Barron B, Fang B, Wagner L, Dhother S, Kramer L,
Abramson D, Huang D, Ratkos L, Vogelson L, Johnson B: Neuropsychological
Effects of Chronic Cocaine Use. Collegium Interenationale NeuroPsychopharmacologicum /Colegio Mexicana de Neuropsicofarmacologia, Acapulco,
Mexico, August 1997.
73.
Barron B, Holoye P, Lamki L, Bull J, Redwine MD, Ephron V: Tc-99m-L12
Monoclonal Antibody in the Initial Staging and Restaging of Patients with B-Cell
Non-Hodgkin’s Lymphoma. Initial Experience and Pitfalls: A Pictorial Essay. 83rd
Scientific Assembly and Annual Meeting of the Radiological Society of North
America, Chicago, IL, December 1997 (Accepted as Alternate Scientific Paper).
74.
Barron B, Johnson B, Lamki LM, Wagner LK, Fang B, Wells LT, Abramson D,
Simms KP, Overton D: Effect of Isradipine on Brain Perfusion Alterations Induced
by Intravenous Cocaine: Measured by Brain Perfusion Index (BPI) and Quantitative
SPECT for Regional Cerebral Perfusion. 83rd Scientific Assembly and Annual
Meeting of the Radiological Society of North America, Chicago, IL, December 1997.
Selected for "RSNA On-the-Air" Radio Interview for distribution to local radio
stations. Interview done by L. Lamki.
75.
Odita JC, Ross PJ, Barron BJ, Lamki LM, Cross CA, Burau KD: The Impact of
Teenage Pregnancy on Bone Mineral Content. 83rd Scientific Assembly and Annual
Meeting of the Radiological Society of North America, Chicago, IL, December 1997
(Accepted as Alternate Scientific Paper).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 80
76.
Lamki L, Barron BJ, Dandia F, Ephron V, Fang, B: Utility of "Clamping" Procedure
in Computer Analysis of SPECT Images of Tc-99m Labeled Monoclonal Antibody
Studies. 43rd Annual Meeting of the Southwestern Chapter of the Society of Nuclear
Medicine, Houston, TX, March 1998.
77.
Barron BJ, Lamki L, Tamm E, Bull J, Holoye P, Fang B, Requenez E, Ephron V:
Utility of Tc-99m-LL2 (Monoclonal Antibody Against Raji Cells) in the Evaluation
of Patients with a B-Cell Lymphoma. 43rd Annual Meeting of the Southwestern
Chapter of the Society of Nuclear Medicine, Houston, TX, March 1998.
78.
Lamki L, Dandia F, Barron B, Ephron V, Fang B: Correcting for SPECT Artifacts
During Tc-99m Labeled Monoclonal Antibodies Imaging by Clamping of the High
Counts Regions: A Novel Approach. Joint Congress of the European Association of
Nuclear Medicine and the World Federation of Nuclear Medicine and Biology,
Berlin, Germany, August-September 1998.
79.
Nabi HA, Goldenberg DM, Lamki L, Barron B, and the Immunomedics Study
Group: The Role of Carcinoembryonic Antigen (CEA) Imaging in the Diagnosis of
Breast Carcinoma. Joint Congress of the European Association of Nuclear Medicine
and the World Federation of Nuclear Medicine and Biology, Berlin, Germany,
August-September 1998.
80.
Mullani, NA, van Horn, G, Lamki L, Barron B, Gould, K: Brain Blood Flow and
Metabolism Imaging of Parkinson’s Disease Patients Pre and Post Pallidotomy –
a. Preliminary Results. 44th annual Meeting of the Southwestern Chapter,
Society of Nuclear Medicine, Santa Fe, NM, March 1999.
81.
Barron, BJ, Lamki, L, Kipper, S, Stroehlein, K, Ephron, V: Newer Imaging Methods
for the Diagnosis of Acute Appendicitis: A Review. 44th Annual Meeting of the
Southwestern Chapter, Society of Nuclear Medicine, Santa Fe, NM, March 1999.
82.
Barron, B, Lamki, L, Wheless, J, Bhosale, P, Papanicolau, A, Simos, P, Su, J:
Localization of Epileptogenic Foci: The Utility of Magnetoencephalography (MEG)
and Brain SPECT. 44th Annual Meeting of the Southwestern Chapter, Society of
Nuclear Medicine, Santa Fe, NM, March 1999.
83.
Lamki, L.M., Barron, B.J., Mullani, N., Joseph, U., Ehret, E.: Delayed Additional
PET Images Improve Lesion Detection Rate in Oncology Patients. Presented at the
49th Annual Meeting of The Society of Nuclear Medicine in Los Angeles, Ca. June,
2002.
84.
Lamki, L.M., Barron, B.J., Mullani, N., Joseph, U., Ehert, E.: Acquiring Additional
Delayed PET Imnages Improves Sensitivity and Specificity in Oncology Cases.
World Federation of Nuclear Medicine and Biology Congress, Santiago, Chile,
October 2002.
85.
Lamki, L.M., Barron, B.J., Nguye, H., Mullani, N., Joseph, U., Ehert, E., Dilone, A.:
Unusual Cardiovascular Findings on Total-Body F-18-FDG PET Scans in Oncology
Patients. World Federation of Nuclear Medicine and Biology Congress, Santiago,
Chile, October 2002.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 81
86.
Lamk Lamki, Elaine S. Granmayeh: Case Report #0127 - Metabolic Bone Disease.
University of Texas-Houston Health Science Center Website – April, 2004.
http://www.uth.tmc.edu/radiology/faculty/wagner.html.
E.2
EXHIBITS from 1990
1.
Tran HD, Barron BJ, Lamki LM, Carson GC, Twiford TW: Brain Imaging: A
Multimedia Modality Interactive Tutorial, InfoRAD Exhibit, RSNA, 1991.
2.
Tran HD, Barron BJ, Lamki LM, Carson GC, Twiford TW, Zuniga EH: Brain
SPECT: A Multimedia Multimodality Interactive Computer Tutorial, Presented at
Southwestern Chapter of Society of Nuclear Medicine, 1992.
3.
Tran HD, Barron BJ, Lamki LM, Carson GC, Twiford TW, Zuniga EH: Brain
SPECT Imaging: A Multimedia Multimodality Interactive Computer Tutorial.
Society of Nuclear Medicine 39th Annual Meeting, Los Angeles, CA, May 1992
(Certificate of Merit).
4.
Lamki L, Hanson S, Tran H, Barron B, Grotta J: Potential Value of Serial Brain
SPECT and Transcranial Doppler (TCD) in the Last 24 Hours Following Acute
Ischemic Stroke Therapy. Society of Nuclear Medicine 39th Annual Meeting, Los
Angeles, CA, May 1992.
5.
Tran H, Barron B, Lamki LM, Carson GC, Twiford TW: Brain Imaging: A
Multimedia Multimodality Interactive Tutorial. Program Book, American Roentgen
Ray Society, 92nd Annual Meeting in Orlando, FL, May 1992 (F12).
6.
Lamki LM, Barron BJ, Tran HD: Pitfalls and Artifacts in High Resolution Tc-99mExametazime Brain SPECT Imaging and Some Solutions. Society of Nuclear
Medicine Southwestern Chapter 38th Annual Meeting, Dallas, TX, March 1993.
7.
Tran HD, Barron BJ, Lamki LM: Pitfalls and Artifacts in High-Resolution Tc-99m
Exametazime Brain SPECT Imaging and Some Solutions. Annual Meeting of the
American Roentgen Ray Society, San Francisco, CA, April 1993.
8.
Williams JS, Vang M, Tran HD, Barron BJ, Lamki LM: Lung Ventilation/Perfusion
Imaging - The Clinical Perspective: A MacIntosh Interactive Multimedia Tutorial.
Society for Nuclear Medicine Proceedings of the 40th Annual Meeting, Toronto,
Ontario, Canada, June 1993 (#1205).
9.
Tran HD, Barron BJ, Lamki LM, Guthrie A, Hines M, Banerjee A: The Spectrum of
Laparoscopic Cholecystectomy Complications on Hepatobiliary Scintigraphy.
Society for Nuclear Medicine Proceedings of the 40th Annual Meeting, Toronto,
Ontario, Canada, June 1993 (Viewbox #1223) (Certificate of Appreciation).
10.
Tran HD, Barron BJ, Lamki LM: A Gamut of Pitfalls in High-Resolution Brain
SPECT Imaging with Suggestions for Improvement, Society for Nuclear Medicine
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 82
Proceedings of the 40th Annual Meeting, Toronto Ontario, Canada, June 1993
(Viewbox #1224).
11.
Barron B, Lamki LM, Wheless J, Tran HD, Curtis V: Initial Experience with Ictal
Injection of Stabilized Tc-99m Exametazime (HMPAO): Patterns and Pitfalls
(Certificate of Merit). RSNA Annual Meeting, Chicago, IL, November 1993
(#349NR).
12.
Barron BJ, Tran HD, Lamki LM, Guthrie AM, Hines MD: Spectrum of Laparoscopic
Cholecystectomy Complications Seen at Hepatobiliary Scintigraphy. RSNA Annual
Meeting, Chicago, IL, November 1993. Radiology 198(P):416, 1994.
13.
Lamki LM, Tran HD, Barron B: Gamut of Pitfalls in High-Resolution Brain SPECT
Imaging with Suggestions for Improvement. RSNA Annual Meeting, Chicago, IL,
November 1993.
14.
Alexander T, Fang B, Lamki L, Barron B, Brophey M: An Exposition of Various
Filter Choices for Tc-99m-HMPAO Tc-ECD Brain SPECT Reconstruction.
Southwestern Chapter, Society of Nuclear Medicine Annual Meeting, Albuquerque,
NM, April 1994.
15.
Barron BJ, Hovsepian M, Lamki L, Kramer L, Wheless J, Grotta J: Brain SPECT
Findings in Non-Psychiatric and Non-Atherosclerotic Neurological Syndromes: A
Pictorial Essay. 6th World Congress of the World Federation of Nuclear Medicine
and Biology, Sydney, Australia, October 1994 (#701).
16.
Barron BJ, Hovsepian MM, Lamki LM, Kalisky Z, Freeman T, Vang M, Patel N,
Yeakley J, Kramer L, Lilly R, Cassidy J, Walker M, Plenger P: Brain SPECT
Findings in Patients with Memory Loss Secondary to Mild to Moderate Closed Head
Injury: Pictorial Display. 80th RSNA Scientific Assembly and Annual Meeting,
Chicago, IL, November 1994 (#695NR).
17.
Barron B, Lamki LM, Pinero S, Shepard P, Bull JM, Holoye P, Ephron VJ,
MacFadyen B, Ingram L, Oggero K, Duke J: Clinical Use of Tc-99m AntiCarcinoembryonic Antigen Antibody in the Evaluation of the Breast. 80th RSNA
Scientific Assembly and Annual Meeting, Chicago, IL, November 1994 (#440BR).
18.
Barron BJ, Champagne J, Lamki LM: Screening for “Appropriateness” of Nuclear
Medicine Requests: Is It Cost-Effective? 80th RSNA Scientific Assembly and
Annual Meeting, Chicago, IL, November 1994 (#204ED).
19.
Lamki LM, Raval B, Goldman SM: Impact of the Radiologists’ Continuous Quality
Improvement Program on the Referring Physicians and the Institution. 80th RSNA
Scientific Assembly and Annual Meeting, Chicago, IL, November 1994 (#513PH).
20.
Cohen AM, Oldham SA, Lamki LM, Barron BJ, Raval BK: Pulmonary Disease in
HIV Infection: The Changing Spectrum. 80th RSNA Scientific Assembly and
Annual Meeting, Chicago, IL, November 1994 (#377GC).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 83
21.
Fang B, Wagner LK, Lamki LM, Barron BJ, Alexander T: Display of the Effect of
Various Filter Selections for Tc-99m HMPAO and Tc-ECD Brain SPECT. 80th
RSNA Scientific Assembly and Annual Meeting, Chicago, IL, November 1994
(#464PH).
22.
Barron BJ, Hovsepian M, Lamki L, Kramer L, Wheless J, Kalisky Z, Willmore J,
Curtis V, Grotta J: Brain SPECT Findings in Non-Psychiatric and NonAtherosclerotic Neurological Syndromes: A Pictorial Essay. Neuroscience Research
Center Poster Session, The University of Texas-Houston Medical School, Houston,
TX, December 3, 1994.
23.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Cassidy J, Freeman T, Lilly R,
Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Memory Loss
Secondary to Moderate to Severe Closed Head Injury (CHI). 40th Annual Meeting of
the Southwestern Chapter, Society of Nuclear Medicine, San Antonio, TX, March
1995 .
24.
Barron B, Champagne J, Lamki L: Screening for “Appropriateness” of Nuclear
Medicine Requests, Is It Cost Effective? 40th Annual Meeting of the Southwest-ern
Chapter, Society of Nuclear Medicine, San Antonio, TX, March 1995.
25.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Cassidy J, Freeman T, Lilly R,
Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Memory Loss
Secondary to Moderate to Severe Closed Head Injury (CHI). 40th Annual Meeting of
the Southwestern Chapter, Society of Nuclear Medicine, San Antonio, TX, March
1995.
26.
Cohen AM, Lamki L, Barron B, Raval B: Pulmonary Disease in HIV Infection: The
Changing Spectrum. American Roentgen Ray Society, 1995 Annual Meeting,
Washington, DC, April-May 1995 (Viewbox #905).
27.
Barron BJ, Lamki L, Pinero S, Ephron V, Bull J: Clinical Utility of Tc-99mAntibody (IMMU-4) in the Evaluation of Breast Cancer. American Roentgen Ray
Society, 1995 Annual Meeting, Washington, DC, May 1995 (#217) (Certificate of
Merit).
28.
Barron BJ, Hovsepian M, Lamki LM, Kalisky Z, Cassidy J, Freeman T, Lilly R,
Patel N, Walker M, Plenger P: Brain SPECT Findings in Patients with Memory Loss
Secondary to Moderate to Severe Closed Head Injury (CHI). American Roentgen
Ray Society, 1995 Annual Meeting, Washington, DC, May 1995 (#765).
29.
Barron BJ, Hovsepian M, Lamki L, Kramer L, Wheless J, Kalisky Z, Willmore J,
Curtis V, Grotta J: Brain SPECT Findings in Non-Psychiatric and NonAtherosclerotic Neurological Syndromes: A Pictorial Essay. American Roentgen Ray
Society, 1995 Annual Meeting, Washington, DC, May 1995 (#780).
30.
Lamki L, Raval B, Goldman S: The Impact of the Radiologists’ Continuous Quality
Improvement (CQI) Program on the Referring Physicians and the Institution.
American Roentgen Ray Society, 1995 Annual Meeting, Washington, DC, May 1995
(#1203).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 84
31.
Slaton JW, Browne BJ, Lamki L, Kahan BD: 99mTc-MAG-3 Clearance Predicts
Delayed Graft Function after Cadaveric Renal Transplantation. 14th Annual
Scientific Meeting of The American Society of Transplant Physicians, Chicago, IL,
May 1995.
32.
Browne BJ, Slaton JW, Lamki L, Verani R, Kahan BD: 99mTc-DTPA Perfusion
Predicts Acute Rejection but Fails to Differentiate Pathologic Grade in Renal
Allografts. 14th Annual Scientific Meeting of The American Society of Transplant
Physicians, Chicago, IL, May 1995.
33.
Tran HD, Barron BJ, Lamki LM, Pinero S, Ingram L, Day S, Reich H, Bull J, Holoye
P, MacFadyen B, Robins D: How to Diagnose and Stage Primary Breast Cancer with
Scintimammography and SPECT: An Interactive Multimedia Tutorial. Society of
Nuclear Medicine 42nd Annual Meeting, Minneapolis, MN, June 1995 (#1219).
(Honorable Mention Award).
34.
Rodgers BM, Barron BJ, Lamki LM: Imaging in Osteomyelitis: An Algorithmic
Approach. 81st Scientific Assembly and Annual Meeting of the Radiological Society
of North America, Chicago, IL, November 1995 (#227SK).
35.
Barron B, Grotta J, Lamki L, Villar-Cordova C, Ephron V, Patel D: Preliminary
Experience with Technetium-99m BMS-181321, a Nitroimidazole, in the Detection
of Cerebral Ischemia Associated with Acute Stroke. The Society of Nuclear
Medicine 43rd Annual Meeting, Denver, CO, June 1996 (#1218).
36.
Barron BJ, Lamki LM, Zelitt D, Duke JH, Lally KP, Caplan R, Ephron VJ: Clinical
Utility of Tc-99m-MN3 Fab’ Fragment of Anti-Granulocyte Antibody (Leukoscan®)
in the Diagnosis of Atypical Acute Appendicitis. The Society of Nuclear Medicine
43rd Annual Meeting, Denver, CO, June 1996 (Walking Poster Presentation #708).
37.
Lamki L, Slaton JW, Barron B, Browne BJ, Kahan BD: Renal Allograft: Initial Tc99m MAG3 Clearance at 3 Hrs Can Predict Delayed Graft Function (DGF) and Tc99m-DTPA Perfusion Score During Follow-Up Correlates with Rejection. The
Society of Nuclear Medicine 43rd Annual Meeting, Denver, CO, June 1996 (#1306).
38.
Ravichandran GK, Barron B, Lamki LM, Padmanabhan-Ayyar G: Brain SPECT in
attention deficit hyperactivity disorder (ADHD): Utility in Directing Appropriate
Therapy. X World Congress of Psychiatry, Madrid, SPAIN, August 1996 (#G1294).
39.
Goldenberg DM, Pinsky CM, Datz FL, Harwood SJ, Quenzer RW, Hung C, Barron
BJ, Lamki L: Phase-III Trial Results of Leukoscan in the Imaging of Infection and
Inflammation. European Association of Nuclear Medicine Congress, Copenhagen,
Denmark, September 1996 (#PMo599).
40.
Lamki LM, Padmanabhan-Ayyar G, Ravichandran GK, Barron BJ: Attention-Deficit
Hyperactivity Disorder: Utility of Tc-99m ECD Brain SPECT in Diagnosis and
Directing Appropriate Therapy. 82nd Scientific Assembly and Annual Meeting of the
Radiological Society of North America, Chicago, IL, December 1996 (072NR).
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 85
41.
Johnson B, Barron B, Lamki N, Wagner L, Fang B, Simms D, Kenny P, Overton D,
Wells L, Chen R, Abramson D, Minkowitz H, Shafer A, Lamki L: The Effect of
Acute IV Cocaine Challenge in Abusers on Brain Perfusion as Shown by
Quantitative SPECT and Brain Perfusion Index (BPI). The Society of Nuclear
Medicine 44th Annual Meeting, San Antonio, TX, June 1997 (#1156).
42.
Odita JC, Ross PJ, Barron BJ, Lamki LM, Cross CA, Burau KD: The Impact of
Teenage Pregnancy on Bone Mineral Content. The Society of Nuclear Medicine
44th Annual Meeting, San Antonio, TX, June 1997 (“Meet the Author” Poster
Session #1229).
43.
Saad YD, Lamki LM (sponsor): Role of Lymphoscintigraphy in Traumatic Pediatric
Chylothorax. The University of Texas-Houston Health Science Center Summer
Research Program Student Poster Presentations, Undergraduate Students, Summer
1997.
44.
Adham WK, Lamki LM (sponsor): Impact of Brain SPECT Imaging on the
Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD). The
University of Texas-Houston Health Science Center Summer Research Program
Student Poster Presentations, Undergraduate Students, Summer 1997.
45.
Lamki L, Raval B, Goldman S. Evaluation of a Comprehensive CQI Program for
Radiologists in a Changing Healthcare Environment--A Story Book. 83rd Scientific
Assembly and Annual Meeting of the Radiological Society of North America,
Chicago, IL, December 1997 (CATEGORY I Scientific Exhibit #MS 3341).
46.
Barron B, Holoye P, Lamki L, Bull J, Redwine MD, Ephron V: Tc-99m-L12
Monoclonal Antibody in the Initial Staging and Restaging of Patients with B-Cell
Non-Hodgkin’s Lymphoma. Initial Experience and Pitfalls: A Pictorial Essay. 83rd
Scientific Assembly and Annual Meeting of the Radiological Society of North
America, Chicago, IL, December 1997 (Scientific Exhibit #RO 3764, Space
0702RO).
47.
Zelitt DL, Raval BK, Dinwiddie S, Lamki LM, Goldman SG: Improvement in
Turnaround Time for the Radiology Report in a Teaching Hospital. 83rd Scientific
Assembly and Annual Meeting of the Radiological Society of North America,
Chicago, IL, December 1997 (Scientific Exhibit, Space 0864CEPH).
48.
Johnson BA, Wagner L, Lamki L Fang B, Barron B, Wells LT, Kramer L, Bordnick
PS, Chen R, Abramson D, Dhother S, Vogelson L: Reliability of a Novel
Quantitative SPECT Technique for Measuring Low, High, and Normal Blood Flow
States in the Brain. 36th Annual Meeting of American College of
Neuropsychopharmacology, Waikoloa, Hawaii, December 1997
49.
Barron BJ, Andijar R, Lamki L, Fang B: Tc-99m-ECD (Neurolite) Cerebral Blood
Flow in the Determination of Brain Death: A Pictorial Essay of Complicating
Factors. 43rd Annual Meeting of the Southwestern Chapter of the Society of Nuclear
Medicine, Houston, TX, March 1998.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 86
50.
Huynh SL, Amin RS, Barron B, Nikolaidis P, Lamki L: Nuclear Imaging of
Meckel’s Diverticulum: A Pictorial Essay of Pitfalls. American Roentgen Ray
Society 98th Annual Meeting, San Francisco, CA, April 1998.
51.
Tamm E, Barron BJ, Lamki LM, Roarke M, Bull J, Holoye P, Requenez E, Ephron
V: Potential Clinical Utility of TC-99M-LL2, Anti-Raji Cell Monoclonal Antibody
in the Follow-Up and Staging of Patients with B-Cell Lymphoma. American
Roentgen Ray Society 98th Annual Meeting, San Francisco, CA, April 1998.
52.
Lamki L, Raval B, Goldman S: The Impact of Changing Health-Care Environment
on Nuclear and Radiology Continuous Quality Improvement (CQI) Activities -Response of a Teaching Hospital Department. The Society of Nuclear Medicine 45th
Annual Meeting, Toronto, Canada, June 1998 (Scientific Exhibit, #1307, Ref
#39951).
53.
Huynh S, Amin R, Barron B, Dhekne R, Lamki L: Pitfalls of Nuclear Imaging of
Meckel's Diverticulum: A Pictorial Essay. The Society of Nuclear Medicine 45th
Annual Meeting, Toronto, Canada, June 1998 (Scientific Exhibit, #1308, Ref
#40963).
54.
Barron B, Rachal L, Lamki L, Nisbet R, Stroehlein K, Ephron V: Predictive Value of
Gallbladder Ejection Fraction in the Outcome of Cholecystectomy for Chronic
Biliary Dysfunction: A Follow-Up Study and Comparison with Pathology Findings.
The Society of Nuclear Medicine 45th Annual Meeting, Toronto, Canada, June 1998
("Meet the Author" Poster Session, #1198, Ref #39933).
55.
Barron B, Lamki L, Stroehlein K, Tamm E, Bull J, Holoye P, Fang B, Requenez E,
Ephron V: Tc-99m-LL2 (Monoclonal Antibody Against Raji Cells) in Evaluation of
Patients with B-Cell Lymphoma: Comparison of Uptake with Histology Findings and
Flow Cytometry Results. The Society of Nuclear Medicine 45th Annual Meeting,
Toronto, Canada, June 1998 ("Meet the Author" Poster Session, #1076, Ref
#39935).
56.
Lamki L, Barron B, Stroehlein K, Tamm E, Bull J, Holoye P, Fang B, Requenez E,
Ephron V: Tc-99m-LL2 (Monoclonal Antibody Against RAJI Cells) in the Initial
Staging and Follow-Up of B-Cell Lymphoma; Utility After Therapy. Joint Congress
of the European Association of Nuclear Medicine and the World Federation of
Nuclear Medicine and Biology, Berlin, Germany, September 1998.
57.
Barron, B, Lamki, L: The Standardized Uptake Value (SUV): Is It Necessary for
Diagnosing Malignant Tissue by FDG-PET? American Roentgen Ray Society 1999
annual Scientific Meeting, New Orleans, LA, May 1999 (Exhibit, Abstract ID 2576).
58.
Lamki, LM, Anidjar, R, Barron, BJ, Fang B: Diagnosis of Brain Death by TC-99mECD: Exhibit of Patterns Encountered and Pitfalls to be Avoided. Society of
Nuclear Medicine, Los Angeles, CA, June 1999 (Computer Exhibit # 1464).
59.
Gayed, I, Lamki, LM, Barron, B, Ingram, L, Casey, C, Huynh, P, Glass, D: Patterns
of Tc-99m MIBI, Tc-99m Anti-CEA Antibody, and F-18 FDG Uptake in Various
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 87
Breast Conditions Benign and Malignant. Society of Nuclear Medicine, Los
Angeles, CA, June, 1999 (Computer Exhibit #1463).
60.
Barron, BJ, Lamki, L, Kim, E, Mullani, N, Mitchell, T, Chin, H: Patterns and
Pitfalls of PET Imaging of Lung Cancer: A Pictorial Essay. Society of Nuclear
Medicine, Los Angeles, CA, June 1999 (Computer Exhibit #1462).
61.
Lamki, LM, Bhosale, P, Barron, BJ, Stroehlein, K, Grilley, K: Tc-99m-HMPAOWBC Four Phase Imaging in the Diagnosis of Osteomyelitis (OM) in Patients with
Diabetic Foot Ulcers: Comparison with Biopsy Findings. Society of Nuclear
Medicine, Los Angles, Ca, June, 1999. (Meet the Author Poster Session, Poster
Exhibit #902).
62.
Mitchell, TA, Barron, BJ, Oldham, SA, Lamki, LM, Tamm, EP, Chen, PC, Bass, EJ,
Bhosale, P: Correlation of VQ Scans, Doppler Ultrasound and Chest Radiographs
with CT Angiography in Patients with Clinical Suspicion of Pulmonary Embolus: A
suggested Algorithm for Patient Management. 85th Scientific Assembly and Annual
Meeting of the RSNA in Chicago, IL., in November 28 – December 3, 1999
63.
Lamki, LM, Barron, BJ, Stroehlein, K, Grilley, K.: Tc-99m-HMPAO-WBC FourPhase Imaging in the Diagnosis of Osteomyelitis (OM) in Patients with Diabetic Foot
Ulcers: Comparison with Biopsy Findings: 85th Scientific Assembly and Annual
Meeting of the RSNA in Chicago, IL., in November 28 – December 3, 1999
64.
Barron, BJ, Mitchell, TA, Lamki, LM, Chin, H, Mullani, N, Kim, E: FDG-PET
Imaging of Lung Cancer: A Pictorial Essay of Patterns and Pitfalls. . 85th Scientific
Assembly and Annual Meeting of the RSNA in Chicago, IL., in November 28 –
December 3, 1999.
Censullo, M.L., Barron, B.J., Lamki, L.M. Podoloff, D.A.: Radionuclide
Venography as an Adjunct to Ventillation-Perfusion Lung Scintigraphy in the
Detection of Pulmonary Thromboembolic Disease. Radiological Society of Nuclear
Medicine, Chicago, IL, Dec., 2000.
65.
66.
Barron, B.J., Censullo, M.L., Lamki, L.M., Hoots, K., Clyburn, T.: Radiation
Synovectomy in Hemophiliac Patients: A How-to Instructional Guide with Digital
Video Demonstrations. Radiological Society of North America, Chicago, Il.
December, 2000.
E.3
INVITED LECTURES:
(International, National, State/Regional, and Local)
INTERNATIONAL
1.
”Nuclear Medicine Update and Evaluation”. Guest Lecturer, Ministry of Health
Hospitals Staff, Muscat, Oman, January 1982.
2.
”Evaluation of Diagnostic and Screening Tests”. Guest Lecturer, Gulf States
Symposium, Abu Dhabi, United Arab Emirates, January 1982.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 88
3.
”The Effect of Increasing Unlabeled Monoclonal Antibody (MoAb) Doses on
Metastases Detection and on Body Distribution of Various In-111 MoAbs”. Invited
Guest Speaker, Symposium on Radiopharmacology, IV World Federation of Nuclear
Medicine and Biology, Buenos Aires, Argentina, November 1986.
4.
”Update on Nuclear Medicine”. Invited Lecturer, Sultan Qaboos University, College
of Medicine, Oman, March 1988.
5.
”Monoclonal Antibody Radioimaging in Nuclear Oncology”, Guest Speaker, 3rd
United Arab Emirates Cancer Conference, University of United Arab Emirates at AlAin, Abu Dhabi, U.A.E., February 1989.
6.
”New Applications of Nuclear Medicine Tests in Patients with Cancer”, Guest
Speaker, 3rd United Arab Emirates Cancer Conference, University of United Arab
Emirates at Al-Ain, Abu Dhabi, U.A.E., February 1989.
7.
”Pain Control in Oncology: Role of Nuclear Medicine”. Participant in Panel
Discussion, 3rd United Arab Emirates Cancer Conference, University of United Arab
Emirates at Al-Ain, Abu Dhabi, U.A.E., February 1989.
8.
”Radiolabel as a Factor in Radioimmunoimaging”. Invited Guest Speaker at Sixth
International Symposium on Radiopharmacology, Sydney, Australia, August 1989.
9.
”Future Prospects in Immunoscintigraphy and Therapy”. Invited Guest Lecturer,
Symposium on Radioimmunoscintigraphy at Kuwait University, Kuwait, December
1989.
10.
”Fragments vs. Intact IgG”. Invited Guest Lecturer, Symposium on
Radioimmunoscintigraphy at Kuwait University, Kuwait, December 1989.
11.
”Problems in Immunoscintigraphy”. Invited Guest Lecturer, Symposium on
Radioimmunoscintigraphy at Kuwait University, Kuwait, December 1989.
12.
”Radioimmunotherapy of Ovarian Cancer, Using Intraperitoneal Y-90 B72.3 With
and Without EDTA as Scavenger”. Invited Speaker, 8th Hammersmith International
Conference on Advances in the Applications of Monoclonal Antibodies in Clinical
Oncology, Halkidiki, Greece, May 1991.
13.
”Radioimmunodiagnosis and Therapy in Clinical Medicine”. Invited Speaker, Queens
University Gynecology Department, Belfast, Northern Ireland, November 1991.
14.
”Nuclear Medicine Update”. Invited Speaker, Sultan Qaboos University, Muscat,
Oman, February 1992.
15.
”CQI, TQM and the Physician”. Dean’s Lecture by Invited Speaker, Sultan Qaboos
University, Muscat, Oman, February 1992.
16.
“Basic Principles and Recent Developments”. Invited Lecturer, First Radiological
Update of Oman, Institute of Health and Sciences, Sultanate of Oman, February
1993.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 89
17.
”Brain & Heart -Functional Imaging - SPECT and PET”. Invited Lecturer, First
Radiological Update of Oman, Institute of Health and Sciences, Sultanate of Oman,
February 1993.
18.
”Sensitivity, Specificity and Predictive Value of Tests”. Invited Lecturer, First
Radiological Update of Oman, Institute of Health and Sciences, Sultanate of Oman,
February 1993.
19.
“Quality Assurance in Medical Care”. Invited Lecturer, First Radiological Update of
Oman, Institute of Health and Sciences, Sultanate of Oman, February 1993.
20.
”Nuclear Image Advances in the Cerebral Vascular Disease”. Invited Lecturer, Ninth
International meeting of Medicine, Instituto Technologico y de Estudios Superiores
de Monterrey Medicine School, Monterrey, Mexico, February 1993.
21.
”Total Quality Management”. Invited lecturer, Ninth International Meeting of
Medicine, Instituto Technologico y de Estudios Superiores de Monterrey Medicine
School, Monterrey, Mexico, February 1993.
22.
”Brain SPECT”. Invited Lecturer, Unidad de Patologia Clinica, Guadalajara, Mexico,
May 1993.
23.
”Brain SPECT”. Invited Lecturer, XXVII Annual Congress of Sociedad, Mexicana de
Medicina Nuclear, Ajijic, Chapala, Mexico, May 1993.
24.
”Total Quality Management”. Invited Lecturer, XXVII Annual Congress of Sociedad,
Mexicana de Medicina Nuclear Ajijic, Chapala, Mexico, May 1993.
25.
”Hot Topics in Nuclear Medicine”. Dean's Lecture by Invited Speaker, Sultan Qaboos
University, College of Medicine, Oman, January 1995.
26.
“New Roles of Functional Nuclear Medicine Imaging”. Invited Lecturer, Sultan
Qaboos University, College of Medicine, Oman, February 1996.
27.
“Anti-Granulocyte Monoclonal Antibody Imaging of Acute Atypical Appendicitis”.
Invited Speaker, Immunomedics Symposium at EANM Congress, Copenhagen,
Denmark, September 1996.
28.
“Breast Cancer Radio-Immuno-Imaging: Houston Experience”. Invited Speaker,
International Symposium on Breast Imaging, Bonn, Germany, September 1996.
29.
"Brain SPECT in Clinical Practice, Review Talk". Invited Speaker, The 2nd Annual
Congress of the Syrian Radiological Society, Damascas, Syria, Oct, 1997.
30.
"Role of Nuclear Imaging in Renal Transplantation and Liver Allografts, Review
Talk". Invited Speaker, The 2nd Annual Congress of the Syrian Radiological Society,
Damascas, Syria, October, 1997.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 90
31.
"Continuous Quality Improvement in the Departments of Radiology and Nuclear
Medicine". Invited speaker, The 2nd Annual Congress of the Syrian Radiological
Society, Damascus, Syria, October 1997.
32.
“Nuclear Imaging in Sports Medicine in the New Millennium” The Third Asian
Federation of Sports Medicine Congress Muscat, Sultanate in Oman, Muscat.
January 29 through February 2, 2000.
33.
“Imaging of the Patho-Physiologic Changes in Sports Injury.” The Third Asian
Federation of Sports Medicine Congress Muscat, Sultanate in Oman, Muscat.
January 29 through February 2, 2000.
34.
“PET imaging in clinical practice”. Sultan Qaboos University – College of Medicine
& Health Sciences – Dean's Invitational Lecture, Oman, December, 2003.
35.
“Molecular Imaging and PET Scanning” – Gulf Medical Association Conference,
Jeddah. Saudi Arabia. March 2005
36.
Radiology Board Review for Nuclear Medicine - Invited Lecturer, University of
Texas Residents. March 2006.
37.
"PET in Pediatric Oncology". Invited Speaker, 2nd Gulf Nuclear Medicine
Conference - Dubai, UAE. November 07, 2006.
38.
"PET in G.I. Oncology". Invited Speaker, 2nd Gulf Nuclear Medicine Conference Dubai, UAE. November 08, 2006.
39.
"Setting Up Quality Assurance / Performance Improvement in Nuclear / Radiology
Departments". Invited Speaker, 2nd Gulf Nuclear Medicine Conference - Dubai,
UAE. November 08, 2006.
40.
"PET Imaging in Pediatrics". Invited Speaker, Third Annual Symposium of National
Institute of Child Health – Karachi, Pakistan. January 13, 2007.
41.
"Role of PET Scan in Head and Neck Cancer" – Invited Speaker, Head and Neck
Conference – Kuwait, March 07, 2007.
42.
"PET in Gastro-Intestinal Oncology" 3rd Radiological Society of Saudi Arabia
Conference. Jeddah, Saudi Arabia. 09 April 2007.
43.
"PET in Lymphoma" 3rd Radiological Society of Saudi Arabia Conference. Jeddah,
Saudi Arabia. 10 April 2007.
44.
"Read with the Experts" 3rd Radiological Society of Saudi Arabia Conference.
Jeddah, Saudi Arabia. 12 April 2007.
45.
"PET/CT" Annual Riyadh Radiology Review – Riyadh, Saudi Arabia, 03 September
2007.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 91
46.
"PET in Oncology". Radiological Society of Saudi Arabia (RSSA 4) – Nuclear
Medicine Program. Jeddah, Saudi Arabia. 02 April 2008.
47.
"SPECT in Epilepsy and other CNS Disorders". Radiological Society of Saudi
Arabia (RSSA 4) – Nuclear Medicine Program. Jeddah, Saudi Arabia. 02 April
2008.
48.
"PET/CT in Lymphoma and Melanoma". 3rd Gulf Nuclear Medicine Conference.
Kuwait, 30 March 2009.
49.
"PET/CT in Colorectal Cancer". 3rd Gulf Nuclear Medicine Conference. Kuwait.
30 March 2009.
50.
"Pitfalls & Artefacts in PET/CT Imaging". 3rd Gulf Nuclear Medicine Conference.
Kuwait. 30 March 2009.
NATIONAL
1.
“UPDATE - Status of Monoclonal Antibody Imaging”. Invited Lecture, Southwest
Chapter of Society of Nuclear Medicine Annual Meeting, Dallas, TX, March 1986.
2.
“Monoclonal Antibody Fragments Vs. Intact IgG”. Invited Speaker, American
College of Nuclear Medicine 15th Annual Scientific Meeting, Lake Tahoe, NE,
September 1988.
3.
“Imaging of Breast Cancer”. Invited Lecturer, Hahnemann Medical School and
Hospital, Philadelphia, PA, March 1989.
4.
“Detection of Occult Recurrence of Colon Cancer”. Invited Lecturer, Hahnemann
Medical School and Hospital, Philadelphia, PA, March 1989.
5.
“Monoclonal Antibody Imaging Update”. Invited Speaker, Philadelphia Nuclear
Medicine Conference, Philadelphia, PA, March 1989.
6.
“Tc-Monoclonal Antibodies in the Localization and Follow-Up of Lung Cancer”.
Invited guest Speaker, Conference on Current Status and Future Direction in
Immunoconjugates, Orlando, FL, February 1990.
7.
“Intraperitoneal Radioimmunotherapy”. Invited Guest Speaker, Department of
Radiation and Cellular Oncology, University of Chicago, Chicago, IL, November
1990.
8.
“Monoclonal Antibodies”. Invited Speaker, Society of Nuclear Medicine/Southwestern Chapter Annual Meeting, Oklahoma City, OK, April 1991.
9.
“SPECT II: Imaging of Tumors”. Invited Speaker, Society of Nuclear Medicine
Annual Meeting, Cincinnati, OH, June 1991.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 92
10.
“Monoclonal Antibodies: Diagnostic and Therapeutic Uses in Nuclear Medicine:
Problems in Radioimmunoimaging of Tumors”. Invited Speaker, Society of Nuclear
Medicine Annual Meeting, Cincinnati, OH, June 1991.
11.
“Potential Clinical Role of Monoclonal Antibodies in Oncology and Non-Oncology
Practice”. Invited Lecture (Visiting Professor) to Clinicians and Residents, Baptist
Medical Center, Oklahoma City, OK, November 1992.
12.
“Monoclonal Antibodies - Basic Principles”. Invited Lecture (Visiting Professor),
Baptist Medical Center Radiology Residency Program, Oklahoma City, OK,
November 1992.
13.
“Clinical Utility of Brain SPECT”. Invited Lecture (Visiting Professor), Baptist
Medical Center, Oklahoma City, OK, November 1992.
14.
“Monoclonal Antibodies: Present and Future Applications”. Invited Guest Speaker,
Nuclear Medicine Update 1993, A Discussion on Clinical Advances in Nuclear
Oncology, St. Agnes Medical Center, Fresno, CA, October 1993.
15.
“Brain SPECT in Epilepsy, Closed Head Injuries, Stroke and Psychiatric Disorders”.
Invited Lecturer, Fall Symposium of the Oklahoma Section of Society of Nuclear
Medicine, Oklahoma City, OK, November 1993.
16.
“An Update on Current Gastrointestinal Nuclear Medicine Imaging”. Invited Faculty,
American College of Nuclear Medicine, Annual Scientific Meeting, Houston, TX,
March 1994.
17.
“Monoclonal Antibodies: Genetic Bioengineering and Designer Antibodies, An
Update”. Keynote Speaker, Central Oklahoma Radiological Society (ORS),
Oklahoma City, OK, May 1996.
18.
“Renal Transplant: Immunology and Nuclear Evaluation”. Guest Lecturer to the
Transplant Program Faculty/Personnel, University of Oklahoma Medical School,
Oklahoma City, OK, May 1996.
19.
“Brain SPECT: New Roles in Clinical Neurology/Psychiatry”. Guest Lecturer,
Nuclear Medicine Seminar, University Hospital, San Antonio, TX, August 1996.
20.
“Nuclear Medicine QA/CQI: A Practical Approach”. Invited Speaker, Scientific
Session, Annual Meeting of the American College of Nuclear Medicine, Palm
Springs, CA, February 1997.
21.
“Brain SPECT in the Clinical Setting”. Invited Speaker, Scientific Session, Annual
Meeting of the American College of Nuclear Medicine, Palm Springs, CA, February
1997.
22.
”Organ Transplants: Principles and Role of Nuclear Medicine”. Invited Speaker,
Southwestern Chapter of The Society of Nuclear Medicine 42nd Annual Meeting and
Cardiac Nuclear Medicine Symposium, New Orleans, LA, April 1997.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 93
23.
"Pediatric Nuclear Medicine: New Tests, New Uses, Old Fears". Invited Speaker,
Scientific Session, 25th Annual Meeting of the American College of Nuclear
Medicine, Las Vegas, NE, January 1998.
24.
“Brain SPECT: Clinical Utility”. Invited Speaker, 52nd Annual Midwinter
Radiological Conference of the Los Angeles Radiological Society, Pasadena, CA.
January, 2000.
25.
“RadionuclideTumor Imaging: Current Trends”. Invited Speaker, 52nd Annual
Midwinter Radiological Conference of the Los Angeles Radiological Society,
Pasadena, CA. January, 2000.
26.
“PET Scanning: The Impact On Management of Oncology Patients”. Daniel
Freeman Memorial Hospital, Los Angeles, CA. June, 2002.
27.
“PET Imaging: Principles and Clinical Utility”: Annual Meeting, Radiology Club
of Oman, SUR, Oman., March 2005
28.
“How to write a Winning Research Grant Proposal” : Annual Research Day
Symposium of Sultan Qaboos University, Crown Plaza, Muscat, Oman, Feb, 2005
29.
"Communication Skills and Attitude". Invited Speaker - Oman Association of
Radiographers, Professionalism in Health Care Seminar - Muscat, Sultanate of
Oman. January 26, 2006.
30.
“Clinical Nuclear Medicine for Technologists”, Institute of Health Science / Ministry
of Health, Muscat, Oman, 27 March 2006.
31.
“Nuclear Medicine in Pregnancy”
32.
"PET in Epilepsy and Other Neurological Disorders", Radiology Club of Oman
Meeting. Crown Plaza Hotel, Muscat, Oman. 01 November 2007.
33.
"Ethics". White Coat Ceremony. Oman Medical College, Sohar Campus. Sohar,
Sultanate of Oman. 14 December 2008.
34.
"Services Offered by the Department of Nuclear Medicine in Sultan Qaboos
University Hospital (SQUH)". Workshop on Nuclear Techniques in Human Health.
Al Bustan Palace Hotel, Sultanate of Oman. 16 March 2009.
35.
"Quality Assurance and Patient Safety". Management Workshop. CPE Dept., Royal
Hospital. 22 March 2009.
36.
"PEER REVIEW for Oman Medical College and Sohar Hospital". Sohar Hospital
Auditorium. Sohar Hospital, Sohar, Sultanate of Oman. 29 April 2009.
37.
"How to write a Scientific Paper". Continuing Professional Education, Al Nadha
Hospital, Muscat, Sultanate of Oman. 14 December 2009.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 94
38.
“Specialty-Specific Criteria for Accreditation for ENT Training Program”. Lecture
about ACGME-I Requirements, Oman Medical Specialty Board, Lecture Hall. 19th
January 2013.
39.
Lecture on “Reseach Ethics”. Research Methodology Workshop for Central
Committee, Muscat Holiday, Muscan, Oman. 10-12 March 2013
STATE / REGIONAL
1.
”Nuclear Medicine in Assessment of Acute Renal Failure”. Invited Lecturer,
Canadian Association of Nuclear Medicine Annual Meeting, Annual Meeting, April
1981.
2.
”Gated Blood Pool Imaging”. Guest Lecturer, Nuclear Cardiology Seminar of the
Toronto Institute of Medical Technology, Toronto, Canada, April 1982.
3.
”Monoclonal Antibodies-Immunoscintigraphy”. Invited Guest Speaker, Texas
Medical Association Section of Nuclear Medicine, San Antonio, TX, May 1988.
4.
”The Future of Radioimmunoscintigraphy”. Invited Guest Speaker, Texas Medical
Association Annual Session, Corpus Christi, TX, May 1990.
5.
”Brain Imaging with a Multi-Headed Detector”. Keynote Speaker, Texas Medical
Association 1991 Annual Session, Dallas, TX, May 1991.
6.
”Brain SPECT Using 3-Head Camera and Tc-HMPAO”. Invited Speaker/San
Antonio Society of Nuclear Medicine Annual Meeting, San Antonio, TX, March
1991.
7.
”Functional Brain SPECT Imaging”. Invited Lecturer to Medical Staff, St. Joseph’s
a. Hospital, Bryan, TX, November 1992.
8.
”Brain SPECT”. Invited Speaker, San Antonio Nuclear Medicine Society, San
Antonio, Texas, February 1992.
9.
”Brain SPECT”. Invited Speaker, Houston/Galveston Nuclear Medicine Technicians
Association, August 1992.
10.
”Total Quality Management/Quality Improvement”. Invited Lecturer, Society of
Nuclear Medicine/Southwestern Chapter, Dallas, TX, March 1993.
11.
”Total Quality Management”. Invited Lecturer, Texas Medical Association, Houston,
TX, May 1993.
12.
“General Cardiac Imaging”. Invited Guest Speaker, Houston Technologist Section,
Society of Nuclear Medicine/Southwest Chapter Annual Symposium, Conroe, TX,
October 1993.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 95
13.
“MIBG Imaging of the Adrenal Medullary”. Invited Lecturer, Fall Symposium of the
Texas Gulf Coast Chapter of Nuclear Medicine Technologists, Galveston, TX,
October 1994.
14.
“Fundamentals of PET and SPECT Imaging in Nuclear Medicine”. Invited Speaker,
South Texas Chapter of the Health Physics Society, Houston, TX, November 1994.
15.
“An Overview of Modern Nuclear Medicine”. Invited speaker, South Texas Chapter
of the Health Physics Society, Houston, TX, November 1994.
16.
“Nuclear Medicine Brain SPECT”. Invited Speaker, Society for Nuclear Medicine,
Radiologic Technology Week Seminar, Good Shepard Medical Center, Longview,
TX, November 1994.
17.
“QA and TQI”. Invited Speaker, Society for Nuclear Medicine, Radiologic
Technology Week Seminar, Good Shepard Medical Center, Longview, TX,
November 1994.
18.
“TQM: Operational Examples and Results”. Invited Lecturer, School of Public
Health, The University of Texas at Houston, TX, April 1996.
19.
“Role of Nuclear Imaging in Thyroid Cancer”. Weekly Oncology Combined
Modality Conference, Hermann Hospital/UTMS, Houston, TX, April 1996.
20.
“Recent Developments in Antibody Subfragments, Peptides, and Receptor Imaging”.
Guest Lecturer, Nuclear Medicine Seminar Series, South Texas Veterans Health Care
System, San Antonio, TX, August 1996.
21.
PET: A Payable Procedure” Texas Radiological Society 90th Annual Scientific
Meeting (The American College of Radiology) The Woodlands, Texas, April 3,
2003.
22.
“Sultan Qaboos University Academic Health Science Center – A Proposal.” AAHCI
Middle East and North Africa Regional Conference. Hamad Medical Corporation,
Doha, Qatar. 17-19 March 2013
LOCAL
1.
”Endocrine Aspects of Sports Medicine”. Invited Lecturer, Annual Clinical Day of
the Orthopaedic and Arthritic Hospital, Toronto, Canada, May 1980.
2.
”Thyroid Nodule and Radionuclides”. Invited Speaker, Dept. of Medicine Meeting,
Victoria Hospital, University of Western Ontario, London, Ontario, Canada,
February 1982.
3.
”Radionuclide Investigation of the Biliary Tree”. Guest Lecturer, City-Wide
Gastroenterology Meeting, University of Western Ontario, London, Ontario, Canada,
September 1982.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 96
4.
”Nuclear Medicine and Nephrology”. Guest Lecturer, City-Wide Renal Meeting,
University of Western Ontario, London, Ontario, Canada, December 1982.
5.
“Indications for Technetium Thyroid Scanning”. Guest Panelist, Interhospital
Endocrinology Meeting, St. Joseph’s Hospital, London, Ontario, Canada, January
1983.
6.
”Advantages of 99m-Tc-Pertechnetate Thyroid Scan”. Guest Lecturer, Inter-Hospital
Endocrine Meeting, University of Western Ontario, London, Ontario, Canada,
January 1983.
7.
“Indications for Technetium Thyroid Scanning”. Guest Panelist, Interhospital
Endocrinology Meeting, St. Joseph’s Hospital, London, Ontario, Canada, January
1983.
8.
”Advantages of 99m-Tc-Pertechnetate Thyroid Scan”. Guest Lecturer, Inter-Hospital
Endocrine Meeting, University of Western Ontario, London, Ontario, Canada,
January 1983.
9.
”Nuclear Medicine and Nephrology”. Guest Lecturer, City-Wide Renal Meeting,
University of Western Ontario, London, Ontario, Canada, December 1982.
10.
”Radionuclide Investigation of the Biliary Tree”. Guest Lecturer, City-Wide
Gastroenterology Meeting, University of Western Ontario, London, Ontario, Canada,
September 1982.
11.
“Indications for Technetium Thyroid Scanning”. Guest Panelist, Interhospital
Endocrinology Meeting, St. Joseph’s Hospital, London, Ontario, Canada, January
1983.
12.
”Advantages of 99m-Tc-Pertechnetate Thyroid Scan”. Guest Lecturer, Inter-Hospital
Endocrine Meeting, Univ. of Western Ontario, London, Ontario, Canada, January
1983.
13.
”Nuclear Medicine and Nephrology”. Guest Lecturer, City-Wide Renal Meeting,
University of Western Ontario, London, Ontario, Canada, December 1982.
14.
”Radionuclide Investigation of the Biliary Tree”. Guest Lecturer, City-Wide
Gastroenterology Meeting, University of Western Ontario, London, Ontario, Canada,
September 1982.
15.
“Computers in Nuclear Medicine Interpretation”. Invited Lecturer, Isotopes and
Nuclear Medicine Seminar of Graduate School of Biomedical Sciences, University of
Texas Health Science Center, Houston, TX, December 1984.
16.
“Case Reports from Nuclear Medicine Illustrating the Role of Radionuclide
Procedures in Acute Renal Failure”. Invited Lecturer, Department of Internal
Medicine Monthly Staff Meeting, University of Texas System Cancer Center M.D.
Anderson Hospital and Tumor Institute, Houston, TX, June 1984.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 97
17.
“Opiate Receptors in Gastrointestinal Physiology”. Invited Lecturer, Isotopes and
Nuclear Medicine Seminar, The University of Texas system Cancer Center M.D.
Anderson Hospital and Tumor Institute, Houston, TX, April 1984.
18.
“Nuclear Medicine in the Critically Ill”. Invited Lecturer, Symposium on Critical
Care, London, Ontario, Canada, November 1983.
19.
”Nuclear Medicine in Orthopaedics”. Invited Speaker, Orthopaedic Postgraduate
Course, Victoria Hospital, London, Ontario, Canada, August 1983.
20.
”Nuclear Medicine of GI Bleed, Gallbladder Disease and Pulmonary Embolus”.
Series of Invited Lectures, I.C.U. Faculty, Victoria Hospital, July - August, 1983.
21.
”Radionuclide Imaging in G.I. Practice”. Invited Lecturer, Department of Medicine
Postgraduate Medical Education, University of Western Ontario, London, Ontario,
Canada, May 1983.
22.
”Dynamic Renal Scanning in Hypertension and Balloon Angioplasty”. Invited CoLecturer (with Dr. JD Spence) to Medical Students, University of Western Ontario,
London, Ontario, Canada, March 1983.
23.
”Genitourinary System and Testicular Studies”. Invited Speaker, Three Invited
Lectures to Nuclear Medicine Technology Students, Houston Community College,
1986 and 1987.
24.
”Musculoskeletal System”. Three Invited Lectures to Nuclear Medicine Technology
Students, Houston Community College, Houston, Texas, 1986 and 1987.
25.
”Nuclear Medicine Update”. Series of Invited Lectures to VA Medical Center,
Radiology Department, and Baylor College of Medicine, Houston, TX, 1985, 1986,
1987, 1988.
26.
”Detection of Cancer Using Monoclonal Antibodies: Problems and Some Solutions”.
Invited Speaker, Clinical Oncology Grand Rounds, University of Texas M.D.
Anderson Cancer Center, Houston, TX, February 1988.
27.
”Adrenal Gland-Nuclear Imaging 1988”. Invited Guest Speaker, Joint Endocrine
Conference, The University of Texas-Houston Medical School and M.D. Anderson
Cancer Center, Houston, TX, May 1988.
28.
”Status and Application of Monoclonal Antibodies in Cancer Detection and
Treatment”. Guest Panelist, Mike Hogg Award Lecture (Dr. Clive Taylor),
University of Texas M.D. Anderson Cancer Center, Houston, TX, September 1988.
29.
”Newer Nuclear Medicine Tests”. Series of Lectures for Department of Obstetrics and
Gynecology, University of Texas M.D. Anderson Cancer Center, Houston, TX,
October and November, 1988.
30.
”Nuclear Medicine in Surgical Practice”. Guest Speaker, V.A. Medical Center
Surgical Grand Rounds, Houston, TX, December 1988.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 98
31.
”Choice of Isotopes for Radioimmunotherapy”. Invited Lecturer, Symposium on
“Leptomeningeal Neoplasia: Therapeutic Consideration”, University of Texas M.D.
Anderson Cancer Center, Houston, TX, March 1989.
32.
”Monoclonal Antibodies Imaging”, Invited Lecturer to Baylor College of Medicine
Nuclear Medicine Technology Students, St. Luke’s Hospital, and Texas Heart
Institute, Houston, TX, May 1989.
33.
”Radioimmunoimaging in Cancer”. Invited Speaker, Research Seminar, University of
Texas M.D. Anderson Cancer Center, June 1989.
34.
”Monoclonal Antibody Imaging of Cancer”. Invited Guest Faculty, Society of Nuclear
Medicine/Southwestern Chapter Annual Meeting, Houston, TX, April 1990.
35.
”The Hypoperfusion Syndrome in Psychiatry: Brain SPECT in Diagnosis and
Treatment”. Guest Speaker at The University of Texas Psychiatry Grand Rounds,
Houston, TX, February 1991.
36.
”Nuclear Medicine Basics and Clinical”. Invited Lecturer, Radiology Curriculum
Core Course to Third Year Medical Students, 1991, 1992, 1993, 1994, 1995, 1996,
University of Texas, Houston, Texas.
37.
”Brain SPECT”. Invited Speaker, San Antonio Nuclear Medicine Society, San
Antonio, Texas, February 1992.
38.
”Brain SPECT”. Invited Speaker, Houston/Galveston Nuclear Medicine Technicians
Association, August 1992.
39.
”Functional Brain SPECT Imaging”. Invited Lecturer to Medical Staff, St. Joseph’s
Hospital, Bryan, TX, November 1992.
40.
“Nuclear Medicine’s Role in Management of Hybernating Myocardium and
Myocardial Infarction”. Invited Lecturer, Seminars in Nuclear Medicine, Department
of Nuclear Medicine, The University of Texas M.D. Anderson Cancer Center,
Houston, TX, April 1993.
41.
”Functional Breast Nuclear Imaging: Current and Future Applications”. Invited
lecturer, Imaging Perspective, Diagnosis and Treatment of Breast Diseases, The
University of Texas-Houston Medical School and The Houston Radiological Society,
Houston, TX, September 1993.
42.
”Tc-ECD Brain SPECT - Initial Experience in Dementia and Epilepsy and Stabilized
Tc-HMPAO: Experience with Ictal Injections”. Invited Speaker, Seminars in Nuclear
Medicine, M.D. Anderson Cancer Center, Houston, TX, December 1993.
43.
“Renal Transplants: Update”. Invited Speaker, Seminars in Nuclear Medicine, M.D.
Anderson Cancer Center, Houston, TX, March 1994.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 99
44.
“Musculo-Skeletal System”. Invited Lecturer, Houston Community College System
Nuclear Medicine Technology Students, Houston, TX, July 1994.
45.
“Brain SPECT Scan: Current Applications and Future Perspectives”. Invited Speaker,
Neurology/Neurosurgery Grand Rounds, The University of Texas-Houston Medical
School, Houston, TX, August 1994.
46.
“Quantitative Brain SPECT in Cocaine Users and Semi-Quantitative in NonPsychiatric Syndromes”. Invited Speaker, Seminars in Nuclear Medicine, M.D.
Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX, October
1994.
47.
“Genito-Urinary System”. Invited Lecturer, Houston Community College System
Nuclear Medicine Technology Students, Houston, TX, July 1995.
48.
“Brain SPECT”. Invited Speaker, Seminars in Nuclear Medicine, M.D. Anderson
Cancer Center, Division of Diagnostic Imaging, Houston, TX, March 1996.
49.
“Report on SNM”. Invited Speaker, Seminars in Nuclear Medicine, M.D. Anderson
Cancer Center, Division of Diagnostic Imaging, Houston, TX, April 1996.
50.
“SNM Preview”. Invited Speaker, Seminars in Nuclear Medicine, M.D. Anderson
Cancer Center, Division of Diagnostic Imaging, Houston, TX, May 1996.
51.
“Nuclear Evaluation of Renal Transplant Complications”. Invited Speaker,
Association of Radiological Nurses, Veterans Administration Hospital, Houston, TX,
June 1996.
52.
“Research Statistics, Tests, Interpretation & Bayes’ Theorem”. Invited Speaker,
Seminars for Nuclear Medicine Summer Student Research Program, Department of
Radiology, University of Texas-Houston Medical School , Houston, TX, July 1996.
53.
“GI-Related Nuclear Medicine”. Invited Speaker, Baylor College of Medicine
Nuclear Medicine Residency Program, Baylor College of Medicine, Houston, TX,
October 1996.
54.
“RSNA Preview”. Invited Lecturer, M.D. Anderson Cancer Center Seminars in
Nuclear Medicine, October 1996.
55.
“Brain SPECT in the Clinical Setting”. Invited Speaker, Seminars in Nuclear
Medicine, M.D. Anderson Cancer Center, Houston, TX, March 1997.
“Role of Nuclear Imaging in Thyroid Cancer”. Invited Speaker, Oncology Combined
Modality Physicians, Nurses and Associates, UTMS, Houston, TX, April 1997.
56.
57.
“Brain SPECT in Clinical Neurology”. Invited Speaker, Neurology Grand Rounds,
Baylor College of Medicine, Houston, TX, May 1997.
58.
”Genitourinary System and Testicular Studies”. Invited Speaker, Three Invited
Lectures to Nuclear Medicine Technology Students, Houston Community College,
June 1997.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 100
59.
“Research Statistics, Tests, Interpretation & Bayes’ Theorem”. Invited Speaker,
Seminars for Nuclear Medicine Summer Student Research Program, Department of
Radiology, University of Texas-Houston Medical School, Houston, TX, July 1997.
60.
"Brain SPECT in Psychiatric Disorders - Clinical and Experimental". Invited Speaker,
Department of Psychiatry and Behavioral Sciences Lecture Series, Mental Sciences
Institute, the University of Texas Health Science Center, Houston, TX, January 1998.
61.
“Report on SWSNM”. Invited Speaker, Seminars in Nuclear Medicine, M.D.
Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX, April 1998.
62.
”Genitourinary System and Testicular Studies”. Invited Speaker, Three Invited
Lectures to Nuclear Medicine Technology Students, Houston Community College,
June 1998.
63.
"Leukoscintigraphy Clinical Trials for Acute Non-Classic Appendicitis". Invited
Speaker, Fourth Radiology Research Symposium, Department of Radiology, The
University of Texas-Houston Medical School, Houston, TX, November 1998.
64.
“Report on SWSNM”. Invited Speaker, Seminars in Nuclear Medicine, M.D.
Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX, April 1999.
65.
“Genitourinary System and Testicular Studies”. Invited Lecture to Technology
Students, Houston Community College, July 1999.
66.
Advances in Medical Imaging for the Referring Physician. The University of TexasHouston Medical School. May, 2000.
67.
Brain Death – Cerebral Blood Flow. LifeGift Organ Donation Center. Houston,
Texas May, 2000
68.
“Genitourinary System and Testicular Studies”. Invited Lecture to Technology
Students, Houston, Community College, July 2000.
69.
"Prospects for Student Research in Imaging Sciences at UT-Houston": Lecture to
Medical School Applicants of UTHSC, Houston, Texas October, 2000.
70.
“Infection Imaging Using Monoclonal Antibodies”. Nuclear Medicine Technologist
of Houston Fall Symposium 2000, given at St. Joseph’s Hospital, Houston, Texas
October, 2000.
“Introduction to Nuclear Medicine”. Future Radiologists of America, Houston,
Texas, November, 2000.
71.
72.
“PET Lecture”: Northwest Cancer Center, Houston, Texas, May, 2001.
73.
Recent Advances in GI Medicine: Baylor College of Medicine, December, 2001
74.
“PET In Oncology”. Houston Medical Imaging Course, Houston, Texas, March 9,
2002.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 101
75.
Nuclear Medicine in Endocrinology II: Baylor College of Medicine April, 2002.
76.
“Applications for PET in Management of the Cancer Patient”. Southwest Chapter of
the American Association of Physicists in Medicine. Dallas, Texas, April 26, 2002.
77.
UTMS-Houston – Department of Psychiatry Grand Rounds. March 10, 2004.
78.
"Diagnostic Techniques in Rich and Poor Nations". Sultan Qaboos University,
College of Medicine & Health Sciences - Interdisciplinary Activity Week: Medicine,
Ethics and Society - Muscat, Sultanate of Oman. January 29, 2006.
79.
"Role of Peer Review in Improving Service Safety". The Second Symposium on
Patient Safety Quality Management Department - SQUH, Muscat, Sultanate of
Oman, 21 January 2007.
80.
"Diagnostic Imaging: Functional Imaging". Oman Medical Specialty Board Core
Programme in Basic Medical Sciences, Medical Lecture Theater, College of
Medicine and Health Sciences, SQUH, Muscat, Sultanate of Oman, 22 January 2007.
81.
"Experiences of an Editor and Reviewer". Workshop on Publishing Scientific
Papers, College of Agriculture and Marine Sciences Conference Room, SQU Muscat
Sultanate of Oman, 15 May 2007.
82.
"Law on Patient Safety". First International Conference of Quality Management in
Health Care. SQUH, Muscat, Sultanate of Oman, 22 January 2008.
83.
"The Perspective of an Editor / Reviewer". Paper Writing Workshop. College of
Agriculture and Marine Sciences Conference Room, SQU, Muscat, Sultante of
Oman. 16 and 23 November 2008.
84.
"Peer Review". Nurse's Talk. SQUH Radiology Seminar Room, SQUH, Muscat,
Sultanate of Oman. 20 December 2008.
85.
"Peer Review". Surgery Talk. SQUH, Muscat, Sultanate of Oman. 27 December
2008.
86.
"How to Write a Successful Grant Application". Post Graduate Studies. SQUH,
Muscat, Sultanate of Oman. 25 January 2009.
87.
"How to Write a Manuscript for Publication". Post Graduate Studies. SQUH,
Muscat, Sultanate of Oman. 25 January 2009.
88.
89.
90.
"How to Write a Research Manuscript". Plenary Session. Basic Clinical Research
Design and Health Informatics Workshop. Lecture Theater I. SQU, Muscat,
Sultanate of Oman, 10 January 2009.
"How to Write a Successful Grant Application". Post-Graduate Studies. SQU
College of Medicine. SQU, Muscat, Sultanate of Oman. 25 January 2009.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 102
91.
"How to Write a Manuscript for Publication". Post-Graduate Studies. SQU College
of Medicine. SQU, Muscat, Sultanate of Oman. 25 January 2009.
92.
Peer Review (Clinical Physiology). CPH Seminar Room. Sultan Qaboos University
Hospital, Muscat, Sultanate of Oman. 10 February 2009.
93.
"How to write a Manuscript: Perspective of a Reviewer and an Editor". PostGraduate Studies. SQU College of Nursing. SQU, Muscat, Sultanate of Oman. 11
February 2009.
94.
"How to Write a Manuscript and Publication Ethics". OMSB Radiology Residency
Lecture with Dr. Albert Driedger. Radiology Dept. Seminar Room, SQUH, Muscat,
Sultanate of Oman. 22 February 2009.
95.
"Peer Review and Medical Audit". OMSB Radiology Residency Lecture with Dr.
Albert Driedger. Radiology Dept. Seminar Room, SQUH, Muscat, Sultanate of
Oman. 22 February 2009.
96.
PEER REVIEW (Obstetrics & Gynecology). 2 Red Seminar Room. Sultan Qaboos
University Hospital, Muscat, Sultanate of Oman. 23 February 2009.
97.
PEER REVIEW (FAMCO). FAMCO Seminar Room. Sultan Qaboos University
Hospital, Muscat, Sultanate of Oman. 24 February 2009.
98.
PEER REVIEW (Hematology). 3 Purple Seminar Room. Sultan Qaboos University
Hospital, Muscat, Sultanate of Oman. 04 March 2009.
99.
PEER REVIEW (Ophthalmology). 4 Blue Seminar Room. Sultan Qaboos
University Hospital, Muscat, Sultanate of Oman. 14 March 2009.
100.
"Services offered by the Department of Nuclear Medicine of the Sultan Qaboos
University Hospital (SQUH)". Workshop on Nuclear Techniques in Human Health.
Ministry of Foreign Affairs, Office of Peaceful Nuclear Technology. Al Bustan
Hotel, Muscat, Oman. 16 March 2009.
101.
"Quality Assurance and Patient Safety". Management Workshop 2009. Royal
Hospital, Muscat, Oman. 22 March 2009.
102.
"PEER REVIEW" for Internal Medicine. 3 Red Seminar Room. Sultan Qaboos
University Hospital, Muscat, Sultanate of Oman. 22 April 2009.
103.
"PEER REVIEW" for Pharmacists. Pharmacy Meeting Room, SQUH, Al Khoud,
Sultanate of Oman. 04 May 2009.
"PEER REVIEW" for Biochemistry, Pathology & Microbiology Faculty Staff.
Radiology Seminar Room, SQUH, Al Khoud, Sultanate of Oman. 06 May 2009.
104.
105.
"PEER REVIEW" for Accident and Emergency faculty Staff. Radiology Seminar
Room, SQUH, Muscat Sultanate of Oman. 16 May 2009.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 103
106.
"PEER REVIEW" (Pharmacy). Pharmacy Meeting Room, SQUH, Sultanate of
Oman. 16 May 2009.
107.
"How to write a Manuscript: Perspective of a Reviewer and an Editor." Paper
Writing Workshop organized by Dean of Post Graduate Studies, at the College of
Agriculture, SQU, Sultanate of Oman. 20 May 2009.
108.
What does it mean to be a Doctor? & Medical Profession – Commitment,
Confidentiality, & Various Issues. "Medical Ethics" Pep-talk with 5th year Medical
Students. College of Medicine and Health Sciences, SQU Medical Lecture Theater,
Sultanate of Oman. 17 August 2009.
109.
"How to write a Manuscript: Perspective of a Reviewer and an Editor." Paper
Writing Workshop. College of Post Graduate Studies, SQU, Muscat, Sultanate of
Oman. 07 October 2009.
110.
"PEER REVIEW." College of Nursing, SQU, Muscat, Sultanate of Oman. 07
October 2009.
111.
"Continuous Quality Assurance." Quality Improvement Seminar – Invited talk to
Royal Hospital Staff. Muscat, Sultanate of Oman. 13 October 2009.
112.
"Plagiarism and Recommendations." College of Nursing, SQU, Muscat, Sultanate of
Oman. 14 October 2009.
113.
"How to write a Manuscript: Perspective of a Reviewer and an Editor." Paper
Writing Workshop, conducted by College of Post Graduate Studies. College of
Agriculture and Marine Sciences Conference Room, SQU, Muscat, Sultanate of
Oman. 18 November 2009.
114.
"Ethics of Publishing a Scientific Paper", Interdisciplinary Week – Medical Students,
SQU, Muscat, Sultanate of Oman. 07 February 2010.
115.
"How to write a Manuscript: Perspective of a Reviewer and an Editor." Paper
Writing Workshop, conducted by Deanship of Post Graduate Studies and Research.
College of Agriculture and Marine Sciences Conference Room, SQU, Muscat,
Sultanate of Oman. 17 February 2010.
116.
“Myocardial Viability Studies: Caveats”. 9th Gulf Heart Association. Muscat, Oman.
13-14 April 2011.
117.
“Peer Review for Healthcare Institutions.” 3rd International Conference of Quality
Management in Healthcare. Muscat, Oman. 6-8 February 2012.
118.
“Medical Ethics in Clinical Research.” Training Workshop on Building Research
Capabilities Part I. MOH, Muscat, Oman. Muscat, Oman. 3-4 March 2012.
119.
“Medical Ethics in Clinical Research.” Training Workshop on Building Research
Capabilities Part II. MOH, Muscat, Oman. Muscat, Oman. 5-6 March 2012.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 104
120.
“How To Write A Scientific Manuscript”. Oman Nursing Institute. Ministry of
Health, Muscat, Oman. 22 October 2013.
E.4
LETTERS to the Editor:
1.
Lamki L: Hyperparathyroidism Nomenclature. Lancet 1:888 (L), 1969.
2.
Lamki, L, Schearer R: Tc-99m DMSA Uptake by Metastatic Carcinoma of the
Prostate. J Nucl Med 25(6):733-734, 1984.
3.
Lamki, L: Technetium-99m DMSA Uptake by Metastatic Carcinoma of the Prostate:
Reply. J Nucl Med 27:1224, 1986.
4.
Lamki, L: Neuroimaging of Juvenile Pilocytic Astrocytomas (letter; comment).
Radiology 191(1):288, 1994.
E.5
Special MEDIA COVERAGE:
1.
International, National, and Local press and Television Coverage for our work on
Attention Deficit Hyperactive Disorder presented at the Radiological Society of
North America, November 1996. Over 100 “spots”, including major TV Network
news, ABC Good Morning America, CNN Headline News, FOX, and many more; as
well as News Now, Chicago Tribune, USA Today, TIME Magazine, and many
others.
2.
Lamki, L: Attention Deficit, SPECT is Studied for Resistant Kids (Jean McCann,
Editor). Synopsis published in Physicians Weekly XIV (2):1, 1997.
3.
Also Feature article on our work in Attention Deficit Disorder: “Health Notes:
Radiology Technique Improves Diagnosis, Drug Decisions for Attention Deficit
Disorder”. In: Lifetime Health Letter, The University of Texas-Houston Health
Science Newsletter, Vol. 9, No. 3, March 1997, p. 2.
4.
“Lamki, L.: Focuses on ADD”. In: Uthouston, University of Texas Health Science
Center, March 1997, pp. 2-3.
5.
Cover: “New Hope for the Brain and the Mind: Dr. Lamk Lamki finds brain signature
for Attention Deficit Disorder”, Uthouston, University of Texas Health Science
Center, March 1997.
6.
Feature article on Dr. Lamki and work in ADHD: “Scintillation sheds light on
psychiatric disorders”. In: Biophotonics International, Laurin Publishing Co., Inc.,
Pittsfield, MA. 4(3):54-55, May/June 1997.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 105
7.
Feature article in ADVANCE for Administrators in Radiology. Jalali L: Target:
SPEC--SPECT Aids in Diagnosis for Children with Behavior Problems.
ADVANCE, 150-152, November 1997.
E.6
CONFERENCE Facilitator:
1.
Moderator, Renal Nuclear Medicine Session: "Nuclear Medicine, Renal Miscellaneous", XVIth International Congress of Radiology, Honolulu, Hawaii, July
1985.
2.
Moderator, Oncology Session: “Monoclonal Antibody Therapy”, Society of Nuclear
Medicine Annual Meeting, San Francisco, CA, 1988.
3.
Moderator, Oncology/Hematology Session: “Monoclonal Antibodies Therapy”,
Society of Nuclear Medicine Annual Meeting, St. Louis, MO, June 15, 1989.
4.
Moderator, Scientific Session III, Society of Nuclear Medicine/Southwestern Chapter
Annual Meeting, Houston, TX, April, 1990.
5.
Moderator, Scientific Session: ”Monoclonal Antibodies”, Society of Nuclear
Medicine/ Southwestern Chapter Annual Meeting, Oklahoma City, OK, April 1991.
6.
Moderator, Scientific Session: “Immunology II”, Society of Nuclear Medicine
Annual Meeting, Cincinnati, OH, June 12, 1991.
7.
Moderator, Immunology, Scientific Session: “Radioimmuno-Diagnosis II”, Society
of Nuclear Medicine Annual Meeting, Los Angeles, CA, June 11, 1992.
8.
Co-Moderator for Scientific Paper Session: “Oncology/Antibody II: GI/GYN Cancer
Imaging”, Society of Nuclear Medicine Annual Meeting, Toronto, Ontario, Canada,
June 1993.
9.
Moderator, Scientific Paper Session “Oncology Diagnosis/Antibody II”, Society of
Nuclear Medicine Annual Meeting, Orlando, FL, June 1994.
10.
Presiding Officer (Moderator), Scientific Session: "Nuclear Medicine (Cardiac)”,
Radiological Society of North America 81st Scientific Assembly and Annual
Meeting, Chicago, IL, November 1995.
11.
Moderator, Scientific Session: “Mini-Symposium on the New Role of Functional
Imaging in Oncology”, Society of Nuclear Medicine/Southwestern Chapter Annual
Meeting, Austin, TX, March 1996.
12.
Moderator, Session, “SPECT Data Management and Semi-Quantitative Methods of
Analysis”, SPECT Safe Thrombolysis Study (SSTS), Steering and Advisory
Committee Meeting/Amersham Healthcare, Houston, TX, July 1996.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 106
13.
Presiding Officer (Moderator), Scientific Session: “Nuclear Medicine (Neoplasm,
Miscellaneous)”, Radiological Society of North America 82nd Scientific Assembly
and Annual Meeting, Chicago, IL, December 1996.
14.
Moderator, Scientific Papers Session, Southwestern Chapter Society of Nuclear
Medicine 42nd Annual Meeting & Cardiac Nuclear Medicine Symposium, New
Orleans, LA, April 1997.
15.
Presiding Officer, Scientific Session: “Nuclear Medicine (Central Nervous System)
Session”, Radiological Society of North America 83rd Scientific Assembly and
Annual Meeting, Chicago, IL, December 1997.
16.
Advisor, Organizing Committee, 'Clinical Radiology' Workshop, the 4th Scientific
Conference for Medical Students held Jan. 21-24, 2006 (2005 – 2006)
17.
Chairman, Morning Session, - "Going Digital Radiography' Seminar, Sultan Qaboos
Univeristy Hospital, Muscat, Oman. 25 May 2006
18.
Chairman, "Nuclear Cardiology Day", 2nd Gulf Nuclear Medicine Conference, Dubai
UAE. 09 Nov. 2006
19.
Chairman "Introduction to Medical Errors” Session of the Second Symposium on
Patient Safety, Sultan Qaboos University Muscat, Sultanate of Oman. 21 Jan. 2007
20.
Moderator, Session 5: "Accreditation in Health Care", First International Conference
of Quality Management in Health Care. Conference Hall, Sultan Qaboos University,
21 January 2008.
21.
Chairman, Organizing Committee. First International Radiology Conferences,
Radiology Conferences Oman. "MRI 2008: State-of-the-Art". Conference Hall,
Sultan Qaboos University. February 20-22, 2008.
22.
Chairman, Evidence-Based Medicine in Alternative Medicine. Seminar on EvidenceBased Complimentary and Alternative Medicine. Indian Embassy Auditorium,
Diplomatic Area, Al Khuwair, Sultanate of Oman. 16 November 2008.
23.
Chairman, Morning-Session. 4th Patient Safety Symposium. SQU Conference Hall.
Muscat, Sultanate of Oman. 02-04 February 2009.
24.
Chairman, Morning-Session, National Symposium on Radiation Protection for
Radiation Protection Supervisers and Officers, IHS Auditorium, Wattayah, Sultanate
of Oman. 05 March 2009.
25.
Moderator - Session 7, Total Quality Management (TQM). 2nd International
Conference of Quality Management in Health Care. SQU Conference Hall, Muscat,
Sultanate of Oman. 03 February 2010.
26.
Chairman – Session 5, Risk Management Safety Measures. 3rd International
Conference of Quality Management in Healthcare. SQU Conference Hall, Muscat,
Sultanate of Oman, 07 February 2012.
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 107
27.
Moderator, Session 7, Concepts Principles and Studies of Patient Safety Economics.
Second GCC International Conference on Patient Safety. SQU Conference Hall,
Muscat, Sultanate of Oman, 20-23 January 2013.
E.7.
RECENT CONFERENCES Participated:
1.
Management Development. Sultan Qaboos University, Muscat, Sultanate of Oman.
04 – 08 March 2006.
2.
American College of Nuclear Medicine Annual Conference. San Antonio, Texas. 31
March - 02 April 2006.
3.
Annual Conference of Association of University Radiologists. USA. 04 - 08 April
2006.
4.
3rd Annual Radiological Society of Saudi Arabia Conference. Jeddah, Saudi Arabia.
09-12 April 2007.
5.
Arab Board Meeting for Radiology (Oman Representative). Damascus, Syria. 17 May
2007.
6.
Strategic Planning Workshop of OMSB. Grand Hyatt Hotel, Muscat, Sultanate of
Oman. 11-13 February 2008.
7.
Magnetic Resonance Imaging 2008: State-of-the-Art. SQU Conference Hall, SQU,
Muscat, Sultanate of Oman. 18 – 21 February 2008.
8.
4th Regional Conference in Medical Journal in the Eastern Mediterranean Region.
Theme: Research and Publication are cornerstones of Health Care Development in
the Eastern Mediterranean Region. Manama, Bahrain 05-07 November 2008.
9.
Fifth Regional Workshop on Evidence Based Medicine. Sultan Qaboos University
Conference Hall, Muscat, Sultanate of Oman. 12-14 January 2009.
10.
National Association of Quality Assurance and Accreditation of Egypt (NAQAAE) &
World Federation of Medical Education (WFME) Conference. Cairo, Egypt. 07 – 09
December 2009.
11.
Workshop on Safety in the Sultanate – Traffic Safety Workshop. Traffic Safety
Institute, Seeb, Sultanate of Oman. 29 – 30 December 2009.
12.
International Medical Educators Leaders Forum; by Royal College of Canada.
Victoria, British Columbia, Canada,Sept. 23, 2009
13.
International Conference on Residency Education; by Royal College of Canada.
Victoria, British Columbia, Canada, Sept. 24-26, 2009
LAMK M. LAMKI, M.D., FRCPC, FACR
CURRICULUM VITAE, Page 108
14.
Controversies in Breast Cancer Conference, Al Bustan Palace Hotel. Muscat, Oman,
12-13 February 2011
15.
Quality Management and Enhancement in Higher Education, Muscat, Oman. 20-21
February 2012
E.8.
Administrative Courses Attended:
1.
Management Development - Institute of International Research.
04-08 March 2006
E.9.
CONSULTANCY Services:
1.
OMSB Delegation Visit to India. Oman Medical Specialty Board. 16 – 24 August
2008.
2.
Travelled with the Vice Chancellor on a Canadian Tour consulting on Memorundum
on Understanding with some Canadian Universities, 2008
3.
Advisor, AFH Committee on Promotions of Faculty. Armed Forces Hospital,
Muscat, Oman. 2009 – 2010.
4.
Ministry of Higher Education Committee to review Private Higher Education
Institutions - chairman of subcommittee that reviewed “Oman Medical College”,
2009. Produced a Technical Report to H.E. the Minister of Higher Education.
5.
Ministry of Higher Education Committee to review Private Higher Education
Institutions - chairman of subcommittee that reviewed “Institute of Health Science –
Radiography BSc. Program”, 2011. Produced a Technical Report to H.E. the Minister
of Higher Education.